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Résumé 
 
Les systèmes cholinergique et dopaminergique jouent un rôle 
prépondérant dans les fonctions cognitives. Ce rôle est exercé principalement 
grâce à leur action modulatrice de l‟activité des neurones pyramidaux du cortex 
préfrontal. L‟interaction pharmacologique entre ces systèmes est bien 
documentée mais les études de leurs interactions neuroanatomiques sont 
rares, étant donné qu‟ils sont impliqués dans une transmission diffuse plutôt 
que synaptique.  Ce travail de thèse visait à développer une expertise pour 
analyser ce type de transmission diffuse en microscopie confocale.  
 
Nous avons étudié les relations de microproximité entre ces différents 
systèmes dans le cortex préfrontal médian (mPFC) de rats et souris. En 
particulier, la densité des varicosités axonales en passant a été quantifiée dans 
les segments des fibres cholinergiques et dopaminergiques à une distance 
mutuelle de moins de 3 µm ou à moins de 3 µm des somas de cellules 
pyramidales. Cette microproximité était considérée comme une zone 
d‟interaction probable entre les éléments neuronaux. La quantification était 
effectuée après triple-marquage par immunofluorescence et acquisition des 
images de 1 µm par microscopie confocale. Afin d‟étudier la plasticité de ces 
relations de microproximité, cette analyse a été effectuée dans des conditions 
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témoins, après une activation du mPFC et dans un modèle de schizophrénie 
par déplétion des neurones cholinergiques du noyau accumbens.  
 
Les résultats démontrent que  
1. Les fibres cholinergiques interagissent avec des fibres 
dopaminergiques et ce sur les mêmes neurones pyramidaux de la couche V du 
mPFC. Ce résultat suggère différents apports des systèmes cholinergique et 
dopaminergique dans l‟intégration effectuée par une même cellule pyramidale.  
 
2. La densité des varicosités en passant cholinergiques et 
dopaminergiques sur des segments de fibre en microproximité réciproque est 
plus élevée comparé aux segments plus distants les uns des autres. Ce 
résultat suggère un enrichissement du nombre de varicosités axonales  dans 
les zones d‟interaction. 
 
3. La densité des varicosités en passant sur des segments de fibre 
cholinergique en microproximité de cellules pyramidales, immunoúactives pour 
c-Fos après une stimulation visuelle et une stimulation électrique des noyaux 
cholinergiques projetant au mPFC est plus élevée que la densité des 
varicosités de segments en microproximité de cellules pyramidales non-
activées. Ce résultat suggère un enrichissement des varicosités axonales 
dépendant de l‟activité neuronale locale au niveau de la zone d'interaction avec 
d'autres éléments neuronaux. 
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4. La densité des varicosités en passant des fibres dopaminergiques a 
été significativement diminuée dans le mPFC de rats ayant subi une déplétion 
cholinergique dans le noyau accumbens, comparée aux témoins. Ces résultats 
supportent des interrelations entre la plasticité structurelle des varicosités 
dopaminergiques et le fonctionnement cortical. 
 
L‟ensemble des donneès démontre une plasticité de la densité locale 
des varicosités axonales en fonction de l‟activité neuronale locale. Cet 
enrichissement activité-dépendant contribue vraisemblablement au maintien 
d‟une interaction neurochimique entre deux éléments neuronaux. 
 
 
Mots-clés : acétylcholine, cognition, cortex préfrontal médian, dopamine, 
glutamate, morphométrie, neurones pyramidaux, transmission diffuse, 
varicosités axonales, schizophrénie. 
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 Abstract 
 
The cognitive functions of the rat medial prefrontal cortex (mPFC) are 
modulated by ascending modulatory systems such as the cholinergic and 
dopaminergic afferent systems. However, despite the well-documented 
pharmacological interactions between the cholinergic and dopaminergic 
afferents and pyramidal cells in the PFC, there is only scarce neuroanatomical 
data on the reciprocal interrelationships between these neuronal elements in 
the mPFC. This might be due to the diffuse rather than synaptic transmission 
mode of intercellular communication of the cholinergic system in the mPFC. For 
these reasons, the neuroanatomical relationships between the cholinergic and 
dopaminergic systems and pyramidal cells in the mPFC are examined, with an 
emphasis on the local density of the cholinergic and dopaminergic axon 
varicosities. To analyze the plasticity of these interrelationships, the two 
systems were examined in condition of increased neuronal activity in the 
mPFC, or of decrease dopaminergic activity in a model of schizophrenia. 
 
The microproximity relationships between cholinergic and dopaminergic 
fibers as well as with pyramidal cells were studied in the mPFC of rats and 
mice. In particular, the number of axon varicosities in cholinergic and 
dopaminergic fiber segments within 3 µm from each other or from pyramidal 
cells were quantified. This microproximity was considered as a possible 
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interaction zone between two neuronal elements. Quantification was performed 
using triple immunofluorescence labeling and acquisition of 1 µm optic sections 
using confocal microscopy. To assess the plasticity of these relationships, the 
analysis has been performed in control condition as well as after a cortical 
activation or a decreased dopaminergic input in a schizophrenia model. 
 
Our results demonstrate a neuroanatomical convergence of cholinergic 
and dopaminergic fibers on the same pyramidal cell from layer V (output) of 
mPFC, suggestinggests the integration of different types of inputs by the same 
pyramidal cell, which may be transmitted to subcortical areas to execute 
prefrontal cognitive control.  Close apposition between cholinergic and 
dopaminergic fibers could also be seen in the mPFC.  
 
There was an increase of the density of cholinergic and dopaminergic en 
passant varicosities on those fiber segments within microproximity of each 
other, compared to those outside the reciprocal microproximity, supporting 
functional importance of the close apposition between those two ascending 
neuromodulatory systems into the mPFC.  
 
There was enrichment of cholinergic en passant varicosities on the fiber 
segments within microproximity of c-Fos activated pyramidal cells in the mPFC 
of visually and HDB electrically stimulated rats, indicating association between 
axonal varicosity density and the local neuronal activity.  
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There was decrease of dopaminergic en passant varicosities in the 
mPFC of rats with ChAT depletion in the N.Acc., compared to controls. This 
evidence supports the association between dopaminergic axonal varicosities 
and relevant neuronal activity in a complex neuronal network. 
 
This thesis shows that the density of cholinergic and dopaminergic 
axonal varicosity density in the mPFC is influenced by and contributes to the 
relevant local neuronal activity from the interactions of different transmitter 
systems. Such interactions of different systems in a complex and intricate 
prefrontal neuronal network endeavour to maintain the delicate balance for 
cognitive processes.  
 
Keywords: acetylcholine, axon varicosity, cognition, diffuse transmission, 
dopamine, glutamate, pyramidal cells, medial prefrontal cortex, morphometry, 
schizophrenia. 
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General Introduction 
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The central nervous system (CNS) is a global network wherein the dynamic 
influences of a variety of neuromodulators on afferent input versus intrinsic input 
depend on broad and diffuse transmission, which enables the “entire provinces of 
the CNS” to be in the appropriate functional setting and to work as a unit (Agnati et 
al., 1995; Descarries et al., 1997; Giocomo and Hasselmo, 2007; Lendvai and Vizi, 
2008). 
 
I.1 Introduction to the cerebral cortex 
 
I.1.1 Functional and anatomic organization of the cerebral cortex 
 
The grey matter covering the cerebral hemispheres is the cerebral cortex   
(Ellis and Keswick, 2011), Figure I.1), which is divided in four anatomically distinct 
lobes: frontal, parietal, temporal, and occipital (Kandel et al., 2000). A great 
number of cortical areas have been defined in relation to their functional 
specialization, from primary sensory areas, to association and motor cortex. The 
cerebral cortex is primarily responsible for cognitive abilities, integrating information 
from a diverse range of sources  by processing bottom-up sensory signals of 
relevant behavioral significance, top-down feedback carrying goal-related 
information, as well as intrinsic horizontal signals carrying contextual information 
(Miller and Cohen, 2001, Raizada and Grossberg, 2003). Cortical areas are richly 
interconnected with each other and with subcortical structures, and many mental 
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functions are processed by the serial and parallel interlinking of several cortical 
regions and neuronal pathways (Shipp, 2007). 
 
Figure I.1.  
 
 
Figure I.1. Representation of the frontal, parietal, temporal, and the occipital lobe of 
the brain. The cerebral cortex covers the surface of the cerebral hemispheres. 
Figure from http://www.stockmedicalart.com/medicalartlibrary/brain-lobes.html 
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The cerebral cortex is organized in functional layers. In general the neocortex has 
a six-layered structure, although some cortical structures such as the hippocampus 
have fewer than six layers (Raizada and Grossberg, 2003). The uniformity of this 
layered pattern suggests cortex‟s basic “housekeeping” operations that generalize 
across diverse cortical functions (Shipp, 2007). Generally, neurons in layers II and 
III tend to form corticocortical connections, those in layers V and VI project to 
subcortical areas, and those in layers I and IV extend axons locally within the 
cortex. Different layers have distinctive densities and morphologies of their 
constituent neurons (Leone et al., 2008). Moreover, different cortical projection 
systems also demonstrate specific laminar distributions of efferent terminations 
and their neurons of origin.  For example, a study of the occipital lobe from the 
rhesus monkey demonstrates that, rostrally directed cortical connections originate 
from neurons in layer IIIc and terminate in layer IV, whereas caudally directed 
connections originate in layers Vb, VI and IIIa, and terminate in layer I (Rockland 
and Pandya, 1979). The laminar fate of a neuron is under the control of specific 
genetic and molecular mechanisms (Yamamori and Rockland, 2006; Leone et al., 
2008). 
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 I.1.2 Nerve cells – basic units of the cerebral cortex 
 
The basic units of the brain are individual nerve cells. Four morphologically 
defined structures in a typical neuron are the cell body, dendrites, the axon, and 
axon terminals. The cell body or soma surrounds the nucleus, the dendrites are the 
main target of incoming signals from other nerve cells, whereas the axon carries 
signals to other neurons by projecting to target cells and the nerve terminals 
release neurotransmitters (Kandel et al., 2000, Cooper et al., 2003). Axo-axonal 
and axo-somatic relationship has also been evidenced.  There is a large variety of 
neurons in the cortex with different physiological properties but two maincortical 
types are classified: interneurons with short axons to process information within 
local circuits, and projection neurons (pyramidal neurons) with long axons to carry 
signals from one brain region to another over long distances (Rockland, 1998, 
Kandel et al., 2000). The interneurons are mostly GABAergic and inhibitory, 
although spiny stellate cells of layer IV and local pyramidal neurons of layer II-III 
are glutamatergic. The pyramidal cells are glutamatergic and excitatory. 
 
 
The neurons communicate together through synaptic transmission and diffuse 
transmission. Synapses are specialized zones of  communication between neurons 
(Cooper et al., 2003). The presynaptic cell and the postsynaptic cell are separated 
by the synaptic cleft. When an action potential reaches a neuron‟s terminal it 
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stimulates the release of transmitters, which diffuse across the synaptic cleft and 
bind  to receptors in the membrane of the postsynaptic neurons to influence the 
neuronal activity (Kandel et al., 2000). This synaptic transmission has been 
extensively described, However, in the past decades, the existence of nonsynaptic 
interactions or diffuse transmission has also been recognized, whereby the 
transmitters are released from axon terminals without synaptic contacts, diffuse 
and stimulate extrasynaptically located receptors to influence the activity of other 
neurons in their microenvironment (Agnati et al., 1995, Descarries et al., 1997, 
Lendvai and Vizi, 2008).  
 
I.1.3 Major neurotransmitter systems in the cortex  
 
The complex and subtle control of the state of the nervous system is 
executed by a wide variety of transmitter systems abundantly distributed in the 
cortex with region-specific and layer-specific patterns (Eickhoff et al., 2007). 
Glutamatergic and GABAergic (ץ-aminobutyric acid) neurons are among the major 
cortical neurons (DeFelipe et al., 2002). Transmitters that are more prolonged in 
duration are typically involved in the control of the state of the executive networks 
such as arousal and attention, including acetylcholine, norepinephrine, serotonin, 
dopamine, histamine, adenosine, and probably numerous other agents 
(McCormick, 1992, Briand et al., 2007). A single neurotransmitter may produce a 
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diverse range of postsynaptic responses via coupling of different subtypes of 
receptors to different second messenger systems. (McCormick, 1992).  
 
I.2 The rat medial prefrontal cortex 
 
I.2.1 Neuroanatomy of the medial prefrontal cortex 
 
Located over the medial, orbital, and insular surfaces of the rostral cerebral 
hemispheres, the prefrontal cortex (PFC) consists of the medial prefrontal cortex 
(mPFC), the orbital prefrontal cortex, and the lateral or sulcal prefrontal cortex 
(Heidbreder and Groenewegen, 2003), which process specific aspects of cognitive 
processing including working memory, behavioral inhibition, attentional processing, 
and organization, planning and flexibility of behavior (Uylings et al., 2003, Dalley et 
al., 2004a, Gabbott et al., 2005, Briand et al., 2007). The rodent cortex serves as a 
good model for analyzing prefrontal functions (Uylings et al., 2003). The 
connectivity between the PFC with virtually all sensory neocortical regions, motor 
regions, and subcortical structures (Groenewegen and Uylings, 2000) enables its 
“top-down” processing of behaviorally relevant sensory stimuli. 
 
The rat medial prefrontal cortex (mPFC) has four main subdivisions: the 
medial precentral, the anterior cingulate (Cg1), the prelimbic (PrL) and the 
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infralimbic (IL) areas (Vertes, 2004, Tavares and Correa, 2006). In the rat, Cg1, 
PrL and IL are typical agranular cortical fields, that is, regions without a layer 4 
(Gabbott et al., 1997, Ding et al., 2001). The mPFC in rodents has been suggested 
to be functionally equivalent to the dorsolateral PFC in primates (Brown and 
Bowman, 2002, Uylings et al., 2003). Functional differentiation between the dorsal 
mPFC (Cg1 and the dorsal PrL) and ventral mPFC (IL and the ventral PrL) has 
been discussed, with the involvement of the dorsal mPFC in the temporal shifting 
of behavioral sequences, and the role of the ventral mPFC in a flexible shifting to 
new strategies related to spatial cues (Heidbreder and Groenewegen, 2003, 
Uylings et al., 2003).  
 
I.2.2 Involvement of the medial prefrontal cortex in a variety of 
cognitive functions 
 
The mPFC in rodents is involved in a variety of cognitive and emotional 
processes (Brown and Bowman, 2002, Heidbreder and Groenewegen, 2003), and 
has been implicated in many of the cognitive and behavioral disturbances 
associated with major neuropsychiatric disorders, such as ADHD and 
schizophrenia (Brown and Bowman, 2002, Dalley et al., 2004a). The dorsal mPFC 
is involved in the temporal patterning of behavioral sequences, whereas the ventral 
part the mPFC plays an important role in flexible shifting to new strategies, and the 
preparatory processes of reaction time performance (Heidbreder and 
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Groenewegen, 2003). Attentional selectivity in the visual domain resides mainly in 
Cg1 (Dalley et al., 2004b), and the rostral part of the Cg1 responds to electrical 
stimulation of the visual cortex (Golmayo et al., 2003). The Cg1 is also crucial in 
processing negative events such as errors and losses of reward, which is involved 
in initiating increases in attentional effort (Sarter et al., 2006). In contrast, infusions 
of scopolamine, a muscarinic antagonist, into the rat PrL/IL, results in significant 
impairments in a spatial working memory task (12-arm radial maze using 
recognition go/no-go procedure) (Ragozzino and Kesner, 1998). Local lesions of 
the rat PrL and IL by infusion of ibotenic acid result in selective impairments of 
extra-dimensional attentional set-shifting (Birrell and Brown, 2000). PrL neuronal 
activity is modulated by task variables during sustained attentional performance 
(Gill et al., 2000).  
 
I.2.3 Prefrontal glutamatergic output to the basal forebrain 
 
The PFC sends a glutamatergic output to the basal forebrain (BF), which 
modulate its activity (Zaborszky et al., 1997, Hur et al., 2009). Projections from the 
medial and ventral prefrontal areas give rise to dense arborizations in BF, 
particularly to horizontal limb nuclei of the diagonal band of Broca (HDB) and the 
region ventral to it (Zaborszky et al., 1997). Descending fibers from neocortical 
areas to BF are smooth and devoid of terminal varicosities, and contained 
glutamate immunoreactivity (Zaborszky et al., 1997). Many large Glutamate 
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Receptor subtype 1 (GluR1) - positive neuronal perikarya and aspiny dendrites are 
present within the medial septal nucleus, the nucleus of the diagonal band of 
Broca, and the nucleus basalis of Meynert, as shown in an immunocytochemistry 
study using antipeptide antibodies that recognized GluR subunit proteins in rat and 
monkey (Martin et al., 1993).   
 
I.3 Cholinergic system in the medial prefrontal cortex  
 
The cholinergic innervation of the cerebral cortex from the basal forebrain 
neurons has a strong modulatory role of the cortical activity. It is mostly involved in 
cognitive functions. 
 
I.3.1 Cholinergic projections 
 
Cholinergic neurons use acetylcholine (ACh) as their neurotransmitter. ACh 
is synthesized from choline in one single step, in which choline acetyltransferase 
(ChAT) mediates the transfer of an acetyl group from acetyl coenzyme A to choline 
(Sarter and Parikh, 2005), and then ACh is pumped into synaptic vesicles by the 
vesicular ACh transporter (VAChT) (Okuda and Haga, 2003). After ACh is 
released, it is rapidly metabolized into choline by acetylcholinesterase (AChE) 
(Nikonenko et al., 2003). ACh is the only classical neurotransmitter to be removed 
not by reuptake, but via fast hydrolysis by AChE (Silman and Sussman, 2005).   
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The Na+-dependent, high-affinity choline transporter in the plasma membrane 
takes up choline into the presynaptic terminals, which is subsequently used for 
ACh synthesis. Choline uptake is thought to be the rate limiting step in ACh 
synthesis (Okuda and Haga, 2003). Measuring ChAT activity is the most specific 
indicator for monitoring the functional state of cholinergic neurons in the CNS 
(Trachtenberg et al., 2002). ChAT is a specific marker of cholinergic cells and 
fibres and allows for a maximal immunocytochemical detection of cholinergic axons 
and varicosities in the rat neocortex (Umbriaco et al., 1994, Mechawar et al., 
2000).  
 
The main nuclei of cholinergic soma are located in the basal forebrain and 
the pons. They constitutes two major cholinergic projection systems in the rat 
central nervous system, (Everitt and Robbins, 1997) (Figure I.2). The basal 
forebrain (BF) within the medial septal nucleus (MS), vertical (VDB) and horizontal 
(HDB) limb nuclei of the diagonal band of Broca, and the nucleus basalis 
magnocellularis (nBM) send broad cholinergic projections throughout the cortex 
and hippocampus. Cholinergic neurons in the pedunculopontine tegmentum and 
the laterodorsal pontine tegmentum provide widespread projections mainly to the 
thalamus, midbrain and the brain stem (Everitt and Robbins, 1997, Dani, 2001).  
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Figure I.2 
 
 
 
Figure I.2. Distribution of central cholinergic neurons and their projections in 
the rat brain. (Woolf, 1991) Abbreviations: MS, medial septum; VDB, vertical limb 
nuclei of the diagonal band of Broca; HDB, horizontal limb nuclei of the diagonal 
band of Broca; nBM, nucleus basalis magnocellularis; tpp, pedunculopontine 
tegmental nucleus; dltn, laterodorsal tegmental nucleus; PFC, prefrontal cortex; 
ICj, islands of Calleja; SN, substantia nigra; IP, interpeduncular nucleus; DR, 
dorsal raphé; LC, locus ceruleus. 
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Cholinergic neurons are involved in a wide variety of cognitive functions 
including attention, learning, memory, arousal, sleep and movement, and their loss 
of functional deficit are associated with neurological disorders such as attention 
deficit hyperactivity disorder (ADHD), Alzheimer‟s disease and schizophrenia 
(Dunnett et al., 1991, Breese et al., 2000, Sarter and Bruno, 2000, Trachtenberg et 
al., 2002, Kozak et al., 2006, Zhang, 2006, Bellgrove and Mattingley, 2008, Jones, 
2008, Lester et al., 2010, Bohnen and Albin, 2011, Hasselmo and Sarter, 2011, 
Robinson et al., 2011, Wallace et al., 2011). 
 
I.3.2 Cholinergic receptors 
 
ACh released from the nerve terminals interacts with and activates the 
ionotropic nicotinic ACh receptors (nAChRs) or the metabotropic muscarinic ACh 
receptors (mAChRs) (Hasselmo and Sarter, 2011). Although being activated by the 
same ligand, ACh, nAChRs and mAChRs are members of two quite separate gene 
superfamilies (Hulme et al., 1990).  
 
Ionotropic nAChRs are pentameric acetylcholine-gated ion-channel 
receptors which are sensitive to nicotine and mediate fast excitatory synaptic 
transmission (Zhang, 2006, Albuquerque et al., 2009, Sydserff et al., 2009, 
Wallace et al., 2011). nAChRs are assembled from twelve subunits, α2-α10 and 
β2-β4, which combin to form homomeric or heteromeric nAChRs (Anderson et al., 
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2009). The heteromeric assembly of α 4β2 subunits (the high-affinity nicotine-
binding sites), and the homomeric assembly of α7 subunits (the majority of the a-
bungarotoxin binding sites) are the two major types of functional nAChRs within the 
brain (Dani, 2001, Couey et al., 2007, Albuquerque et al., 2009, Wallace et al., 
2011). nAChRs have predominantly modulatory functions in the brain (Livingstone 
et al., 2010). α4β2 neuronal nicotinic receptors are localized in the dopaminergic-
rich brain regions including cerebral cortex, hippocampus, ventral tegmentum and 
substantia nigra (Gotti et al., 2006), and can exist in high (nM) and low (µM) 
sensitivity states (Anderson et al., 2009, Wallace et al., 2011). α7 nAChRs are 
localized almost exclusively in the brain, with high calcium permeability and rapid 
desensitization  upon agonist binding (Wallace et al., 2011).  
 
In contrast, activation of mAChRs induces slower and more sustained 
response compared to nAChRs. M1-like (M1, M3, and M5) receptors are coupled to 
Gq proteins which lead to activation of a phospholipase, and M2-like (M2 and M4) 
receptors are coupled to Gi proteins which inhibits adenylate cyclase (Hulme et al., 
1990, Lester et al., 2010). All of the mAChR subtypes exist in the CNS, with M1 
mAChR as the predominant brain mAChR (Wallace et al., 2011). M1 and M3 
receptors are necessary for tonic cholinergic signaling (Gulledge et al., 2009). 
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I.3.3 Basal forebrain projection to the prefrontal cortex 
 
The BF is located close to the medial and ventral surfaces of the cerebral 
hemispheres (Zaborszky et al., 1997, Zaborszky et al., 1999). The BF areas 
include the MS, VDB, HDB, sublenticular substantia innominata and pallidal 
regions (Zaborszky and Duque, 2000). The substantia innominata (SI) was also 
known as the basal nucleus of Meynert (Heimer and Van Hoesen, 2006), and SI 
and the ventral pallidum (VP) are often referred to collectively as the magnocellular 
basal nucleus (MBN). The cholinergic nuclei are located in all of these BF areas 
(Eckenstein and Sofroniew, 1983, Luiten et al., 1987). 
 
The frontal cortex is the chief target of MBN and HDB projections (Luiten et 
al., 1987, Gaykema et al., 1990). The posterior MBN projects predominantly to 
lateral neo- and mesocortex,  the anterior MBN sends more fibers to the medial 
cortical regions, and the HDB projects almost exclusively to the medial mesocortex 
and provides rich projections to Cg1, PrL and IL (Figure I.3, (Luiten et al., 1987). 
The BF sends three virtually non-overlapping groups of glutamatergic, GABAergic 
and cholinergic varicose fiber systems into the PFC. In IL ~19% of BF terminals are 
cholinergic,  ~15% are glutamatergic, and ~52% are GABAergic (Henny and 
Jones, 2008).  In the BF, cholinergic and non-cholinergic projection neurons as 
well as interneurons are intermingled (Martin et al., 1993, Zaborszky and Duque, 
2000, Gritti et al., 2006). ץ- aminobutyric acid (GABA) – synthesizing cells in BF 
also send their projections to the cortex, as well as glutamatergic neurons (Gritti et 
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al., 2003, Henny and Jones, 2008).  The BF projection is the primary source of 
cortical ACh (Rye et al., 1984, Golmayo et al., 2003).Pyramidal neurons in layers 
III and V are preferentially innervated by those ascending axons (Briand et al., 
2007). 
 
Figure I.3 
 
Figure I.3. Major basal forebrain cortical projections. Projections from BF to the 
various neocortical areas in a dorsal view of the brain found in a study using the 
anterograde tracer Phaseolus vulgaris leucoagglutinin (PHA-L) (Luiten et al., 
1987). 
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Abbreviations: AC: anterior cingulate cortex; AI: agranular insular cortex: AO 
anterior olfactory nucleus; BL: basolateral amygdaloid nucleus; ENT: entorhinal 
cortex; L: lateral amygdaloid nucleus; HDB: horizontal limb nuclei of diagonal band 
of Broca; MBNa: magnocellular basal nucleus, anterior; MBNi:     magnocellular 
basal nucleus, anterior intermediate; MBNp: magnocellular basal nucleus, 
posterior; MS: medial septum; OC occipital cortex; PCI: lateral precentral cortex; 
PCm: medial precentral cortex; PIR: piriform cortex; PL: prelimbic cortex; PR: 
perirhinal cortex; PV: paraventricular hypothalamic nucleus; RS: retrosplenial 
cortex; SS1/SS: 2 somatosensory cortex 1 and 2; TE: temporal cortex; VDB: 
vertical limb nuclei of diagonal band of Broca; VTA: ventral tegmental area 
 
 
I.3.4 Basal forebrain cholinergic projections to the prefrontal 
cortex in cognitive functions 
 
The dense cholinergic projections from BF to the PFC have been implicated 
in a variety of behavioral functions, including attention, learning, , and cortical 
arousal (Everitt and Robbins, 1997, Golmayo et al., 2003, Sarter et al., 2003, 
Chudasama et al., 2004, Fournier et al., 2004, Gritti et al., 2006, Briand et al., 
2007, Hur et al., 2009).  It has been hypothesized that cholinergic inputs to PFC 
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mediate the „recruitment‟ of top-down attentional mechanisms underlying increased 
demands on attentional processes and capacities in challenging conditions (Gill et 
al., 2000, Sarter et al., 2005, Kozak et al., 2006), and hyperactive cortical 
cholinergic inputs mediate hyperattentional dysfunctions (Sarter and Bruno, 2000). 
The BF cortical cholinergic system is robustly activated in attentional performance, 
and cortical release of ACh increases selective sensory input processing (Golmayo 
et al., 2003, Sarter et al., 2005).The MBN and HDB cortical projections play an 
important role in attentional functions (Everitt and Robbins, 1997). In contrast, loss 
of cortical cholinergic inputs and changes in optimal levels of cortical ACh have 
detrimental effects on an animal‟s performance in attentional tasks (Zaborszky et 
al., 1999, Gill et al., 2000, Chudasama et al., 2004, Dalley et al., 2004b, Sarter et 
al., 2005, Kozak et al., 2006). Attentional dysfunction is the most consistent deficit 
following lesions of the BF-mPFC cholinergic system (Muir et al., 1994, Voytko et 
al., 1994). The BF cholinergic projection to the cortex is also involved in learning-
induced synaptic plasticity in the cortex (Zaborszky et al., 1999, Zaborszky and 
Duque, 2000). Schizophrenics who smoke demonstrate an overall reduction in the 
normal up-regulation of high affinity neuronal nicotinic receptors in most brain 
regions, including the cortex, compared to control smokers (Breese et al., 2000). 
Particularly, the α7 nAChR is profoundly impaired in patients with schizophrenia 
(Wallace et al., 2011), and decreased P50 inhibition in schizophrenia is linked to a 
dinucleotide polymorphism at chromosome 15q13-14, the site of the α7 nAChR 
(Freedman et al., 1997). The BF facilitates the selective processing by the PFC of 
behaviorally relevant sensory stimuli (Sarter et al., 2003). This processing capacity 
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is decreased in a crossmodal divided attention task in rats with 192 IgG-saporin-
induced lesions of the cholinergic neurons of the BF (Turchi and Sarter, 1997). 
Local perfusion with the ionotropic glutamate receptor antagonist kynurenate in the 
ipsilateral BF attenuates ACh release in the mPFC evoked by behaviorally relevant 
stimuli in awake rats, whereas perfusion of NMDA in BF following exposure to 
stimuli enhances both the magnitude and duration of stimulated mPFC ACh efflux 
(Fadel et al., 2001). BF organization supports selective cortical processing. The BF 
stimulation results in differential amount of ACh efflux from the visual cortex 
compared with the somatosensory cortex (Jimenez-Capdeville et al., 1997). 
Different BF glutamate receptor subtypes differentially mediate ACh release in the 
mPFC (Fadel et al., 2001). Anatomical studies and microdialysis data suggest that 
cholinergic BF projections to the cortex are modality and region-specific. Thus, 
distinct populations of neurons in the BF may be activated by different sensory 
inputs (Fournier et al., 2004, Robinson et al., 2011).  
 
It has been proposed that novel, salient or unexpected sensory inputs from 
sensory cortical areas are transferred to the BF via PFC topographic projections  
(Zaborszky et al., 1999, Golmayo et al., 2003), because BF in rodents does not 
seem to receive specific sensory inputs from the brainstem or via thalamic sensory 
areas (Zaborszky et al., 1991).  Consistent with this hypothesis, glutamatergic 
inputs to basal forebrain neurons are a major source of  basal forebrain neuronal 
stimulation in visual attentional task-performing animals (Sarter and Bruno, 2000). 
In animals performing attention tasks, in addition to the cholinergic transients 
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mediating cue detection, there is also a more tonic increase in cholinergic activity 
that remains relatively stable, evoked by the anticipation and/or the initiation of the 
test session and mediated via projections from the PFC to the BF (Parikh et al., 
2010).  
 
I.4 Dopaminergic system in the mPFC 
 
The dopaminergic innervation of the mPFC from the ventral tegmental area 
facilitates neuronal activity in the mPFC.  It modulates cognitive functions including 
working memory, stress, attention, and reward. 
 
I.4.1 Synthesis and uptake of dopamine 
 
Dopamine is synthesized from the essential amino acid tyrosine. Tyrosine 
hydroxylase (TH) converts tyrosine to L-dyhydroxyphenylalanine (L-DOPA), which 
is then decarboxylated into dopamine (DA) and CO2 (Kandel et al., 2000). DA is 
removed from the extracellular space and transported back into DA neurons by the 
DA transporter, DAT. This is an important mechanism for inactivating DA 
neurotransmission (Zahniser and Sorkin, 2004). TH is the rate-limiting enzyme for 
the synthesis of both dopamine and norepinephrine (NE). However, in the PFC, 
only about 10% of the profiles expressing NE transporters (NET) display 
immunoreactivity for TH, indicating that TH immunoreactivity is primarily 
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representative of DA rather than NE axons in this cortical region (Miner et al., 
2003).  
 
I.4.2 The mesocortical dopaminergic projection 
 
There are two major DA projection systems in the CNS. One is the 
mesocorticolimbic system. Its dopamine-containing cell bodies are located in the 
ventral tegmental area (VTA) of the midbrain and project to limbic structures and 
the mPFC(Siegel et al., 1999) (Figure I.4). The other is the nigrostriatal system, 
whose dopamine-containing cell bodies are located in the substantia nigra pars 
compacta (SNc) of the midbrain, and project predominantly to the dorsal striatum 
(Seamans and Yang, 2004, Lester et al., 2010). The mesocorticolimbic DA system 
can be further divided into the mesocortical DA pathway and the mesolimbic DA 
pathway. The dopaminergic projection from the paranigral VTA subdivision to the 
nucleus accumbens, amygdala, and hippocampus constitutes the mesolimbic DA 
pathway (Lester et al., 2010). The mesocortical DA pathway consists of DA 
projections from the parabrachial VTA subdivision that innervate prefrontal cortical 
structures (Descarries et al., 1987, Tam and Roth, 1997, Tzschentke, 2001, Lester 
et al., 2010). In a radioautography study, the supragenual cingulate cortex and the 
anteromedial PFC receive higher DA innervation compared to other cortical areas, 
with predominance of DA varicosities in the upper layers of cingulate cortex in 
contrast with their predominance in the deep layers of the anteromedial PFC.  The 
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perithinal and rostl rhinal cortex show moderate DA innervation, the dorsalfrontal, 
parietal and temporal neocortex show only light innervation, and the primary visual 
cortex show the smallest number of DA varicosities (Descarries et al., 1987). 
However, the mean diameter of these varicosities, which is estimated as 0.74 µm, 
demonstrates little difference across different cortical areas (Descarries et al., 
1987). This DA projection facilitates neuronal activity in the mPFC and modulates 
cognitive functions such as working memory, motor control, attention, stress, and 
impulsion (Tam and Roth, 1997, Seamans and Yang, 2004, Floresco and Magyar, 
2006, Chen et al., 2007, Li et al., 2007, Livingstone et al., 2009, Lester et al., 
2010).  
 
Figure I.4 
Figure I.4. The mesocorticolimbic dopaminergic projection orginates from 
cell bodies in the ventral tegmental area and innervates the frontal cortex 
and limbic forebrain. (George J Siegel et al., 1999) 
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I.4.3 Dopaminergic receptors 
 
All the DA receptors are slow, metabotropic, G-protein-coupled receptors 
that functionally modulate other receptor systems and ion channels. There are five 
DA receptor subtypes in the CNS, named (D1R), D5 (D5R) (Kostrzewa, 1995, 
Seamans and Yang, 2004). D1R and D5R belong to the Gs-, Gq-, or GOlf- coupled 
D1 family, whereas D2R, D3R and D4R belong to Gi-/o D2 family (Seamans and 
Yang, 2004). D5R have a much higher affinity for DA than D1R (Sunahara et al., 
1991), and D3R and D4R have a higher affinity than D2R (Sokoloff et al., 1990). 
Since DA receptors have different affinities and their expression levels and 
neuronal localization in the cortex vary, the effects are determined by both the 
receptor subtype as well as the amount of DA released . Lower concentrations of 
DA preferentially activate D1R, but higher concentrations activate both D1R and 
D2R (Trantham-Davidson et al., 2004). Different types of executive functions 
engage different patterns of activation of DA receptors in the PFC. D1R activity 
mediates working memory, whereas the cooperation of D1R and D2R mediates 
behavioral flexibility (Floresco and Magyar, 2006). It has been suggested that D2R 
are expressed in both pyramidal and nonpyramidal cells, whereas D1R are 
expressed predominantly in non-pyramidal cells (Vincent et al., 1995, Tzschentke, 
2001). D2R activation is thought to decrease inhibition of PFC pyramidal neurons 
(Seamans and Yang, 2004, Trantham-Davidson et al., 2004). There is an inverted-
„U‟ function for DA related to cognitive performance. Deviation from the critical 
levels of PFC DA can disrupt cognitive processes (Seamans and Yang, 2004).  
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I.4.4 Role of the mesocortical DA system in cognitive functions 
 
The mesocortical DA system has been implicated in cognitive functions 
including working memory, stress, attention, and reward (Schultz, 2002). Event 
unpredictability in a wide range of stimuli with rewarding characteristics is an 
important feature to activate dopamine neurons (Schultz et al., 1997). DA plays an 
important role in goal-directed behaviors (Kiyatkin and Rebec, 2001). The D2/D3 
receptor antagonist S33138 elevates extracellular levels of ACh in the frontal 
cortex, and reverses the effect of scopolamine in social recognition (Millan et al., 
2008, Wallace et al., 2011). DA is also involved in attention, especially when novel 
stimuli or positive reward is involved (Schultz, 1997, Robbins, 2005). Impairments 
in set shifting in patients with schizophrenia or ADHD are due in part to alterations 
in mesocortical DA activity (Floresco and Magyar, 2006). In marmosets PFC DA 
improves attentional set-shifting, and frontal DA system in rats with high 
performance is recruited effectively to optimize attentional task performance (Goto 
and Grace, 2005, Robbins, 2005). Infusion of 0.06 g/side dose of DA agonist into 
the rat PrL enhances the accuracy of attentional performance. In contrast, 
intracortical infusion of 0.3 g of the D1 antagonist produces selective impairments 
of performance accuracy (Granon et al., 2000). An association was found between 
ADHD and DAT1 440-bp polymorphism (Todd et al., 2005).  
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I.5. Pyramidal cells in the mPFC 
 
I.5.1 Glutamate 
 
Pyramidal cells are abundant in brain structures such as the cerebral cortex 
and the hippocampus (Spruston, 2008). Pyramidal neurons typically have a 
prominent apical dendrite (Shipp, 2007), and  are likely to use glutamate as their 
neurotransmitter (Kandel et al., 2000, Lewis et al., 2003). In the brain, glutamate 
can be synthesized from glucose via the Krebs cycle and the transamination of α-
oxoglutarate, or recycled through the glutamate/glutamine cycle (Sanacora et al., 
2008). The glutamate/glutamine cycle‟ involves a rapid uptake of glutamate from 
the synaptic cleft mainly into the astrocytes, where glutamate is converted into 
glutamine and further transferred to nerve terminals (Nieoullon et al., 2006). 
Glutamate is transported into synaptic vesicles by vesicular glutamate transporters. 
Glutamate is cleared from the extracellular space via high-affinity excitatory amino-
acid transporters (EAATs). Uptake by the EAATs is the primary mechanism to 
terminate action of extracellular glutamate (Sanacora et al., 2008). Glutamate is 
the major mediator of excitatory synaptic transmission in the brain (Tzschentke, 
2002, Sanacora et al., 2008), and pyramidal cells are the targets of the majority of 
glutamate-containing axon terminals (Lewis et al., 2003). Among the different 
populations in the mPFC, about 85% of total neurons are pyramidal projection 
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cells, and 15% are GABAergic interneurons (DeFelipe et al., 2002). Glutamate is 
the main transmitter of the efferent mPFC projections (Tzschentke, 2001).  
 
I.5.2 Glutamate receptors 
 
Glutamate is the ligand of two main classes of receptors: the ionotropic 
glutamate receptors (iGluRs) displaying rapid signaling and the metabotropic 
glutamate receptors (mGluRs) involved in more sustained actions. There are three 
types of iGluRs, N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-
isoazolepropionic acid (AMPA) and 2-carboxy-3-carboxymethyl-4-
isopropenylpyrrolidine (kainate) receptors, as well as eight types of the G-protein-
coupled mGluRs (mGluR1-8) (Kew, 2004).  
 
I.5.3 Roles of prefrontal pyramidal cells in brain functions 
 
Glutamate-containing neuronal systems support rapid transfer of excitatory 
information in neuronal networks and are involved in most of the brain processes 
associated with sensorimotor, neurovegetative, limbic and cognitive functions  
(Nieoullon et al., 2006). They are the basic components of neuronal plasticity 
supporting learning and memory (Nieoullon et al., 2006). Pyramidal cells are major 
recipients of inputs and  the major source of outputs for the PFC. They transmit 
activity in local circuits (Rotaru et al., 2007), and the projections from pyramidal 
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neurons in deep layers V and VI transmit neural information processed by the PFC 
to the neural networks in subcortical sites (Carr and Sesack, 2000, DeFelipe et al., 
2002, Gabbott et al., 2005). mPFC glutamate neurotransmission plays an 
important role in response selection and inhibition. Intra-mPFC infusions of NMDA 
and AMPA receptor antagonists disrupt attentional set shifting (Murphy et al., 
2005).  PFC glutamatergic projections into the BF likely influence cortically 
projecting cholinergic neurons (Zaborszky et al., 1997). Glutamate is also a potent 
neuronal excitotoxin triggering neurotoxicity in pathological conditions. Failure of 
the EAATs to effectively clear glutamate from the extracellular space leads to 
various forms of cellular damage (Sanacora et al., 2008). Abnormal function of the 
glutamatergic system has been implicated in the pathophysiology of many 
disorders including Alzheimer‟s disease, schizophrenia and anxiety disorders 
(Tzschentke, 2002, Sanacora et al., 2008, Javitt, 2010).  
 
I.6. Relationship between the cholinergic and 
dopaminergic afferents and pyramidal cells 
 
I.6.1 An intricate and complex neuron network 
 
The neuronal basis of the role of the PFC in cognitive functions is an 
intricate and extensive neuronal network (Agnati et al., 2006, Semyanov, 2008), 
where the regulation of PFC function by the interaction between the ascending 
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neuromodulators such as DA and ACh plays an important role (Robbins, 2005). 
Neuronal elements are not isolated but interact in a intricate and complex network. 
Pyramidal cells are the skeleton of the basic cortical microcircuit composed of a 
large number of different elements in this network, with multiple connections 
between inputs and outputs (DeFelipe et al., 2002). A number of neurotransmitter 
agents including GABA, serotonin, and adenosine may increase potassium 
conductance in cortical pyramidal cells, and a number of different 
neurotransmitters such as ACh and serotonin may block the M-current. This allows 
the ascending modulatory transmitter systems to control the excitability and 
responsiveness of cortical pyramidal neurons (McCormick, 1992). The PFC 
integrates widespread glutamatergic inputs from sensorimotor and limbic regions to 
perform executive functions, with mesocortical dopamine projections and basal 
forebrain cholinergic projections exerting important and distinct modulatory 
influences on PFC functions (Robbins, 2005, Livingstone et al., 2010). Abnormal 
interactions among those ascending neuromodulatory systems lead to disrupted 
PFC function in many neurological, psychiatric and drug-addictive disorders 
(Briand et al., 2007). Restoration of the dynamic balance between these 
neurotransmitter systems is the main approach for treating such disorders (Lester 
et al., 2010). The idea that the actions of one type of neurotransmitter must be 
viewed within a wider context of interactions with other neurotransmitter systems is 
an important development of insight into these cognitive diseases (Goldman-Rakic, 
1996). Indeed, reciprocal modulation between the dopaminergic and cholinergic 
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systems and pyramidal cells have been documented in a variety of 
pharmacological and electrophysiological studies, as discussed below. 
 
I.6.2 Reciprocal modulation between the prefrontal dopaminergic 
and cholinergic system 
 
The modulation of the prefrontal dopaminergic response by acetylcholine is 
well documented. Parasynaptic and preterminal nAChRs modulate the release of 
all the major neurotransmitters that have been tested such as dopamine, 
norepinephrine, serotonin, GABA, and glutamate (Dani, 2001). Activation of 
presynaptic nicotinic receptors can evoke the release of various monoamines from 
brain slices (Lendvai et al., 2000, De Paola et al., 2003, Vizi et al., 2004). Nicotine 
inhaled during smoking results in the release of excitatory amino acids and NE, 
DA, or 5-HT, which can diffuse to affect tonically the release of other transmitters 
or the firing rate of other circuitries (Vizi, 2000). Due to nicotinic modulation of 
dopamine release, nAChRs are therapeutic targets for pathological conditions 
involving dopaminergic dysfunction, including schizophrenia, ADHD, Parkinson‟s 
disease, and Alzheimer‟s disease (Livingstone and Wonnacott, 2009). Different 
nicotinic ACh receptor subtypes modulate dopamine release from the PFC and 
striatum. A selective nAChR antagonist, MG 624, inhibits cortical DA by 53%, but 
has no effect on striatal release (Cao et al., 2005). The highly sensitive, but not the 
low sensitive, form of α4β2 nAChR mediates [3H]dopamine release from slices of 
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rat prefrontal cortex and striatum (Anderson et al., 2009). Low doses of AZD0328, 
a partial agonist of α7 neuronal nicotinic receptor, increase the firing of dopamine 
neurons in VTA, and improve novel object recognition in mice (Sydserff et al., 
2009). In the mPFC, α7 nAChRs present on glutamate terminals increase 
glutamate release which could coordinately enhance dopamine release from 
neighboring boutons (Livingstone et al., 2010). Intracellular recordings in horizontal 
slices of ventral midbrain from adult male rats demonstrated the increase of 
potassium conductance resulting from release of calcium from internal stores via 
activation of muscarinic receptors on DA neurons by ACh application (Fiorillo and 
Williams, 2000). In awake, freely moving rats, the muscarinic M1 receptor agonist 
AC260584, xanomeline and sabcomeline enhance cortical ACh and DA efflux in 
mPFC (Li et al., 2007, Li et al., 2008). The inhibition of cholinesterase elevated the 
extracellular level of cortical dopamine by 80% (Giacobini et al., 1996).  
 
In the PFC, DA also exerts its influence on the cholinergic system. Prefrontal 
dopaminergic activity mediates particularly the amplitude of α7 nAChR-evoked 
ACh release (Parikh et al., 2010). D1R exerts a tonic, facilitatory influence upon 
cholinergic transmission. The D1R agonist, SKF82958, robustly increases the 
extracellular levels of ACh in the PFC of freely moving rats, whereas the D1R 
antagonist SCH 23390 decreases the levels of ACh and abolishes the facilitatory 
influence of SKF 82958 upon ACh levels (Di Cara et al., 2007). The systemic 
administration of two selective D3R antagonists, SB-277011A and SB-414796A, 
produces a significant increase in extracellular levels of ACh compared to vehicle-
31 
 
treated animals (Lacroix et al., 2006). The associations between polymorphisms of 
the DAT1 or DRD4 genes and ADHD were strengthened in children whose mothers 
smoked during their pregnancy (Neuman et al., 2007). Selective blockade of D3R 
elicits dose-dependent, pronounced and sustained elevations of extracellular ACh 
levels in the frontal cortex and improves social learning in rats (Millan et al., 2007). 
The DA uptake blocker nomifensine increases extracellular ACh concentrations in 
the PFC at all days of treatment in awake rats (Hernandez et al., 2008). The 
release of AChE is regulated by extracellular DA as well. Local administration of D-
amphetamine and the inhibitor of dopamine uptake GBR12909 both significantly 
increases the spontaneous release of ACHE in the rat substantia nigra (Dally et al., 
1996). 
 
I.6.3 Reciprocal modulation between PFC pyramidal cells and the 
cholinergic system 
 
Acetylcholine release regulates the output of neocortical pyramidal neurons. 
Individual cortical pyramidal neurons faithfully respond to phasic and tonic ACh 
release in the cortex (Gulledge and Stuart, 2005, Parikh et al., 2007). Nicotine 
increases the frequency and amplitude of spontaneous excitatory postsynaptic 
currents in pyramidal cells in mouse PFC (Couey et al., 2007). Multiple subtypes of 
nAChR regulate glutamate release (Wonnacott et al., 2006). Nicotine evokes 
[3H]D-aspartate (a surrogate for glutamate) release from rat synaptosomes, which 
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are sensitive to both DHβE and α-bungarotoxin (Marchi et al., 2002, Rousseau et 
al., 2005). Application of nicotine induced a large increase in glutamate release 
onto layer V pyramidal neurons, as measured by an increase in spontaneous 
excitatory postsynaptic currents (sEPSCs) (Lambe et al., 2003). The interaction 
between the α7 nAChR and glutamatergic neurons is important for cellular events 
underlying executive functions (Livingstone et al., 2010). Both α7 and β2 receptor 
agonists evoked release of glutamate (Dickinson et al., 2008). The α4β2 nAChR 
agonist, ABT-089 evokes potent glutamate release (Parikh and Sarter, 2008). Via 
muscarinic acetylcholine receptor activation, ACh can directly inhibit the output of 
neocortical layer V pyramidal neurons (Gulledge and Stuart, 2005). Whole-cell 
recordings of layer V pyramidal neurons in cortical slices demonstrate strong and 
direct inhibition of neocortical pyramidal neurons by transient mAChR activation by 
agonists (Gulledge and Stuart, 2005). M1 receptor stimulation in layer V pyramidal 
cells of the rodent PrL/IL produces a strong depolarization, leads to tonic firing, and 
dramatically enhances the summation of excitatory synaptic potentials (Carr and 
Surmeier, 2007). Both M1R and M3R regulate the output of cortical pyramidal 
neurons (Gulledge et al., 2009). Layer V pyramidal neurons are modulated by ACh 
and carbachol to a greater degree than neurons in layer II/III (Gulledge et al., 
2007).  
 
Reciprocally, glutamatergic mechanisms modulate the cholinergic effects in 
the PFC. As demonstrated by a microdialysis study, the AMPA receptor antagonist 
DNQX and the NMDA receptor antagonist APV attenuate cholinergic signals 
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evoked by the α4β2 nAChR agonist, ABT-089 (Parikh and Sarter, 2008). The 
NMDA receptor antagonist CPP decreases the improvement in attentional function 
produced by nicotine (Quarta et al., 2007). Lack of β2-containing nAChRs leads to 
partial attenuation of both cholinergic and glutamatergic transients evoked by 
nicotine, and complete attenuation evoked by ABT-089, indicating that the 
amplitude of glutamatergic transients controls the amplitude of cholinergic 
transients (Parikh et al., 2010). Activation of α4β2 nAChRs residing on prefrontal 
dopaminergic and glutamatergic afferents could evoke ACh release in the PFC 
(Briand et al., 2007, Parikh and Sarter, 2008). An electron microscopic study of 
vesicular glutamate transporters (Vglut1 and Vglut2) and ChAT in BF 
demonstrated that Vglut1 and Vglut2 boutons synapse with cholinergic dendrites 
(Hur et al., 2009).  
 
I.6.4 Reciprocal modulation between PFC pyramidal cells and the 
dopaminergic system 
 
The output of cortical pyramidal cells is also modulated by dopaminergic 
afferents to the mPFC. Prefrontal pyramidal cells are the primary targets of the 
ascending dopaminergic fibers (Tzschentke, 2001). Application of the D1R agonist 
SKF 81297 attenuates simulated EPSP (sEPSP) amplification in layer 5 pyramidal 
neurons in rat mPFC at depolarized potentials in a concentration-dependent 
manner.  The effects of different concentrations of SKF81297 on sEPSP area are 
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well fitted by a sigmoideal function, and ∼1.3 μm of the SKF81297 concentration 
produces 50% of the maximum effect. The SKF81297 effects are abolished by the 
D1R antagonist SCH23390 (Rotaru et al., 2007). NMDA, AMPA, and the D1R 
agonist SKF38393 increase the excitability of deep layer pyramidal neurons in PFC 
in a concentration-dependent manner, whereas the D2R agonist quinpirole induces 
the opposite effect (Tseng et al., 2007). D2R activation was shown to decrease 
inhibition of PFC pyramidal neurons (Seamans and Yang, 2004, Trantham-
Davidson et al., 2004), and excessive activation of D2R is detrimental to induction 
of long term potentiation (LTP)  in the PFC (Xu et al., 2009). The inhibitory D2R 
effects on pyramidal cell excitability may be important cellular mechanisms for the 
selection of relevant information in the PFC (Tseng and O'Donnell, 2004).  
 
On the other hand, glutamate exerts a local modulation on DA release in the 
PFC (Del Arco et al., 2003).  Prefrontal glutamate ionotropic receptors seem to 
have a local inhibitory modulation on DA release in the PFC. Local perfusion of 
ketamine, a non-competitive NMDA receptor antagonist, enhances DA release 
within the mPFC, while NMDA decreases DA release (Lorrain et al., 2003). Local 
infusion of the AMPA/kainate antagonist CNQX produces a 40% increase in 
dopamine levels in the mPFC (Wu et al., 2002). Prefrontal perfusion of NMDA 
decreases the basal release of dopamine, and significantly reduces dopamine 
release stimulated by stress (Del Arco and Mora, 2001), suggesting an inhibitory 
role for NMDA receptors on dopamine release. NMDA and AMPA prefrontal 
activation could also inhibit dopamine release indirectly via GABA receptors 
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located on dopamine terminals (Del Arco and Mora, 2005). A balanced prefrontal 
glutamate-dopamine interaction is crucial to the function and activity of PFC and 
other interconnected brain areas such as nucleus accumbens (Del Arco and Mora, 
2005).  
 
 
I.7 Diffuse transmission 
 
I.7.1 Synaptic versus diffuse transmission 
 
Classical synaptic transmission and diffuse transmission are the two main 
modes of intercellular communication that have been proposed in the CNS 
(Umbriaco et al., 1994, Descarries et al., 1997, Zoli et al., 1999, Descarries and 
Mechawar, 2000, Vizi et al., 2004, Agnati et al., 2006). Synaptic transmission, or 
wired transmission, occurs when a cell is connected to another cell via a physically 
distinct communication channel, such as a synapse, a gap-junction or membrane 
juxtapositions (Agnati et al., 2006). In contrast, in diffuse transmission, there are no 
synaptic contacts or appositions of a postsynaptic density. Transmitters are 
released from axon terminals into the extracellular space, diffuse, and stimulate 
extrasynaptically located receptors to influence the activity of other neurons 
(Lendvai and Vizi, 2008). Compared to classic synaptic transmission, diffuse 
transmission has longer transmission delay, more than one target, and a lower 
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energy cost (Agnati et al., 2006). Diffuse transmission allows a global mode of 
operation for the CNS, setting the CNS to the appropriate functional state so that it 
works as a unit (Agnati et al., 1995). The dynamic influences of neuromodulators 
depend on their broad and diffuse transmission (Giocomo and Hasselmo, 2007). 
Many transmitters such as norepinephrine, serotonin, ACh, glutamate, GABA, and 
nitirc oxide have been implicated in diffuse transmission (Umbriaco et al., 1994, 
Descarries et al., 1997, Huang, 1998, Cragg et al., 2001, Lapish et al., 2007). They 
can be released nonsynaptically (Descarries et al., 1997, Isaacson, 2000), and 
virtually all the transmitters are found in the extracellular fluid, as indicated in 
microdialysis studies (Garris and Wightman, 1994, Del Arco et al., 2003). The 
existence of nonsynaptic varicosities is a quite general feature of the CNS (Vizi, 
2000, Descarries et al., 2008). Although the receptors involved in diffuse 
transmission are hypothesized to be mainly high-affinity metabotropic receptors 
(Kiss et al., 1999), extrasynaptic locations have been demonstrated for cholinergic, 
peptidergic, monoamine and glutamatergic ion channel-gated receptors (Jacob and 
Berg, 1983, Yung et al., 1995). Most presynaptic receptors are nonsynaptic and 
regulate the tonic release of transmitters (Vizi et al., 2004).  
 
I.7.2 The brain extracellular space 
 
The structure of the brain extracellular space supports the feasibility of 
diffuse transmission (Nicholson and Sykova, 1998). 20% of the brain volume is 
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extracellular space, which provides a significant extracellular microenvironment 
and acts as communication channels between cells in diffuse transmission 
(Nicholson and Sykova, 1998). Repetitive neuronal activity and pathological states 
can lead to long-term changes in the properties of the extracellular space 
(Nicholson and Sykova, 1998), thus affecting diffuse transmission of various 
neuromodulators. Neurotransmitters diffuse in their 3D microenvironment in 
preferential pathways, because tortuosity and volume fraction, the two main 
features of the cerebral microenvironment, are not uniform in different regions and 
various physiopathological conditions (Agnati et al., 1995). The tortuosity is the 
length of the diffusion path for a molecule in a given medium with respect to free 
medium (Agnati et al., 1995), a measure of how diffusing molecules are hindered 
by cellular obstructions (Nicholson and Sykova, 1998). The volume fraction 
represents the amount of volume in which an extracellular molecule can diffuse 
with respect to the overall volume of the brain region (Agnati et al., 1995). Different 
chemical-physical phenomena such as intracranial pressure waves, temperature 
and concentration gradients could also exert their influence in volume transmission 
(Fiorillo and Williams, 2000, Santha et al., 2001).  
 
I.7.3 Role of diffuse transmission in brain function 
 
The view has been developed in recent years that alterations in the diffuse 
transmission of neurotransmitters contribute more to dysregulations and 
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pathological disorders in the brain than the cessation of their actions at synaptic 
release sites (Meshul et al., 1999, Marti et al., 2000, Sykova and Chvatal, 2000, 
Del Arco et al., 2003). Many functions of the nervous system are influenced by the 
presynaptic modulation of transmitter release and postsynaptic effects of 
endogenous molecules released from far away varicosities (Vizi et al., 2004). 
Besides, extrasynaptic receptors are among the primary targets of medicine, partly 
due to the reason that micromolar blood concentrations of drugs require high 
affinity receptors (Zoli et al., 1999, Vizi, 2000). These drugs diffuse in the cerebral 
extracellular space and interact more effectively with diffuse transmission than 
synaptic transmission (Zoli et al., 1999).  
 
I.7.4 Diffuse transmission of ACh 
 
Diffuse transmission is proposed to be the major mode of neuronal 
communication for ACh in the PFC (Umbriaco et al., 1994, Descarries et al., 1997, 
Descarries and Mechawar, 2000). Little evidence has been shown for classical 
nicotinic synaptic transmission in the CNS (McGehee, 1995). In contrast, many 
features of ACh transmission support diffuse transmission. The majority of 
cholinergic boutons in the CNS do not make synaptic contacts (Umbriaco et al., 
1994, Descarries et al., 1997, Mechawar et al., 2000). Both muscarinic (Yamasaki 
et al., 2010) and nicotinic AChRs such as α7 (Duffy et al., 2009) and high-affinity 
type of α 4 β 2 (Hill et al., 1993, Ullian and Sargent, 1995, Lendvai and Vizi, 2008) 
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have been implicated in diffuse transmission. nAChRs were mainly found in 
nonsynaptic sites (Fabian-Fine et al., 2001, Jones and Wonnacott, 2004). Electron 
microscopic immunolabeling of the α7nAChR and vesicular acetylcholine 
transporter (VAChT) in single sections through the PFC demonstrated that, in rat 
and mouse, there were no recognizable synaptic specializations in the spatial or 
intracellular relationship between α7nAChR and VAChT-containing axonal profiles 
(Duffy et al., 2009). In the chick lateral spiriform nucleus, most clusters of α5 and 
β2 are extrasynaptic, as demonstrated by double-label immunofluorescence with 
mAbs to AChRs and to synaptic vesicle antigens (Ullian and Sargent, 1995). M1R 
likely mediate cholinergic diffuse transmission in the cortex by sensing the ambient 
ACh. M1R  were found to be preferentially expressed in pyramidal cells, far more 
outnumbered cholinergic varicosities and localized widely on the extrasynaptic 
membrane (Yamasaki et al., 2010). The cholinergic system modulates cortical 
functions via axo-axonic interactions. Extracellular and intracellular recordings in 
rat cortical slices from rat piriform cortex demonstrated that cholinergic agonists 
suppress synaptic transmission through a presynaptic mechanism via M1R 
(Hasselmo and Bower, 1992). 
 
I.7.5 Diffuse transmission despite ACh hydrolysis by AChE 
 
It has been proposed that cholinergic varicosities should be in close 
proximity to target elements in diffuse transmission (Lendvai and Vizi, 2008)in 
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regard to its fast hydrolysis by AChE (Descarries et al., 1997, Descarries, 1998, 
Sarter et al., 2009b), However, it has been argued by (Descarries et al., 1997) that 
the main  action of AChE in CNS is to keep the extrasynaptic, ambient level of ACh 
within physiological limits (Descarries et al., 1997, Descarries, 1998, Lendvai and 
Vizi, 2008). In any event, since inhibition of AChE is correlated with the increase of 
extracellular concentration of ACh in cortex, it may have an impact on cognitive 
function (Giacobini et al., 1996, Giacobini, 1998). The soluble form of AChE and its 
“excess substrate inhibition” also provide selective flexibility to the cholinergic 
system (Descarries et al., 1997, Descarries, 1998, Lendvai and Vizi, 2008).  
 
I.7.6 Synaptic nature of DA transmission in the mPFC 
 
Diffuse transmission has been suggested for DA due to their spatially 
diffusible release, and slow long-term modulations of the neuronal activity of entire 
networks (Agnati et al., 1995, Cass and Gerhardt, 1995, Mundorf et al., 2001, 
Lapish et al., 2007).  Compared with the striatum, in PFC there was relatively low 
levels of DAT proteins, distant localization of DAT from synaptic release sites, and 
less DA uptake by DAT (Garris and Wightman, 1994, Cass and Gerhardt, 1995, 
Sesack et al., 1998). A junctional complex exists on only 56% in the suprarhinal 
cortex (Seguela et al., 1988), suggesting existence coexistence of non-synaptic 
and synaptic transmission of DA in the PFC.   
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However, DA transmission in the mPFC is mainly synaptic. In the rat 
anteromedial PFC, a junctional complex is observed on 93% of the DA varicosities, 
demonstrated by an electron microscopic study using immunocytochemical 
staining with a highly specific polyclonal antiserum directed against DA-
glutaraldehyde-lysyl-protein conjugate (Seguela et al., 1988).  
 
I.7.7 Diffuse transmission of glutamate 
 
Extracellular variations of glutamate are regarded as an index of diffuse 
transmission mediated actions (Del Arco et al., 2003). Synaptically released 
glutamate could spill over to extrasynaptic regions to activate nonsynaptic 
receptors and exert remote effects (Scanziani et al., 1997, Rusakov and Kullmann, 
1998, Bergles et al., 1999, Isaacson, 2000, Giocomo and Hasselmo, 2007). 
Glutamate can also be released by astrocytes through glutamate receptors by 
previous activation of adjacent neurons, and act on neuronal extrasynaptic 
receptors to modulate neurotransmission (Del Arco et al., 2003). There are also 
glutamate receptors (Scanziani et al., 1997, Rusakov and Kullmann, 1998) located 
on glutamatergic axon terminals (autoreceptors), on astrocytes and on other 
neurotransmitter system terminals such as dopaminergic terminals 
(heteroreceptors), and both metabotropic glutamate receptors and ionotropic 
glutamate receptors are involved in diffuse transmission (Scanziani et al., 1997, 
Rusakov and Kullmann, 1998, Del Arco et al., 2003, Semyanov, 2008).  
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I.8. Plasticity of axon varicosities 
 
I.8.1 Axon varicosities 
 
Varicosities or boutons are dilated regions of the axon where vesicles 
containing transmitter substance accumulate (Cooper et al., 2003). En passant 
varicosities are studded along the axonal branches and are of great interest in 
diffuse transmission since most of them do not make synaptic contacts (Vizi, 
2000). En passant varicosities and terminal varicosities may be intermingled along 
the same axon (Anderson and Martin, 2001), and different types of axons have 
distinct densities of varicosities (De Paola et al., 2006). The distribution of 
varicosities is uneven along the axons and can be quite specific (Shepherd and 
Raastad, 2003), suggesting that there are regions in which the local concentration 
of transmitters could be much higher (Vizi, 2000). Formation of varicosities are not 
random but might be intrinsic to axons (Sabo et al., 2006), as well as shaped by 
activities and experiences throughout life (Colicos et al., 2001, Trachtenberg et al., 
2002, Nikonenko et al., 2003, Galimberti et al., 2006). 
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I.8.2 Structural plasticity of axon varicosities 
 
Axon varicosities exhibit vigorous structural plasticity in the brain (De Paola 
et al., 2003, De Paola et al., 2006, Stettler et al., 2006, Gogolla et al., 2007). 
Extrinsic experiences may induce changes in the numbers of axon 
varicosities.Chronic imaging of neuronal structure in vivo via injecting adeno-
associated virus (AAV) carrying the EGFP gene has demonstrated axonal bouton 
turnover dynamics in V1 during the functional reorganization following retinal 
lesions. A significantly higher turnover rate was observed after the lesion, and 
initially more boutons appeared than disappeared, followed by elimination of more 
boutons until a return of the bouton density to the level seen prior to the lesion 
(Yamahachi et al., 2009). A two-photon microscopy imaging of pyramidal neurons 
in the developing rat barrel cortex demonstrated the structural dynamics of 
dendritic spines and filopodia driven by sensory experience. During a critical period 
around postnatal days, sensory deprivation markedly reduced protrusive motility in 
deprived regions of the barrel cortex (Lendvai et al., 2000). Dynamics in the 
number of varicosities may be induced by the activity of postsynaptic elements. A 
study using confocal imaging of DiI-labeled axons demonstrated that short 
anoxia/hypoglycemia and theta burst stimulation induced rapid remodeling of 
presynaptic varicosities (Nikonenko et al., 2003). Studies using cultured 
hippocampal neurons via live imaging and retrospective immunohistochemical 
methodologies demonstrated that functional presynaptic boutons can form within 
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25-30 min of the establishment of an axodendritic contact, some of which were 
recruited from SVs of nearby preexisting boutons (Friedman et al., 2000).  
 
There is also evidence for a spontaneous turnover rate of the axon 
varicosities.  In mature hippocampal networks, a fraction of en passant varicosities 
along mossy fibers demonstrated a turnover within a period of several days (De 
Paola et al., 2003). In the intact adult barrel cortex of GFP transgenic mice, the 
axon varicosities appeared and disappeared over times of days and stable and 
dynamic varicosities intermingled along the axons, as shown via two-photon 
microscopy (De Paola et al., 2006). In anesthetized Macaca fascicularis monkeys 
and mice injected with AAV.EGFP, two-photon imaging sessions of their V1 
showed frequent bouton addition and elimination along collaterals over 1 week 
interval (Stettler et al., 2006).  
 
The mechanisms underlying changes in the density of axon varicosities are 
not clear, but increases in the number of axon varicosities may result from either 
the formation of new varicosities or the mobilization of previously existing ones to 
new sites (Friedman et al., 2000, Trachtenberg et al., 2002). 
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I.8.3 Structural plasticity of axon varicosities in brain diseases 
 
Changes in axonal varicosities have been implicated in pathological 
conditions. In mild to moderate Alzheimer disease, ChAT axonal varicosities in the 
frontal cortex were less and abnormally enlarged compared to healthy controls 
(Ikonomovic et al., 2007). A lower density of parvalbumin-immunoreactive 
varicosities was found in the middle cortical layers in prefrontal cortex of 
schizophrenic patients (Lewis et al., 2001). Compared to young cognitively 
unimpaired rats, there was an increase in the density of dopaminergic varicosities 
in layer V of the prefrontal cortex in aged cognitively unimpaired rats, but a 
decrease in layer III in aged cognitively impaired rats (Allard et al., 2010).  
 
I.9 Summary 
 
The functions of the rat medial prefrontal cortex are modulated by ascending 
modulatory systems such as the ACh and DA afferent systems, in which diffuse 
transmission play an important role. The horizontal nucleus of the diagonal band of 
Broca in the basal forebrain sends prominent projections to Cg1, PrL and IL, the 
subregions of mPFC. Pyramidal neurons in layers III and V were preferentially 
innervated by those ascending axons. PFC and BF are reciprocally involved in the 
processing of behaviorally relevant sensory stimuli. The level of PFC DA is critical 
for modulating normal cognitive and behavioral processes. In the mesocortical DA 
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pathway, DA projections from the parabrachial VTA subdivision innervate 
prefrontal cortical structures and enhance neuronal activity in the mPFC. Pyramidal 
cells use glutamate as their neurotransmitter and are abundant in brain structures 
associated with advanced cognitive functions such as the cerebral cortex.  
Glutamate is the main transmitter of the efferent mPFC projections. PFC pyramidal 
cells transmit activity in local circuits, as well as neural information processed by 
the PFC to the neural networks in subcortical sites. Glutamate-containing neuronal 
systems support rapid transfer of excitatory information in neuronal networks.  
 
The interrelationships between the ascending cholinergic and dopaminergic 
systems and pyramidal cells in the mPFC in rodents have been involved in a 
variety of cognitive and emotional processes including attention, learning and 
plasticity, as well as in cognitive and behavioral disturbances associated with major 
neuropsychiatric disorders such as ADHD and schizophrenia. 
 
The neuronal basis of the role of the PFC in cognitive functions is an 
intricate and extensive neuronal network, in which the regulation of PFC function 
by the interaction between the ascending neuromodulators such as DA and ACh 
plays an important role. Pyramidal cells are the skeleton of the basic cortical 
microcircuit composed of a large number of different elements, and their intrinsic 
and extrinsic connections. The PFC integrates widespread glutamatergic inputs 
from sensorimotor and limbic regions to perform executive functions, with 
mesocortical dopamine projections and basal forebrain cholinergic projections 
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exerting important and distinct modulatory influences on PFC functions. The 
reciprocal modulation among prefrontal ACh, DA and pyramidal cells has been 
reported in a number of pharmacological and electrophysiological studies. A 
balanced interaction among the three neuronal elements is crucial to the function 
and activity of PFC and other interconnected brain areas. Abnormal interactions 
among those ascending neuromodulatory systems and pyramidal cells lead to 
disrupted PFC function in many neurological, psychiatric and drug-addictive 
disorders, and restorations of the dynamic balance between these neurotransmitter 
systems are the main approach for treating such disorders. 
 
Diffuse transmission, an important mode of intercellular communication, 
allows a global mode of operation for the CNS and sets the CNS to an appropriate 
functional state so that the CNS neuronal elements work as a unit.  In diffuse 
transmission, there are no synaptic contacts. Instead, neurotransmitters are 
released from axon terminals into the extracellular space, diffuse, and stimulate 
extrasynaptically located receptors to influence the activity of other neurons. 
Diffuse transmission is crucial for the communication for cortical ACh and DA, and 
enables the dynamic influences of those neurotransmitters on cognitive functions. 
Many features of ACh transmission suggest this system uses a fast form of diffuse 
transmission, in which the axon varicosities must be in relatively close proximity to 
their target elements. DA release is spatially diffuse and prolonged, tonically 
stimulates extrasynaptic receptors in a high affinity state, and exerts slow, long-
term modulatory effects on target neurons. However, the heterogeneity of DA 
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concentration in its microenvironment might limit effective DA diffuse transmission 
to a few micrometers.  
 
Axon varicosities are of great interest in diffuse transmission since most of 
them do not make synaptic contacts. The uneven distribution of varicosities along 
axons suggests heterogeneity in the local concentration of transmitters in the 
extracellular space. The formation of varicosities is not random, but shaped by 
extrinsic sensory experiences throughout life. Thus axon varicosities exhibit 
vigorous structural plasticity in the brain. Changes in axonvaricosities have been 
implicated in pathological conditions such as Alzheimer disease and schizophrenia. 
 
 
I.10 Objectives of the studies 
 
Despite the well-documented interactions between the cholinergic, and 
dopaminergic afferents and pyramidal cells in the PFC, there is only scarce 
neuroanatomical data depicting the reciprocal interrelationships between these 
neuronal elements in the mPFC. Facts and principles of such a network 
organization are also scant (Rockland, 1998).  
 
For these reasons, we examined the ultrastructural neuroanatomical 
relationship between the cholinergic and dopaminergic systems and pyramidal 
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cells in the mPFC, with an emphasis on the structural plasticity of the cholinergic 
and dopaminergic axon varicosities at the subcellular level. These 
interrelationships were also examined in association with neuronal activity in the 
mPFC. 
 
Several questions were thus answered: 
 
(1) Do cholinergic and dopaminergic fibers within the mPFC converge on the 
same pyramidal neurons from layer V (output) in the mPFC? 
 
(2)  Are there close appositions between cholinergic and dopaminergic fibers in 
the mPFC? 
 
(3) Is there any functional importance to the close appositions between 
cholinergic fiber segments and dopaminergic fiber segments, particularly, is 
there structural plasticity of axon varicosities on those fiber segments 
apposing to each other? 
 
(4) Does the activation of pyramidal cells in the mPFC induce changes of 
varicosity density on cholinergic fiber segments in their vicinity? 
 
(5) Does the dopaminergic system in the mPFC demonstrate this plasticity of 
varicosity density induced by neuronal activity as well?
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CHAPTER II 
Confocal analysis of cholinergic and dopaminergic 
inputs onto pyramidal cells in the prefrontal cortex 
of rodents 
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Abstract 
 
Cholinergic and dopaminergic projections to the rat medial prefrontal cortex 
(mPFC) are both involved in cognitive functions including attention. These neuronal 
systems modulate mPFC neuronal activity mainly through diffuse transmission. In 
order to better understand the anatomical level of influence of these systems, 
confocal microscopy with triple-fluorescent immunolabeling was used in three 
subregions of the mPFC of rats and Drd1a-tdTomato/Drd2-EGFP transgenic mice. 
The zone of interaction was defined as a reciprocal microproximity between 
dopaminergic and cholinergic axonal segments as well as pyramidal neurons. The 
density of varicosities, along these segments was considered as a possible 
activity-dependant morphological feature. The percentage of cholinergic and 
dopaminergic fibers in microproximity ranged from 12 to 40% depending on the 
layer and mPFC subregion. The cholinergic system appeared to have more 
influence on dopaminergic fibers since a larger proportion of the dopaminergic 
fibers were within microproximity to cholinergic fibers. The density of both 
cholinergic and dopaminergic varicosities was significantly elevated within 
microproximities. The main results indicate that the cholinergic and dopaminergic 
systems converge on pyramidal cells in mPFC particularly in the layer V. In 
transgenic mice 93% of the pyramidal cells expressed the transgenic marker for 
Drd2 expression, but only 22% expressed the maker for Drd1ar expression. Data 
presented here suggest that the modulation of mPFC by dopaminergic fibers would 
be mostly inhibitory and localized at the output level whereas the cholinergic 
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modulation would be exerted at the input and output level both through direct 
interaction with pyramidal cells and dopaminergic fibers. 
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Introduction 
 
The rat medial prefrontal cortex (mPFC) is involved in a variety of cognitive 
functions including attentional processes, working memory, behavioral flexibility 
and inhibition (Heidbreder and Groenewegen, 2003, Gabbott et al., 2005, Briand et 
al., 2007). Its three main anatomical subdivisions, the anterior cingulate (Cg1), the 
prelimbic (PrL) and the infralimbic (IL) areas (Vertes, 2004, Tavares and Correa, 
2006, Vertes, 2006) receive long ascending projections from cholinergic neurons of 
the basal forebrain (BF) (Golmayo et al., 2003, Henny and Jones, 2008) and from 
dopaminergic neurons of the ventral tegmental area (VTA). Both neuronal systems 
modulate mPFC activity and attentional performance (Gill et al., 2000, Golmayo et 
al., 2003, Sarter et al., 2003, Chudasama et al., 2004, Dalley et al., 2004b, Sarter 
et al., 2005, Goto et al., 2007, Del Arco and Mora, 2009). Particularly, acetylcholine 
(ACh) plays an essential role in the top-down control of attention (Sarter et al., 
2006), orienting and retention in working memory tasks (Broersen et al., 1995, 
Steckler et al., 1998, Thienel et al., 2009). Dopamine (DA) plays a major role in 
motor control, selective attention, impulsivity, executive control (Robbins, 2005, 
Chen et al., 2007, Lapish et al., 2007, Li et al., 2007, Thienel et al., 2009) and has 
a “fine-tuning” effect for optimum cognitive performance (Granon et al., 2000, 
Tzschentke, 2001). Both ACh and DA systems are involved in pathologies such as 
Alzheimer‟s disease, attention deficit hyperactivity disorder and schizophrenia. 
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There is a growing body of pharmacological evidence supporting the 
interaction between ACh and DA in the rat prefrontal cortex. Increase of DA 
release by ACh in the prefrontal cortex seems to happen at a local level through 
nicotinic receptors (nAChR) (Rao et al., 2003, Cao et al., 2005, Rossi et al., 2005, 
Shearman et al., 2005). Inhibition of ACh esterase (Shearman et al., 2006) or 
stimulation of muscarinic receptors (Perry et al., 2001, Ichikawa et al., 2002) also 
induced the release of DA in the mPFC. Likewise, DA has been shown to influence 
ACh transmission (Laplante et al., 2004). Activation of D1 dopaminergic receptors 
(D1R) has been proposed to exert a tonic, facilitatory influence upon cholinergic 
transmission (Yang and Mogenson, 1990). Extracellular levels of ACh were 
robustly enhanced in the PFC following systemic administration of the D1R agonist 
SKF82958 (Di Cara et al., 2007) and the D3R antagonists (Lacroix et al., 2006). 
However, due to the systemic infusion of these dopamine agonists/antagonists, it is 
not clear if the modulation of ACh release by DA in these experiments occurred at 
a local level or is part of a larger neural circuitry modulation. 
 
It has also been shown that both DA and ACh modulate the activity of 
pyramidal neurons and the functional output of the mPFC (Spruston, 2008). The 
excitatory post-synaptic potential (EPSP) of pyramidal neurons in layer V of the rat 
mPFC can be attenuated by the D1R agonist SKF 81297 in vitro (Rotaru et al., 
2007). DA has been shown to have an inhibitory effect on layer V pyramidal cells in 
the rat mPFC through D2R activation in vitro (Gulledge and Jaffe, 1998, Steketee, 
2003) and in vivo (Goto and Grace, 2005). In addition, M1 mAChR stimulation in 
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layer V pyramidal cells of the rodent PrL/IL cortex produces a strong depolarization 
and leads to tonic firing by dramatically enhancing the summation of EPSP (Carr 
and Surmeier, 2007). In slices from rat PrL, nicotinic and muscarinic agonists 
modulate excitatory synaptic transmission, indicating the ascending cholinergic 
systems might participate in information processing in the PrL via control of 
ongoing excitation to pyramidal cells (Vidal and Hidalgo, 1993). 
 
Evidence for the physiological basis for the interaction between ACh, DA, 
and glutamatergic pyramidal cells is extensive, however the neuroanatomical 
correlate within the mPFC supporting this interaction has not been established. 
Diffuse transmission, rather than synaptic transmission, is a widely occurring and 
well-documented phenomenon for ACh and DA in mPFC (Descarries et al., 1997, 
Descarries, 1998, Descarries and Mechawar, 2000, Yamasaki et al., 2010). The 
current study investigated the three-dimensional anatomical relationship among the 
cholinergic system, dopaminergic system, and pyramidal cells by quantifying the 
microproximity among these three neuronal elements in the mPFC of rats using 
confocal laser-scanning microscopy. Microproximity between dopaminergic and 
cholinergic fibers or pyramidal cells (defined as relationships with a gap less than 3 
µm between two neuronal elements) was considered as a possible functional 
interaction zone. As the axonal varicosities are the site of neurotransmitters 
release, the number of en passant varicosities within the axonal segments sharing 
microproximity was quantified, as an index of possible functional activity. As well, 
the expression of D1aR and D2R by pyramidal cells and cholinergic fibers within the 
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mPFC was examined since these receptors are implicated in the top-down 
modulation of subcortical areas via descending PFC (Onn et al., 2006, Del Arco 
and Mora, 2009). For this purpose we used Drd1a-tdTomato/Drd2-EGFP double 
BAC-transgenic mice (Gong et al., 2003, Shuen et al., 2008) expressing tdTomato 
as a reporter for D1aR-expressing neurons and EGFP as a reporter for D2R-
expressing neurons. These mice enabled us to overcome limitations imposed by 
the lack of readily available antibodies that discriminate between these receptor 
subtypes. Anatomical relationships were investigated within different subregions of 
the mPFC (PrL, IL, Cg1) as well as in the layer receiving cortico-cortical input (II/III) 
and the output layer (V) of the mPFC to determine a possible regional specificity of 
the different neuronal systems. 
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Materials and Methods 
 
Animal Preparation 
 
Six Male Long Evans rats (300–325 g, Université de Montréal obtained from 
Charles River Canada (St-Constant, Québec, Canada) and three Drd1a-tdTomato 
Drd2-EGFP double transgenic mice (Gong et al., 2003, Shuen et al., 2008) 
(Université Laval) were housed in a temperature-controlled room (21–25°C) under 
natural daylight, and had free access to food and water. Animals were deeply 
anesthetized with pentobarbital (54 mg/kg body weight i.p.) and then were 
perfused transcardially with 4% paraformaldehyde at room temperature. After 
perfusion, brains were harvested and post fixed for 2 h in fresh fixative. Serial 
coronal vibratome sections (35-µm thick) were cut and collected in 0.1 M 
phosphate buffer (PBS, pH = 7.4), then stored in antifreeze (30% glycerol, 30% 
ethylene glycol, 40% NaPB 0.24 M) solution at –20°C until further use. All 
procedures were approved by the local Animal Care Committee Université de 
Montréal (rats) and Université Laval (mice) and were conducted in accordance with 
the guidelines of the Canadian Council on Animal Care. 
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Immunocytochemistry 
 
Sections were thoroughly washed in 0.1 M PBS, and then incubated in 0.3% 
H2O2 in 0.1 M PBS. The sections were then washed and incubated in 1.5% donkey 
serum in PBS-T (0.1 M phosphate buffer, pH 7.4 and 0.25% triton x-100) for 1 h. 
Rat brain sections were incubated in a cocktail of primary antibodies for 48 h at 
4°C (Table 1 ): anti-choline acetyltransferase (ChAT, 1:200; Chemicon, Billerica, 
MA, USA) for cholinergic fibers (Vaucher et al., 1997, Dotigny et al., 2008); anti-
tyrosine hydroxylase (TH, 1:1000; Pel-Freez Biologicals, Rogers, AR, USA) for 
dopaminergic fibers (Miner et al., 2003) and anti-glutamate transporter (EAAC1, 
excitatory amino acid carrier 1 protein, 1:1000, Chemicon, Billerica, MA, USA) for 
pyramidal cells (Rothstein et al., 1994, He et al., 2000, Furuta et al., 2003, Dotigny 
et al., 2008). Moreover, the pyramidal cell analysis was performed based on the 
pyramidal morphology of the EAAC1 stained cells. Triple immunolabeling of D1aR-
expressing neurons (amplification of the TomatoRed signal with anti-DsRed 
Polyclonal Antibody Rabbit, 1:200, Clonetech, Mountain View, CA, USA), D2R-
expressing neurons (amplification of the GFP signal with monoclonal mouse anti-
GFP (B-2), 1:100, SantaCruz, Santa Cruz, CA, USA), and either pyramidal cells or 
ChAT fibers were carried out on adjacent sections. After washing, the sections 
were incubated in secondary antibodies conjugated with fluorophore CY3, FITC, 
CY5 (Jackson Immunoresearch, West Grove, PA, USA) for 2 h and 30 min. Mouse 
tissue was incubated with Drd1a labeled with CY5, Drd2 labeled with FITC, and 
ChAT and pyramidal cells labeled with CY3 (Table 1 ). Then the sections were 
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washed and mounted onto slides with anti-fading mounting medium and 
coverslipped (ProLong Antifade Kit P7481, Molecular Probe, Carlsbad, CA, USA). 
Adjacent sections were stained with cresyl violet to delineate cortical layers. 
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Table 1. Combination of primary and secondary antibodies for triple-
fluorescent staining procedures. 
 
Series  Primary antibodies 
(48 h) 
Secondary antibodies 
(2 h 30) 
  Antigen AB host Dilution IgG (Donkey) Dilution 
ChAT fibers/TH 
fibers/pyramidal 
cells in rats 
 ChAT goat 1:200 Anti-goat-FITC 1:200 
 TH rabbit 1:1000 Anti-rabbit-CY5 1:200 
 EAAC1 mouse 1:1000 Anti-mouse-CY3 1:200 
 
Drd1a/Drd2/pyra
midal cells in 
mice 
 DsRed rabbit 1:200 Anti-rabbit-CY5 1:200 
 GFP goat 1:100 Anti-goat-FITC 1:200 
 EAAC1 mouse 1:1000 Anti-mouse-CY3 1:200 
 
Drd1a/Drd2/ChAT 
fibers in mice 
 DsRed rabbit 1:200 Anti-rabbit-CY5 1:200 
 GFP mouse 1:100 Anti-mouse-
FITC 
1:200 
 ChAT goat 1:200 Anti-goat-CY3 1:200 
 
Abbreviations: ChAT: choline acetyltransferase; EAAC1: excitatory amino 
acid carrier 1 protein; TH: tyrosine hydroxylase. 
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Confocal Microscopy and Quantification 
 
Based on functional or anatomical relationship between the mPFC and BF 
(Golmayo et al., 2003, Vertes, 2004, Henny and Jones, 2008), Cg1, PrL and IL in 
rats or mice were analyzed. The relationships within layer II/III and V were 
quantified because they constitute the receiving layer of the cortical input (the 
thalamic input is almost absent in this cortex) and the output layer, respectively and 
because the EAAC1 pyramidal cells are present only in these layers. The analysis 
was conducted on two consecutive coronal sections (rats: +2.76 mm from Bregma 
(Paxinos and Watson, 1997); mice: (+1.94 to +1.70 mm from Bregma; (Franklin 
and Paxinos, 2007) per animal using the Leica SP2 confocal microscope (Leica 
Microsystems, Wetzlar, Germany). Argon laser (excitation at 488 nm) was used for 
excitation of FITC, Helium Neon laser (excitation at 543 nm) was used for 
excitation of CY3 and Helium Neon laser (excitation at 633 nm) was used for 
excitation of CY5. Z-series of images were taken using 100 × oil lenses in 
sequential scanning mode for each channel and captured by Leica Confocal 
Software (LCS lite). Z-series of images were randomly taken every 200 µm, 
starting at 0.1 mm above the ventral border of the IL cortex to the dorsal border of 
Cg1 in each layer (Figure 1). A projection was defined as a series of horizontal 
optical scanning sections in the same image. When a projection was generated, 
the sampling points of the individual images superimposed along the projection 
axis were examined throughout all optical sections. In a maximum projection, the 
maximum intensity value was displayed. Each Z-series maximal projection was 
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composed of an average of three optical sections for fiber microproximity analysis 
in rats, and four optical sections for the pyramidal cells analysis in rats, to ensure 
the full capture of pyramidal cells. The step size between any two consecutive 
optical sections was set at 1 µm. In total, 28 images were taken for each section (6 
from IL, 10 from PrL, and 12 from Cg1) and a total of 336 neurons from the six rats 
were analyzed. 
 
To investigate the anatomical relationship between cholinergic and 
dopaminergic fibers, a randomly-chosen region of interest (ROI) of 12500.00 µm2 
on the maximum projection of three consecutive optical scanning sections in each 
image was examined using LCS Lite. Because the step size was set at 1 µm, the 
depth of the ROI on this projection was 3 µm, and the distance between two visible 
fibers did not span more than 3 µm in the z-axis. The total length of dopaminergic 
(TH) and cholinergic nerve fibers (ChAT) were evaluated in ROIs with ImagePro 
using manual tracing (Figure 2 ). The fiber density (µm/µm3) in each ROI was 
determined by dividing the total cholinergic or dopaminergic fiber density over the 
ROI volume. The volume of the ROI on each image was obtained by multiplying 
the area of the ROI (12500.00 µm2) with the depth of the ROI. 
 
Cholinergic and dopaminergic fiber microproximity were quantified semi-
manually using LCS lite (Figure 1). For convergence of dopaminergic and 
cholinergic fibers on mPFC pyramidal neurons, one pyramidal cell per image was 
analyzed (Figure 1). All single optical scanning sections containing that cell were 
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examined to avoid overcounting. Microproximity for cholinergic, dopaminergic and 
pyramidal neurons was operationally defined as relationship between axonal 
segments or axonal segments/pyramidal cell perikaryon with a distance of 3 µm or 
less. This was considered a conservative within-limit distance for the possibility of 
occurrence of diffuse transmission given that extracellular ACh may diffuse over 
short distances and maintain a fast form of non-synaptic transmission, due to the 
ACh esterase activity and high sensitivity of nAChR (Lendvai and Vizi, 2008, Sarter 
et al., 2009b). As well, DA transmission between elements distant from 2 to 10 µm 
has been shown. The median diffusion distance of dopamine was estimated as 4.8 
µm in the striatum, and extracellular dopamine concentration was spatially 
heterogeneous on a dimensional scale commensurate with this diffusion distance 
of individual dopamine molecules (Peters and Michael, 2000). 
 
The total length of ChAT fibers within microproximity of TH fibers was 
measured by manual tracing within each layer of each ROI and the percentage of 
microproximity per mm of axonal length was calculated. In cases where the 
microproximity between two fibers did not span more than 3 µm on the x-y axis, 
more than three consecutive optical sections composing the image were examined 
sequentially to ensure the apposition between the two fibers span more than 3 µm 
in z-axis. The same analysis was made for TH fibers in microproximity of ChAT 
fibers. Furthermore, in order to detect potential activity-related morphological 
structures of axons, the density and diameter of TH and ChAT varicosities within or 
outside the microproximity was evaluated using LCS lite. The varicosities were 
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defined as ellipsoid swelling with a transverse diameter larger than 500 nm 
(Mechawar et al., 2000). Fiber segments were analyzed for TH varicosities within 
microproximity of ChAT fibers, TH varicosities outside microproximity of ChAT 
fibers, ChAT varicosities within microproximity of TH fibers, ChAT varicosities 
outside microproximity of TH fibers. Fiber segments were randomly analyzed in 
Layers V and II/III of PrL and Cg1 and IL. In total, 1208 fiber segments were 
randomly chosen and analyzed in the rat mPFC, with a total length of 10296.65 
µm. 
 
Two mouse brain sections at the level of IL, PrL and Cg1 were analyzed 
using 100× oil lens in sequential scanning mode and captured by LCS lite. Two 
ROI‟s were randomly chosen within each layer of each subregion. To ensure 
sufficient sampling through the z-axis, sections with triple immunolabeling for 
Drd1a, Drd2, and pyramidal cells were composed of five optical sections, and each 
section immunolabeled for Drd1a, Drd2, and ChAT fibers was composed of ten 
optical sections. The step size between any two consecutive optical sections was 
set at 1 µm. The images of triple staining of Drd1a, Drd2 and pyramidal cells were 
exported to Photoshop CS3 and the presence of Drd1a and Drd2 on pyramidal 
cells were quantified by manual counting within the ROI. A total of 1810 pyramidal 
cells were examined. Only pyramidal cells with a clear outline and complete 
shapes were examined. These pyramidal cells were examined both on the five 
single optical sections and the overlay projection to ensure validity of the 
measurements. Colocalization of Drd1a and Drd2 on the images of triple labeling of 
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Drd1a, Drd2, and pyramidal cells, as well as Drd1a and ChAT, and Drd2 and ChAT 
on the images of triple immunostaining of Drd1a, Drd2, and ChAT were quantified 
using the plugin of Intensity Correlation Analysis (Li et al., 2004) in the ImageJ 
software (Collins, 2007). Mander‟s Overlap coefficient (R) was used to indicate the 
colocalization of the two neuronal elements (Manders et al., 1992), with R ranges 
between 1 and 0 with 1 being high-colocalization and 0 being low. Each single 
optical section was examined with ImageJ to avoid overcounting. Background was 
subtracted using areas that did not contain labeled cells or fibers on the same 
section. 
 
 
Statistical Analysis 
 
SPSS (17.0) Wilcoxon signed ranks test (p < 0.05, two tailed) was used to 
compare the regional effects among IL, PrL and Cg1 and the laminar effects 
between layer V and layer II/III in the rats and mice. Pearson correlation (p < 0.05, 
two tailed) was used to evaluate the correlation between the incidents of 
microproximity with fiber density in the rats. Paired student t test (p < 0.05, two-
tailed) was used to compare the density and diameter of varicosities inside 
microproximity and those outside microproximity, as well as the laminar 
distribution. An ANOVA (p < 0.05, two tailed) was used to evaluate the regional 
difference in the density and diameter of varicosities. 
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FIGURE 1 
 
 
 
Figure 1. Methodology for quantification of micropoximities with the 
Leica confocal microscope. Images of the regions of interest (Cg1, PrL, IL) were 
randomly taken using 100× oil lens in sequential scanning mode on the coronal 
sections of rats (A, Bregma, +2.7 mm) and mice (B, Bregma, +1.8 mm). 
Microphotographs were taken every 200 µm, starting at 0.1 mm above the ventral 
border of the IL cortex to the dorsal border of Cg1 in each layer (A, B). Red 
squares indicate location of scanning in Layer V, and blue squares indicate 
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location of scanning in Layer II/III. In the BAC Drd1a-tdTomato and GENSAT BAC 
Drd2-EGFP double transgenic mice, two images were taken in each layer in each 
subregion of the mPFC (B). The close appositions (within 3 µm in 3D) among 
cholinergic (green), dopaminergic (blue) fibers, and pyramidal (red) cells were 
examined on the projection image of three consecutive scanning sections (step 
size of 1 µm) as well as each single scanning section (C–E). Representative 
examples of ChAT and TH fibers microproximity are shown (squares in D). Arrows 
showed examples of pyramidal cells within microproximity of ChAT fibers and TH 
fibers (E). White scale bar: 25 µm; Yellow scale bar: 5 µm. 
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FIGURE 2 
 
 
Figure 2. Density of the ChAT (green) fibers (A,B,E,F,I,J) and TH (blue) 
fibers (C,D,G,H,K,L) in Layer II/III and Layer V of cingulate cortex (Cg1, A–D), 
prelimbic (PrL, E–H) and infralimbic (IL, I–L) subregions of the medial 
prefrontal cortex in rats. The density of ChAT fibers was greater than those of TH 
fibers and showed regional differences. Scale bar: 50 µm. 
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 Results 
 
Cholinergic and Dopaminergic Innervation of IL, PrL and Cg1 Cortical 
areas in Rats 
 
Prominent innervations of IL, PrL and Cg1 by both ChAT and TH fibers were 
observed (Figure 2). The density of TH fibers ranged from 0.008 µm/µm3 in Cg1 to 
0.020 µm/µm3 in IL, and the density of ChAT fibers ranged from 0.021 µm/µm3 in 
Cg1 to 0.044 µm/µm3 in PrL (Table 2). ChAT fibers were significantly denser than 
TH fibers in most subregions in both layers of mPFC, except in layer V of IL, where 
significant level was not reached (p < 0.05). Cg1 had significantly smaller TH and 
ChAT fiber density compared to IL and PrL in both layers (p < 0.05). Part of the 
ChAT fibers could be attributed to the intracortical cholinergic neurons but this did 
not represent more than 10% of the fibers (the ChAT staining was almost absent 
following BF quisqualic acid lesion; data not shown, but see (Vaucher et al., 1995). 
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Table 2. Dopaminergic and cholinergic fiber density in the mPFC of rats. 
 
 
All values are means ± SEM expressed in 10-2µm/µm3 from 6 animals. 
Abbreviations: ChAT: choline acetyltransferase; Ctx: cortex; TH: tyrosine 
hydroxylase. 
& Wilcoxon test, p < 0.05, two-tailed, ChAT vs TH fibers 
* Wilcoxon test, p < 0.05, two-tailed, Region-specific difference  
+ Wilcoxon test, p < 0.05, two-tailed, Layer-specific difference  
 
 Infralimbic Ctx Prelimbic Ctx Cingulate Ctx 
Layer II/III    
TH fiber density 1.56 ± 0.32*&+ 1.35 ± 0.30*& 0.79 ± 0.20*& 
ChAT fiber density 3.53 ± 1.03*&+ 4.44 ± 1.00*&+ 2.52 ± 0.43*&+ 
    
Layer V    
TH fiber density 1.95 ± 0.39*+ 1.79 ± 0.48*& 0.79 ± 0.10*& 
ChAT fiber density 2.50 ± 0.79*+ 3.24 ± 0.63*&+ 2.12 ± 0.37*&+ 
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Microproximity between ChAT and TH Fibers in IL, PrL and Cg1 of Rats 
 
The proportion of the ChAT fibers within the microproximity of TH fibers 
(Figure 3 , Table 3), ranged from 12–18% in layer V of the rat mPFC and 8–13% in 
layer II/III. Layer V of each subregion in mPFC had a significantly larger proportion 
of ChAT fibers close to TH fibers compared to layer II/III (p < 0.05), with the 
exception of IL. In addition, both Cg1 and IL had a significantly larger proportion of 
ChAT fibers in microproximity to TH fibers than PrL in both layers V and II/III. In 
contrast, 21–40% of the TH fibers in layer V as well as II/III shared relationship with 
ChAT fibers (Figure 3; Table 3). Cg1 had a significantly larger proportion of TH 
fibers in microproximity with ChAT fibers compared to IL or PrL in both layers V 
and II/III (p < 0.05). In each subregion of each layer in the mPFC, the proportion of 
TH fibers in microproximity with ChAT fibers was significantly higher than the 
proportion of ChAT fibers in microproximity to TH fibers, with the exception of 
Layer V of IL (p < 0.05). Because the tortuosity and density of TH and ChAT fibers 
were different as well as the fiber density for each neuronal system, the length of 
TH and ChAT microproximities was not symmetrical. 
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FIGURE 3 
 
 
 
Figure 3. Representative examples of ChAT/TH fibers within microproximity 
of each other (arrows) (A–D). The measured lengths of microproximity segments 
are illustrated by drawing of ChAT (green lines) and TH (blue lines) fibers (A’–D’). 
Scale bar: 5 µm. 
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Table 3. Microproximity between ChAT and TH fibers in the mPFC of rats. 
 
 
All values are percentage of axonal segment in microproximity over total 
fiber length from 6 animals. Abbreviations: ChAT: choline acetyltransferase; Ctx: 
cortex; TH: tyrosine hydroxylase.  
& Wilcoxon test, p < 0.05, two-tailed, ChAT vs TH fibers 
* Wilcoxon test, p < 0.05, two-tailed, Region-specific difference  
+ Wilcoxon test, p < 0.05, two-tailed, Layer-specific difference  
 
 Infralimbic Ctx Prelimbic Ctx Cingulate Ctx 
Layer II/III    
ChAT fibers to TH fibers 12.2*+& 8.8*+& 12.3*+& 
TH fibers to  ChAT fibers 23.9*& 28.1*& 39.6*& 
Layer V    
ChAT fibers to TH fibers 17.9*+ 12.9*+& 15.5*+& 
TH fibers to  ChAT fibers 21.4* 22.8*& 40.1*& 
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TH and ChAT Varicosities Density and Morphology within the 
Microproximity Segment or Intersegment in IL, PrL and Cg1 of Rats 
 
The density of both TH and ChAT varicosities (Figure 4 ) was significantly 
elevated within microproximity of the other fiber system in each subregion of both 
Layer V (ChAT: 0.59 ± 0.03 per µm of ChAT fiber length; TH: 0.53 ± 0.04 per µm of 
TH fiber length) and Layer II/III (ChAT: 0.56 ± 0.03, TH: 0.52 ± 0.02) in the rat 
mPFC compared to those outside microproximity (ChAT: 0.43 ± 0.06, TH: 0.36 ± 
0.03; p < 0.05; Table 4; Figure 4). The ChAT varicosity diameter within 
microproximity (664 ± 21 nm) compared to that outside microproximity (646 ± 25 
nm) was significantly larger (p = 0.001). The TH varicosity diameter (677 ± 23 nm) 
within microproximity compared to that outside microproximity was also 
significantly larger (p = 0.016). TH varicosity diameter within microproximity in layer 
V (685 ± 34 nm) was significantly larger than that in layer II/III (670 ± 17 nm; p = 
0.001, Table 5). 
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FIGURE 4 
 
 
Figure 4. Representative examples of ChAT (green) and TH (blue) 
varicosities on fiber segments within (A,B) or outside (C–F) the 
microproximity of the other fiber system in rat mPFC. Note that an increased 
density of varicosities was seen in segments in microproximity. The number of 
varicosities counted on microproximity segments are illustrated by indentations on 
drawing of ChAT (green lines) and TH (blue lines) fibers (A’–F’). Scale bar: 10 µm. 
77 
 
Table 4. Number and diameter of TH and ChAT varicosities within or outside 
microproximity in the mPFC of rats. 
 
 Infralimbic Ctx Prelimbic Ctx Cingulate Ctx 
Layer II/III    
TH varicosities within 
microproximity  
 
0.52 ± 0.03∆ 
(666 ± 28) 
 
0.53 ± 0.04∆& 
(689 ± 44&∆) 
0.50 ± 0.04∆ 
(656 ± 44) 
TH varicosities outside 
microproximity  
 
0.26 ± 0.03∆*+ 
(672 ± 62*+) 
0.33 ± 0.04∆&*+ 
(608 ± 37∆+) 
0.31 ± 0.04∆+ 
(601 ± 12*+) 
ChAT varicosities 
within microproximity  
 
0.53 ± 0.01∆ 
(664 ± 45+) 
0.59 ± 0.03∆& 
(641 ± 09&∆+) 
0.54 ± 0.04∆ 
(641 ± 23) 
ChAT varicosities 
outside microproximity  
 
0.38 ± 0.13∆ 
(654 ± 29+) 
0.38 ± 0.02∆&+ 
(620 ± 12∆+) 
0.35 ± 0.03∆+ 
(626 ± 24) 
Layer V    
TH varicosities within 
microproximity  
  
0.49 ± 0.06∆ 
(688 ± 75) 
0.56 ± 0.02∆ 
(717 ± 36) 
0.53± 0.03∆& 
(649 ± 16∆) 
TH varicosities outside 
microproximity  
 
0.33 ± 0.02∆*+ 
(639 ± 44*+) 
0.39 ± 0.04∆&*+ 
(697 ± 40*+) 
0.37 ± 0.05∆*+ 
(627 ± 13*∆+) 
ChAT varicosities 
within microproximity  
 
0.57 ± 0.05∆* 
(665 ± 21∆+) 
0.61 ± 0.04∆* 
(704 ± 35+) 
0.59 ± 0.02∆& 
(671 ± 19) 
ChAT varicosities 
outside microproximity  
 
0.36 ± 0.02∆ 
(627 ± 28*∆+) 
0.49 ± 0.06∆&+ 
(690 ± 42*+) 
0.42 ± 0.03∆+ 
(657 ± 26) 
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All values are means ± SEM expressed in number of varicosities /µm or 
(diameter)  expressed in nm from 6 animals. Abbreviations: ChAT: choline 
acetyltransferase; Ctx: cortex; TH: tyrosine hydroxylase. 
& Paired student t test, p < 0.05, two-tailed, ChAT vs TH varicosities 
∆ Paired student t test, p < 0.05, two-tailed, within compared outside 
microproximity  
* One-Way Anova, p < 0.05, two-tailed, Region-specific difference  
+ Paired student t test, p < 0.05, two-tailed, Layer-specific difference  
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Table 5. Percentage of pyramidal cells within the microproximity of ChAT 
and/or TH fibers in the mPFC of rats. 
 
 Infralimbic Ctx Prelimbic Ctx Cingulate Ctx 
Layer II/III    
ChAT fibers 80.6 86.7 90.3 
TH fibers 69.4 65.0 61.1+ 
ChAT and TH fibers 63.9 56.7 55.6+ 
Layer V    
ChAT fibers 77.8* 90.0* 88.9* 
TH fibers 86.1 80.0 87.5+ 
ChAT and TH fibers 72.2 70.0 80.6+ 
 
All values are mean percentage of pyramidal cells within the microproximity 
of fibers from 6 animals. 
* Wilcoxon test, p < 0.05, two-tailed, Region-specific difference in fiber 
density  
+ Wilcoxon test, p < 0.05, two-tailed, Layer-specific difference of fiber density  
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Microproximity between Pyramidal Cells and Cholinergic and 
Dopaminergic Fibers in IL, PrL and Cg1 of Rats 
 
The majority of pyramidal cells were found in close proximity with cholinergic 
fibers both in layer V and II/III of the three regions examined (Figure 5). In layer V, 
78% of the pyramidal cells examined in IL, 90% in PrL, and 89% in Cg1 were in 
close microproximity with cholinergic fibers (Table 5). In layer II/III these 
percentages reached 81% in IL, 87% in PrL, and 90% in Cg1. PrL and Cg1 of layer 
V had significantly more pyramidal cells innervated by ChAT fibers than layer V of 
IL (p < 0.05). As well, the majority of pyramidal cells were found in close proximity 
with dopaminergic fibers both in layer V and II/III of the three regions examined. In 
layer V, 86% of pyramidal cells examined in IL, 80% in PrL, and 87% in Cg1 were 
in microproximity with dopaminergic fibers. In layer II/III, these numbers were 69% 
in IL, 65% in PrL, and 61% in Cg1 (Table 5). There were no regional differences 
but there was significantly more pyramidal cells innervated by TH fibers in layer V 
of Cg1 than in Layer II/III of Cg1 (p < 0.05). 
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FIGURE 5 
 
 
Figure 5. Representative overlay projection images (A–D) of triple 
immunolabeling of ChAT (green), TH (blue) fibers, and pyramidal cells (red) 
from three consecutive optic sections in rat mPFC. Arrows show examples of 
microproximities. Most pyramidal cells were within microproximity of both ChAT 
and TH fibers. Scale bar: 5 µm. 
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Most pyramidal cells examined were within the microproximity of both 
cholinergic and dopaminergic fibers. In layer V, 72% of pyramidal cells examined in 
IL, 70% in PrL, and 80% in Cg1 showed microproximity with both cholinergic and 
dopaminergic fibers. In layer II/III these numbers were 64% in IL, 57% in PrL, and 
56% in Cg1 (Table 5). There were no regional differences, but there were 
significantly more pyramidal cells innervated by both ChAT and TH fibers in layer V 
of Cg1 than in Layer II/III of Cg1 (p < 0.05). In layer V, microproximity of cholinergic 
or dopaminergic fibers with pyramidal cells were observed mainly at the level of the 
cell soma, less frequently at their apical dendrites and only scarcely at their basal 
dendrites (Table 6). There was no difference in the preferred localization of the 
zone of contact of the pyramidal cell by cholinergic or dopaminergic fibers. 
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Table 6. Percentage of pyramidal cells innervated at their soma/apical 
dendrites/basal dendrites in Layer V of the mPFC of rats. 
 
 Infralimbic 
Ctx 
Prelimbic   
Ctx 
Cingulate 
Ctx 
Innervation by ChAT fibers    
soma 39.3 51.9 51.6 
apical dendrites 28.6 35.2 37.5 
basal dendrites 
 
0.0 7.4 3.1 
Innervation by TH fibers    
soma 54.8 64.6 54.0 
apical dendrites 22.6 31.3 31.8 
basal dendrites 0.0 0.0 6.4 
 
All values are means percentage of pyramidal cells innervated at 
submorphological compartment from 6 animals.  
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The proportion of pyramidal cells innervated by TH and ChAT fibers was not 
positively correlated with the fiber density in most regions in either layer, indicating 
that the innervations were not random (p < 0.05, r ranged from −0.636 to +0.636). 
The only exception was between the proportion of pyramidal cells innervated by 
ChAT fibers and ChAT fiber density in Cg1 of layer II/III (Pearson correlation, p = 
0.031, r = 0.852). Moreover, a negative correlation was found between the 
proportion of pyramidal cells innervated by both fiber systems and TH fiber density 
in IL of Layer V (Pearson correlation, p = 0.036, r = −0.840). 
 
Presence of D1a and D2 Receptors (D1aR and D2R) on Pyramidal Cells 
and ChAT Fibers in IL, PrL and Cg1 of Mice 
 
Most pyramidal cells (~ 92% to 95%) in the mPFC of mice were stained for 
GFP, i.e. expressing D2R. However, only a small proportion of pyramidal cells (~ 
16% to 26%) were stained for TdTomato, i.e. expressing D1aR (Figure 6). About 
15% to 25% of pyramidal cells expressed both EGFP and TdTomato (Table 7). No 
significant region-specific or layer-specific difference was found (p > 0.05). The 
expression of either D1aR or D2R by cholinergic fibers in the subregions of mPFC 
of mice was low, with the Mander‟s coefficient of colocalization of TdTomato and 
ChAT ranging from ~0.10 to 0.13 and of GFP and ChAT ranging from 0.22 to 0.27 
(Figure 7). No significant region-specific or layer-specific difference was found (p > 
0.05). 
 
85 
 
FIGURE 6 
 
 
 
Figure 6. Colocalization of markers of D1aR (A) or D2R (D) expression 
with EAAC1 pyramidal cells (B,E) in Drd1a-tdTomato/Drd2-EGFP mice 
(overlay images, C,F). A majority of pyramidal cells expressed Drd2 marker (stars 
in A,C) whereas a minority of pyramidal cells (crosses) expressed Drd1a 
marker(stars in D,F). Scale bar: 50 µm. 
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Table 7. Percentage of pyramidal cells containing Drd1a-tdTomato and Drd2-
EGFP in the mPFC of mice. 
 
 Infralimbic Ctx Prelimbic Ctx Cingulate Ctx 
Layer II/III    
Drd1a 21.1 24.2 16.5 
Drd2 92.6 94.4 93.3 
Drd1a and Drd2 
 
21.1 23.0 15.2 
Layer V    
Drd1a 19.3 25.6 21.5 
Drd2 94.6 92.5 92.7 
Drd1a and Drd2 18.4 24.5 20.8 
 
All values are mean percentage of pyramidal cells from 3 Drd1a-
TdTomato/Drd2-EGFP transgenic mice. Abbreviations: Ctx: cortex 
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FIGURE 7 
 
 
 
Figure 7. Colocalization of markers of D1aR (A) or D2R (D) expression 
with ChAT (B,E) in Drd1a-tdTomato/Drd2-EGFP mice (overlay images, C,F). 
The colocalization of Drd1a or Drd2 markers and cholinergic fibers was very 
scarce. Drd1a and Drd2 markers were detected in cortical cell soma but not ChAT 
fibers. Scale bar: 50 µm. 
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Discussion 
 
The goal of this study was to determine the anatomical potential for a 
modulatory interaction between cholinergic and TH afferents in the rodent mPFC 
and with the output pyramidal cells. The results indicate that the cholinergic and 
dopaminergic systems converge on pyramidal cells in mPFC to possibly modulate 
their activity. The level of dopaminergic fibers relationship with pyramidal cells is 
higher in the output layer compared to the cortico-cortical connection layer (layer 
II/III), whereas cholinergic fibers have the same extent of interaction in layers II/III 
and V. The mutual axo-axonal microproximity between the two neuronal systems 
was poor in mPFC. However, the cholinergic system appears to have more 
influence on the dopaminergic fibers since a larger proportion of the TH fibers are 
within microproximity to cholinergic fibers and the cholinergic fibers did not express 
markers of either d1ar or d2r expression. Moreover, ChAT fiber segments bore a 
higher density of varicosities compared to those outside the vicinity of TH fibers, 
which could account for an index of improved ACh transmission in these axonal 
segments. Both ChAT and TH fiber segments bore a higher density of varicosities 
within microproximity compared to those outside microproximity indicating a 
potential for elevated transmission at these sites. In addition, in the mPFC of 
Drd1a-tdTomato/Drd2-EGFP mice, pyramidal cells preferentially expressed markers 
of the inhibitory D2R over D1aR. The result of the present study suggests an 
important role in mPFC output via co-modulation of pyramidal cells by both 
cholinergic and dopaminergic fibers, and the heterogeneity of the three subregions 
89 
 
in mPFC regarding the neuroanatomical relationship among these three neuronal 
elements. 
 
Enrichment of the Microproximities 
 
Confocal microscopy offers a means in which to examine the 
neuroanatomical relationships among individual optical sections at high resolution 
in sequence through the specimen (Wouterlood et al., 2007, Ichinohe et al., 2008). 
Here we examined the frequency of microproximities between fibers and pyramidal 
cells to determine the possible functional interaction between the cholinergic and 
dopaminergic system in the PFC in the context of diffuse transmission. The primary 
interest of the current study was to investigate the extracellular microenvironment, 
where the output of mPFC is modulated by ACh and DA via diffuse transmission. 
Synaptic incidents were not counted since ACh terminals rarely form junctional 
complexes in the neocortex, and only a small proportion of DA varicosities in the 
neostriatum are synaptic (Descarries et al., 1997, Descarries et al., 2008). Rather, 
the density of varicosities in segments in microproximity were counted and 
compared to segments outside of microproximity. We hypothesized that the density 
of varicosities in an axonal segment could be related to the level of activity, like the 
experience-induced increase of the number of dendritic spines and axonal synaptic 
boutons (Stettler et al., 2006). This is in agreement with the hypothesis of the “fast 
form of non-synaptic transmission” of ACh in the rat mPFC. The criterion definition 
for the sphere of influence of ACh and DA poses a challenge due to the scarcity of 
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data describing the temporal and spatial parameters of diffuse transmission. The 
real sphere of influence for a neurotransmitter is limited by a number of factors 
including the initial number of molecules released, the sensitivity and location of 
specific receptors, the extracellular volume, the tortuosity of diffusion, the diffusion 
coefficient of the neurotransmitter, and the regionally distinct uptake mechanisms 
(Nicholson and Sykova, 1998). To our knowledge diffusion properties of DA and 
ACh in the extracellular space of mPFC are unknown. Based on ultrastructural 
studies (Chedotal et al., 1994, Vaucher and Hamel, 1995) a maximal distance of 3 
µm between two fibers was used as a conservative within-limit number for efficient 
diffuse transmission, i.e. in which neurotransmitter concentration would be 
sufficient to induce a significant effect, especially taking into consideration the rapid 
hydrolysis of ACh by AChE (Descarries et al., 1997, Descarries, 1998, Lendvai and 
Vizi, 2008). 
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Proportion of ChAT Fibers within Microproximity of TH Fibers 
 
Mutual interaction between cholinergic and dopaminergic axons 
characterized by proximity of axons within 3 µm could be observed in the mPFC. 
The frequency of microproximity was moderate for the ChAT fibers (9–18%) which 
suggests a weak resultant influence of DA on the cholinergic fibers if any, but quite 
consistent for the TH fibers (20–40%). However, the higher density of TH 
varicosities within the microproximity of ChAT fibers (ranging from 0.49 to 0.56 per 
µm), compared to those outside microproximity of ChAT fibers (ranging from 0.26 
to 0.39 per µm) raises the possibility of a DA release site which could modulate 
ChAT fibers. The value of Mander‟s coefficient of colocalization of tdTomato linked 
to the Drd1a promoter or EGFP associated with the Drd2 promoter with ChAT was 
however low (ranging from 0.10 to 0.25), suggesting that the cholinergic fibers 
were devoid of D1aR and D2R. The lack of clear labeling for markers of 
dopaminergic receptors might be due to a weak transport of the reporter protein, 
although the nigrostriatal pathway is well labeled (Shuen et al., 2008). However, 
the lack of clear labeling of dopaminergic receptors within cholinergic fibers 
indicates that the pharmacological influence of DA over ACh transmission would 
take place at the level of pyramidal cells or interneurons rather than in presynaptic 
modulation of ChAT afferents. It has been shown that DA has an influence on ACh 
release, which leaves open the potential for a local effect. However, the effect of 
DA pharmacological agents on ACh transmission might also be exerted through 
indirect mechanisms when administered systemically, like the involvement of other 
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neurotransmitters systems, instead of local mechanisms. For example, 
dopaminergic fibers might interact with cholinergic cell bodies in the BF (Smiley et 
al., 1999) or on glutamatergic input from the nucleus accumbens (Brooks et al., 
2007) to exert its influence on projecting cholinergic fibers to the mPFC. Finally, it 
cannot be excluded that immunodetection of GFP or tdTomato is weaker in the 
axon compared to the cell body because the gene is expressed in the cell body. 
While it is possible that the lack of dopaminergic receptors on cholinergic fibers 
might be due to low axonal levels of the reporter protein, axonal tdTomato protein 
is readily detectable in the striatonigral pathway (Shuen et al., 2008). 
 
Higher Proportion of TH Fibers within Microproximity of ChAT Fibers 
 
The higher proportion of TH fibers in close proximity with ChAT fibers (22–
40%), especially within layer V would predict a stronger influence of ACh upon 
dopaminergic transmission. The higher density and size of ChAT varicosities on 
the fiber segments that are within microproximity to TH fibers supports the 
possibility that ACh release modulates TH fibers in the rat mPFC. Pharmacological 
evidence also supports the notion that the microproximity of DA and ACh is 
functional since local injections of nicotine or increased level of ACh have been 
shown to increase DA release in mPFC (Shearman et al., 2005, Shearman et al., 
2006). The highest proportion of TH and ChAT microproximity occurs in layer V, 
which suggests that cholinergic fibers modulate the output of mPFC through direct 
contact to pyramidal cells as well as modulation of DA activity. However, it should 
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be noted that densities and diameters of the varicosities examined under confocal 
microscope might be slightly overestimated compared to results obtained under 
electron microscope due to the airy distribution (i.e., a gradient of intensity) of edge 
of the biological object in bitmapped images (Wouterlood et al., 2007). 
 
Combined Effects of ACh and DA on Pyramidal Cells 
 
Most pyramidal cells investigated were within the proximity of both 
cholinergic and dopaminergic fibers. This is consistent with the findings that 
dopaminergic afferents to the mPFC primarily target the cortical pyramidal cells 
(Verney et al., 1990). This spatial closeness makes it likely that dopaminergic and 
cholinergic fibers can modulate mPFC output mostly by innervating the same 
pyramidal neurons and have a combined effect on pyramidal cell output. In layer V, 
microproximities between ChAT fibers and TH fibers and pyramidal cells were 
localized on the soma and apical dendrite. This is consistent with the findings that 
the majority of the D1R and D2R are located on cell bodies and dendrites of cells 
intrinsic to the mPFC (Choi et al., 1995, Tzschentke, 2001). There were relatively 
few microproximities localized on the basal dendrites which is of importance in 
spike generation (Shu et al., 2007), but the EAAC1 staining was not sensitive 
enough to label the extent of the dendritic tree. The observed convergence of 
cholinergic and dopaminergic fibers on pyramidal cells is consistent with various 
pharmacological evidence supporting the modulation of mPFC pyramidal cells by 
ACh and DA (Gulledge and Jaffe, 1998, Carr and Surmeier, 2007, Lopez-Gil et al., 
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2009). Pyramidal cells may integrate inputs from both cholinergic and 
dopaminergic systems that in turn transmit and modulate local activity to 
subcortical target regions. In addition, cholinergic and dopaminergic systems may 
shape the excitatory output of the mPFC, since neonatal ACh or DA depletion 
results in layer V neurons having smaller apical tufts, reduced apical dendrites 
number/density and reduced basilar spine density. Furthermore, combined 
ACh/DA depletion produced morphological effects that were additive compared to 
changes produced by cholinergic and dopaminergic denervation alone (Sherren 
and Pappas, 2005). 
 
Supporting the neuromodulation of pyramidal cells by DA, are findings in the 
Drd1a-td Tomato Drd2-EGFP mice which indicate that more than 90% of the 
pyramidal cells express Drd2 and only about 20% of the pyramidal cells contain 
Drd1a. Our findings are consistent with previous findings showing that D1R were 
primarily found on non-pyramidal cells, and that D1R and D2R showed only a partial 
overlap (Vincent et al., 1993, 1995). About 20% of the pyramidal cells express 
markers for both Drd1a and Drd2, suggesting a possibility of direct D1R–D2R 
association on the same cell (Dziedzicka-Wasylewska et al., 2008). This indicates 
that dopaminergic transmission on output pyramidal cells might be inhibitory. This 
is consistent with previous studies showing an excitatory action of DA on 
GABAergic cells and an inhibitory action on pyramidal cells (Steketee, 2003). In 
contrast, cholinergic fibers have the same extent of innervation in layers II/III and 
V. This indicates that ACh might modulate both the excitatory output and input of 
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the mPFC. As ACh enhances neuronal activity, an increased cholinergic 
transmission would enhance the excitatory output of mPFC. However, the 
concomitant stimulation of TH fibers, which are inhibitory in layer V, would balance 
the level of output. According to our anatomical data, it can be suggested that the 
cholinergic afferents exerts an influence on the excitability of the mPFC at both the 
level of input from associational areas and of output, which can justify an 
involvement of ACh in retention and orienting, whereas DA would act on impulsivity 
and selectivity by decreasing the output of layer V neurons (Steckler et al., 1998). 
 
Regional Heterogeneity in mPFC 
 
In this study, region-specific differences were found among the three sub-
areas in the rat mPFC in terms of the length of ChAT and TH fibers, the incidents 
of close appositions between cholinergic and dopaminergic fibers, as well as the 
proportion of pyramidal cells innervated by cholinergic fibers. Regional 
heterogeneity in rat mPFC has been a widely-accepted view, and it was shown that 
IL, PrL and Cg1 each have different extrinsic connections and functions (Broersen 
et al., 1995, Steckler et al., 1998, Tzschentke, 2001, Heidbreder and 
Groenewegen, 2003, Thienel et al., 2009). The dense interaction of pyramidal cells 
with both ChAT and TH fibers in the mPFC did not show any significant differences 
among the three subregions, implicating the importance of this output mode via co-
modulation of pyramidal cells by both ChAT and TH fibers throughout the mPFC. 
However, more appositions between cholinergic and dopaminergic fibers were 
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found in Cg1 despite the smallest fiber density in this area, suggesting a stronger 
interaction between these systems in Cg1. This is consistent with a lower 
concentration gradient of extracellular DA in Cg1 compared to IL and dorsal PrL 
(Sesack et al., 1998, Heidbreder and Groenewegen, 2003). The results also put an 
emphasis on the relationship of pyramidal cells with cholinergic fibers in layer V of 
PrL and Cg1, suggesting a greater control of the output of these regions by ACh. 
Pharmacological evidence suggests that an increase in tonic levels of extracellular 
ACh mediated enhancement of arousal or readiness for input processing in 
operant tasks testing attention (Briand et al., 2007, Kozak et al., 2007). Since Cg1 
is involved in executive functions (Thienel et al., 2009), ACh potentially plays a role 
in executive function by modulating DA neurotransmission in this area. Finally, the 
regional difference in function of the PFC could be executed via differences in their 
connectivity to other brain regions (Steckler et al., 1998, Gabbott et al., 2005, 
Vertes, 2006, Thienel et al., 2009). 
 
Conclusion 
 
This study has shown that the anatomical positioning between the 
dopaminergic and cholinergic systems in the mPFC seems to be primarily located 
at the level of the intracortical cells. Contrary to dopaminergic fibers, cholinergic 
fibers is positioned to modulate both the input and output of mPFC and influence 
layer V pyramidal cells through direct microproximity and influence on 
dopaminergic fibers. This finding might contribute to improved pharmacological 
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therapies for the treatment of a series of diseases such as schizophrenia, 
depression, drug abuse, and attention deficit disorders that are associated with 
improper function of the PFC. 
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Abstract  
 
Diffuse transmission is an important non-synaptic communication mode in 
the cerebral neocortex, in which neurotransmitters released from en passant 
varicosities interact with surrounding cells. In a previous study we have shown that 
the cholinergic axonal segments which were in the microproximity with 
dopaminergic fibers possessed a greater density of en passant varicosities 
compared to more distant segments, suggesting an activity-dependent level of en 
passant varicosities in the axonal zone of interaction. To further evaluate this 
plastic relationship, the density of cholinergic varicosities was quantified on fiber 
segments within the microproximity of activated or non-activated pyramidal cells of 
the prefrontal cortex (mPFC). Repetitive 14 days patterned visual stimulation 
paired with an electrical stimulation of the cholinergic fibers projecting to the mPFC 
from the HDB was performed to induce persistent axonal plastic changes. The c-
Fos early gene immunoreactivity was used as a neuronal activity marker of layer V 
pyramidal cells, labeled with anti-glutamate transporter EAAC1. Cholinergic fibers 
were labeled with anti-ChAT (choline acetyltransferase) immunostaining. The 
density of ChAT+ varicosities on and the length of fiber segments within the 3 µm 
microproximity of c-Fos positive/negative pyramidal cells were evaluated on 
confocal images. More than 50% of the pyramidal cells in the mPFC were c-Fos 
immunoreactive. Density of ChAT+ varicosities was significantly increased within 3 
µm vicinity of activated pyramidal cells (0.50±0.01 per µm of ChAT+ fiber length) 
compared to non-activated cells in this group (0.34±0.001; p≤0.05) or control rats 
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(0.32±0.02; p≤0.05). Different types of stimulation (visual, HDB or visual/HDB) 
induced similar increase of the density of ChAT+ varicosities within microproximity 
of activated pyramidal cells. This study demonstrated at the subcellular level an 
activity-dependent enrichment of ChAT+ varicosities in the axonal zone of 
interaction with other neuronal elements. 
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Introduction 
 
The modulation of the cortical neuronal activity by the cholinergic system is 
mainly exerted via diffuse transmission by acetylcholine (ACh) released from 
varicosities along axons (Agnati et al., 1995, Descarries et al., 1997, Descarries, 
1998, Descarries and Mechawar, 2000, Vizi et al., 2004, Lendvai and Vizi, 2008, 
Duffy et al., 2009, Yamasaki et al., 2010). Synaptic transmission also occurs but 
more rarely. This diffuse transmission has been suggested in the medial prefrontal 
cortex (mPFC), where cholinergic neurons of the horizontal limb of the diagonal 
band of Broca (HDB) send long projections to its three subareas, the anterior 
cingulate (Cg1), the prelimbic (PrL) and the infralimbic (IL) cortex (Golmayo et al., 
2003, Vertes, 2004, Tavares and Correa, 2006, Vertes, 2006, Henny and Jones, 
2008). In these cortical regions, cholinergic stimulation induces modulation of 
pyramidal cells activity and synaptic plasticity (Golmayo et al., 2003, Henny and 
Jones, 2008, Sarter et al., 2009a, Hasselmo and Sarter, 2010, Parikh et al., 2010), 
including neuroplasticity in layer V pyramidal neurons of mPFC (Brown and Kolb, 
2001), structural alteration of the pyramidal cells (Bergstrom et al., 2008), 
glutamatergic transmission modulation (Gil et al., 1997, Gioanni et al., 1999, Hsieh 
et al., 2000, Carr and Surmeier, 2007, Gulledge et al., 2009). Through this diffuse 
interaction with glutamatergic cells, the prefrontal cholinergic fibers play an active 
role in mPFC cognitive functions (Robbins et al., 1998, Zaborszky et al., 1999, Gill 
et al., 2000, Passetti et al., 2000, Heidbreder and Groenewegen, 2003, Dalley et 
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al., 2004b, Sarter et al., 2005, Sarter et al., 2006, Carr and Surmeier, 2007, Parikh 
and Sarter, 2008). 
 
Recently, it has been suggested that en passant boutons on axonal 
segments are dynamic structures and their density along the axons is not uniform 
(Anderson and Martin, 2001, De Paola et al., 2006, Stettler et al., 2006, Zhang et 
al., 2010). Particularly, we have shown that the density of cholinergic and 
dopaminergic varicosities was significantly higher within fiber segments in 
reciprocal microproximity compared to more distant segments, suggesting 
variations in the density of varicosities could be a useful index for neuronal 
interaction (Zhang et al., 2010). In stationary Macky monkeys, frequent en passant 
boutons addition and elimination along collaterals were observed with in vivo two-
photon imaging (Stettler et al., 2006), as seen for dendritic spines plasticity 
(Luscher et al., 2000, Muller et al., 2000). Cell type-specific rearrangements of 
axonal boutons were also observed in the mouse barrel cortex in vivo (De Paola et 
al., 2006). 
 
In the present study, we hypothesized that varicosity density along the axon 
can be an index of localized neuronal interactions. Cholinergic varicosities on fiber 
segments within the vicinity of activated pyramidal cells of mPFC were examined in 
visually and HDB electrically stimulated rats using triple immunolabelling and 
confocal microscopy.  The stimulation paradigm was designed to allow both post-
synaptic (visual stimulation) and pre-synaptic (HDB stimulation) activation of 
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pyramidal cells in the mPFC which corresponds to the mode of cholinergic system 
functioning, i.e. enhancement of afferent sensory inputs through Hebbs-like 
synaptic plasticity (Kang and Vaucher, 2009a, Hasselmo and Sarter, 2010). HDB 
stimulation activates the cell soma of the cholinergic projections to the mPFC to 
modulate pyramidal cells (Livingstone et al., 2010, Thomsen et al., 2010), whereas 
signal induced by visual stimulation was expected to be modulated and processed 
by the neuronal elements in mPFC as the final step of the visual processing 
hierarchy (Golmayo et al., 2003, Livingstone et al., 2010). A two weeks repetitive 
stimulation was designed to allow structural changes correlating this consolidated 
neuronal network. Activation of the glutamatergic pyramidal cells was identified by 
a colocalization of the early gene c-Fos expression and the excitatory amino acid 
carrier protein 1 (EAAC1), a neuron-specific glutamate transporter (GluT) 
(Rothstein et al., 1994, Dotigny et al., 2008, Zhang et al., 2010). Cholinergic fibers 
and varicosities were labeled by choline acetyltransferase (ChAT) (Dotigny et al., 
2008). Consistent with our hypothesis, significant elevation of ChAT+ varicosity 
density in the vicinity of c-Fos+/GluT(EAAC1)+ cells compared to those in the 
vicinity of c-Fos negative pyramidal cells were observed, suggesting dynamics of 
varicosity density as a useful index for the neuronal activity. 
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Methods 
 
Animal preparation 
 
Thirteen male Long Evans rats (300–325 g) obtained from Charles River 
Canada (St-Constant, Québec, Canada) were housed in a temperature-controlled 
room (21–25°C) under natural daylight, and had free access to food and water.  All 
procedures were approved by the local Animal Care Committee (Comité de 
déontologie de l'expérimentation sur les animaux) and were conducted in 
accordance with the guidelines of the Canadian Council on Animal Care (protocol 
number: 10-133). 
 
For chronic electrode HDB implantation, animals were anesthetized with 
isoflurane (induction 5%, maintain 3%) and placed in a stereotaxic apparatus. The 
stimulating tungsten electrode (impedance: 2 mΩ, FHC, Bowdoinham, ME, USA) 
denuded at each tip was implanted in the left HDB (mm from Bregma: AP -0.3, L 
+2.0, DV -9.0) via a hole made by a drill. The electrode was secured by dental 
cement. A post-operative delay of 2 days was allowed before any further 
experiment. 
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Stimulation paradigm 
 
Awake rats were restrained and head fixed in a frame surrounded by three 
monitors (one in the front and two at each side, placed 21 cm away from the eyes 
of the rat) during 10 min for 14 days. Three groups of rats were prepared for 
treatment. Control group (n = 4) received no visual stimulation (grey screen) and 
no HDB stimulation, visually stimulated group (n = 3) received visual stimulation 
(sine-wave grating) only, HDB stimulated group (n = 3) received HDB electrical 
stimulation only, and visual/HDB stimulated group (n = 3) received both HDB 
electrical stimulation and visual stimulation. All 13 animals including the controls 
received a chronic electrode implantation. Visual training was accomplished via 
exposition of the animal to a sine-wave grating stimulus (orientation 30°, contrast 
90%, 0.12 cycle/deg, phase converting at 1 Hz, produced by Vpixx software, v 8.5; 
Sentinel Medical Research Corp., Quebec, Canada) displayed on the three 
computer monitors (LG, luminance 37 cd/m2) for 10 minutes. HDB electrical 
stimulation was performed over the same 10 min period using pulses (100 Hz, 0.5 
ms, 50 μA, 1 sec on/1 sec off) generated (Pulsemaster A300, WPI, Sarasota, FL) 
and delivered through an isolation unit (WPI 365, WPI, Sarasota, FL) through the 
chronically implanted electrode. 
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Immunocytochemistry 
 
One week after the last stimulation, animals were anesthetised with 
isoflurane, and received a 20 min visual stimulation. This one week period was 
allowed for consolidation of the neuronal network involved during training and also 
for measuring discrimination performance of rats in the visual water maze task 
(Prusky et al., 2000, Dotigny et al., 2008, Kang and Vaucher, 2009b) (data outside 
of the focus of the present paper, not shown). Rats were then deeply anesthetised 
with pentobarbital (54 mg/kg body weight i.p.) and perfused transcardially with 4% 
paraformaldehyde at room temperature. After perfusion, brains were harvested,  
post fixed for 2 h in fresh fixative and stored in 0.1 M phosphate buffer (PBS, pH = 
7.4) overnight. Serial coronal vibratome sections (35 µm thick) from mPFC  (at the 
level of Bregma + 2.7-2.2 mm) were cut using a vibratome (Leica microsystems), 
collected serially in 24 wells plates (4 sections/well) in 0.1 M phosphate buffer 
(PBS, pH = 7.4), so the AP level of the sections could be easily identified according 
to their position in the plate and anatomical references. Sections were then stored 
in antifreeze (30% glycerol, 30% ethylene glycol, 40% NaPB 0.24 M) solution at –
20°C until further use. Selected sections were thoroughly washed in 0.1 M PBS 
and incubated in 0.3% H2O2 in 0.1 M PBS for 20 min. The sections were then 
washed and incubated in 1.5% donkey serum in PBS-T (0.1 M phosphate buffer, 
pH 7.4 and 0.25% triton x-100) for 1 h for non specific sites blockade. To examine 
the ChAT+ varicosities in vicinity of c-Fos expressing pyramidal cells, rat brain 
sections were incubated in a cocktail of primary antibodies for 24 h at room 
temperature (Table 1): anti-ChAT (1:200; Chemicon, Billerica, MA, USA) for 
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cholinergic fibers; anti-c-Fos (1:10000; Oncogene Research Products, San Diego, 
CA, USA) for c-Fos expressing cells (Hughes and Dragunow, 1995, Herdegen and 
Leah, 1998, Dotigny et al., 2008) and anti-GluT(EAAC1) (1:500, Chemicon, 
Billerica, MA, USA) for pyramidal cells (Rothstein et al., 1994, Dotigny et al., 2008, 
Zhang et al., 2010). The morphology of GluT(EAAC1)+ cells was carefully 
examined and the analysis was made on the cells showing a clear pyramidal cell 
morphology. They were thus named pyramidal cells instead of GluT(EAAC1)+ 
cells. After washing, the sections were incubated in secondary antibodies 
conjugated with fluorophore FITC, CY5, TRITC (Jackson Immunoresearch, West 
Grove, PA, USA) for 2 h 30 (Table 1). To examine the c-Fos+ activity and the 
number of pyramidal cells on a larger scale, adjacent sections were double 
immunostained with anti-cFos and anti-GluT(EAAC1), and coupled with TRITC and 
FITC. Then the sections were washed and mounted onto slides with Vectashield 
mounting medium (Vector Laboratories, Burlingame, CA, USA). 
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Table 1: Combination of primary and secondary antibodies for double and 
triple-fluorescent staining procedures 
 
Series Primary antibodies Secondary antibodies 
 Antigen Host Dilution Donkey IgG Dilution 
ChAT/c-Fos/ 
GluT(EAAC1) 
ChAT goat 1:200 Anti-goat-FITC 1:200 
c-Fos rabbit 1:10000 Anti-rabbit-CY5 1:200 
GluT(EAAC1) mouse 1:500 Anti-mouse-
TRITC 
1:200 
c-Fos/ 
GluT(EAAC1) 
c-Fos rabbit 1:10000 Anti-rabbit-CY5 1:200 
GluT(EAAC1) mouse 1:1000 Anti-mouse-
TRITC 
1:200 
 
Abbreviations:   ChAT: choline acetyltransferase;   GluT(EAAC1): glutamate 
transporter. 
 
 
Confocal microscopy and quantification 
 
Confocal microscopy offers a good means to explore into the 
neuroanatomical relationships in the three dimensions (x, y, z). Argon laser 
(excitation at 488 nm) was used for excitation of FITC, Helium Neon laser 
(excitation at 543 nm) was used for excitation of TRITC and Helium Neon laser 
(excitation at 633 nm) was used for excitation of CY5 via the Leica SP2 confocal 
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microscope (Leica Microsystems, Wetzlar, Germany). The pinhole size was always 
set at Airy One (Beam expander 3) and the zoom factor remained at 1 throughout 
the imaging. On the sections with triple immunostaining, Z-series of images were 
taken using 100× oil lens (Plan Apochromatic; Numerical aperture: 1.4) in 
sequential scanning mode and with an image size of 1024 x 1024 pixels for each 
channel and captured by Leica Confocal Software (LCS lite). Sections with c-
Fos/GluT(EAAC1) double immunostaining were imaged using 40× oil lens in 
sequential scanning mode and with an image size of 1024 x 1024 pixels. The step 
size between any two consecutive optical sections was set at 1 μm. A confocal 
projection was a series of horizontal optical scanning sections in the same image. 
When a projection was generated, the sampling points of the individual images 
superimposed along the projection axis were examined throughout all optical 
sections. In a maximum projection, the maximum intensity value was displayed. On 
those coronal sections, the dendrites of the pyramidal cells in layer V extended 
toward the direction of the pial surface and sometimes spanned into upper layers. 
The field size of 150 µm x 150 µm was sufficient to capture the complete shape of 
pyramidal soma and dendrites in the XY direction. To fully capture the full shape of 
soma and dendrites of pyramidal cells in the Z-direction, projection images with a 
total depth of 3 µm instead of single optical scanning images were used for 
quantification. Two ROI‟s (Regions of Interest) were randomly chosen within each 
subregion of the mPFC. 
 
111 
 
Based on functional or anatomical relationship between the mPFC and BF 
(Golmayo et al., 2003, Vertes, 2004, Henny and Jones, 2008), Cg1, PrL and IL 
were analyzed. The neuronal relationships within layer V were quantified because 
they constitute the principal cortical output layer (Gabbott et al., 2005, Bergstrom et 
al., 2008). Confocal images could be confidently ascribed to layer V on the basis of 
the depth of the image below the surface and the characteristics of the distribution 
and shape of pyramidal cells. The density of ChAT+ varicosities on fiber segments 
within the microproximity (3 μm or less) (Zhang et al., 2010) of pyramidal cells 
immunoreactive or not with c-Fos in visual/HDB animals were quantified on 
projection images using Leica confocal software (LAS AF lite). In contrast, only the 
density of ChAT+ varicosities on fiber segments within the microproximity c-Fos 
negative pyramidal cells were examined in control animals, since 98% of the 
pyramidal cells were c-Fos negative (Table 2). To see if it is possible to further 
differentiate the major factor(s) contributing to the morphological changes of 
cholinergic fibers associated with local neuronal activity, the density of ChAT+ 
varicosities on fiber segments within the microproximity c-Fos positive pyramidal 
cells in HDB stimulation only group and in visual stimulation only group were also 
examined in layer V of IL. Considering the rapid hydrolysis of ACh by acetyl 
cholinesterase (Descarries et al., 1997, Descarries, 1998, Lendvai and Vizi, 2008), 
the present research adopted a conservative within-limit number for efficient diffuse 
transmission of ACh, 3 µm in three-dimensions (x, y, z axis in confocal microscopy) 
(Zhang et al., 2010), as a maximal sphere of concentration for ACh to induce 
significant effect (Chedotal et al., 1994, Vaucher and Hamel, 1995). The varicosity 
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density didn‟t vary much with different sections or animals within the same group, 
indicating accurate and reliable detection of varicosities. In total, ChAT+ 
varicosities were counted on 4931.88 µm of ChAT+ fiber segments within the 
vicinity of 546 pyramidal cells (259 of which being c-Fos+). The density of c-Fos+, 
pyramidal and c-Fos+/pyramidal cells were quantified by visual examination using 
photoshop CS3. Each ROI (i.e., each single projection image) covered 3 µm in 
depth of the tissue and corresponded to a field size of 4.3x105 µm3. Therefore, the 
number of c-Fos+ cells was expressed as the number per 4.3x105 µm3. In total, 
3764 pyramidal cells and 4012 c-Fos+ cells were quantified on confocal images of 
double immunolabeling of c-Fos+ and pyramidal cells (40X, oil), within a total 
sampling area of 5.20 x 107 µm3. 
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Table 2: Number of c-Fos+ cells and Pyramidal cells in layer V of mPFC 
 
Number of 
c-Fos+ 
cells 
Number of 
Pyramidal 
cells 
Percentage of 
Pyramidal cells 
which are c-Fos+ 
Percentage of c-
Fos+ cells which 
are 
GluT(EAAC1)+ 
Visual/HDB stimulation     
Infralimbic Ctx 87±39&▲ 30±2▲ 73& 25▲ 
Prelimbic Ctx 80±34&▲ 32±12 78&▲ 31▲ 
Cingulate Ctx 53±27& 31±5 65& 38&▲ 
Visual stimulation     
Infralimbic Ctx 13±6■ 39±15 9*■ 33■ 
Prelimbic Ctx 8±6*■ 33±14 5■ 23■ 
Cingulate Ctx 7±6■ 30±5 8*■ 51* 
HDB stimulation     
Infralimbic Ctx 39±15▲■∆ 46±8▲ 49■∆ 59▲■∆ 
Prelimbic Ctx 37±15▲■∆ 42±14 48▲■∆ 60▲■∆ 
Cingulate Ctx 22±11■∆ 38±5 35■∆ 62▲∆ 
Control     
Infralimbic Ctx 5±3&∆ 38±13 2*&∆ 16∆ 
Prelimbic Ctx 2±1*&∆ 37±8 2&∆ 24∆ 
Cingulate Ctx 1±1&∆ 38±11 0*&∆ 0*∆& 
All values are means ± SEM (number of cells / 4.3x105 µm3) or percentage 
of colocalization of Pyramidal and c-Fos+ cells from 13 adult rats in visual/HDB 
stimulation group. Abbreviations: Ctx: cortex; GluT(EAAC1): glutamate transporter; 
HDB: horizontal limb of the diagonal band; mPFC: medial prefrontal cortex. 
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* p ≤ 0.05, Mann-Whitney U test, two-tailed, group-specific difference 
between control and visual stimulation. 
∆ p ≤ 0.05, Mann-Whitney U test, two-tailed, group-specific difference 
between control and HDB stimulation. 
& p ≤ 0.05, Mann-Whitney U test, two-tailed, group-specific difference 
between control and visual/HDB stimulation. 
▲ p ≤ 0.05, Mann-Whitney U test, two-tailed, group-specific difference 
between visual/HDB stimulation and HDB stimulation. 
■ p ≤ 0.05, Mann-Whitney U test, two-tailed, group-specific difference 
between visual stimulation and HDB stimulation. 
 
 
Statistics 
 
All the statistics in the present study were processed with SPSS (17.0).  For 
each biological parameter investigated in this study (varicosity density, varicosity 
diameter, fiber segment length, c-Fos activity, percentage of c-Fos activated 
pyramidal cells, etc.), region-specific comparisons were carried out between any of 
the subregions in the mPFC in each group (Wilcoxon signed-rank test for paired 
samples, p ≤ 0.05, two-tailed), and group-specific comparisons were made 
between any of the groups in each subregion of the mPFC (Mann-Whitney U test, 
p ≤ 0.05, two-tailed). 
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Results 
 
C-Fos activation of GluT (EAAC1)+  cells in layer V of the mPFC 
 
c-Fos immunoreactivity in layer V of the mPFC was significantly greater in 
visual/HDB stimulation and HDB stimulation group compared to control or to visual 
stimulation groups (Mann-Whitney Test, p ≤ 0.05, two-tailed, Fig. 1, Table 2, 3). It 
was also significantly greater in PrL and IL of visual/HDB stimulation group 
compared to HDB stimulation group but not in Cg1 (Table 2), suggesting that our 
site of HDB stimulation exerted a modulating effect on sensory processing mainly 
in PrL and IL instead of Cg1. c-Fos immunoreactivity in PrL was also significantly 
greater in visually stimulated rats compared to control rats (Mann-Whitney Test, p 
≤ 0.05, Fig. 1, Table 2, 3).  There was no regional difference in the number of c-
Fos+ cells (Wilcoxon signed-rank test, p > 0.05, two-tailed; Fig. 1, Table 2, 3). 
 
Consequently, the proportion of c-Fos immunoreactive pyramidal cells was 
significantly different (Mann-Whitney Test, p ≤ 0.05, Table 2, 3) among the four 
groups of rats. In visual/HDB stimulation group, the majority of the pyramidal cells 
were c-Fos immunoreactive (65% in Cg1, 78% in PrL, and 73% in IL) (Fig. 2, Table 
2, 3). This proportion was significantly lower in HDB stimulation group (35% in Cg1, 
48% in PrL and 49% in IL). Only 0 to 2% and 5 to 9% of the pyramidal cells were c-
Fos immunoreactive in the mPFC from control rats and visually stimulated rats, 
respectively. This was significantly lower compared to either visual/HDB stimulation 
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group (Mann-Whitney Test, p ≤ 0.05, Table 2, 3) or HDB stimulation group (Mann-
Whitney Test, p ≤ 0.05, Table 2, 3), suggesting the frontal cortical representation of 
visual stimuli was enhanced by HDB input into mPFC. No significant difference in 
the number of pyramidal cells in mPFC was found among the four different groups 
of animals (Table 2), with the exception of IL between HDB stimulation group and 
visual/HDB stimulation group, which could be possibly attributed to a slight 
overexpression of GluT(EAAC1) protein in the HDB stimulated animals – resulting 
in an enhanced detectability of the glutamatergic cells. No significant regional 
difference in the proportion of c-Fos+ pyramidal cells was found for each group 
(Wilcoxon signed-rank test, p > 0.05, two-tailed). 
 
The proportion of c-Fos+ cells that were glutamatergic (labeled for 
GluT(EAAC1)) was significantly greater in HDB stimulation group (from 59 to 62%) 
compared to visual/HDB stimulation groups (from 25 to 38%, Mann-Whitney Test, 
p ≤ 0.05, Table 2), or visual stimulation group (from 23 to 33%, Mann-Whitney 
Test, p ≤ 0.05, Table 2). 
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Figure 1.  
 
 
 
Figure 1. c-Fos immunoreactivity in layer V of the mPFC. Representative 
examples of c-Fos activity in layer V of Cg1 (A–C), PrL (D–F), and IL (G–I) in 
visual/HDB stimulated (A,D,G), visual stimulated (B,E,H) and control (C,F,I) rats. c-
Fos+ cells appeared as red cores. In the visual/HDB stimulation group, there were 
significantly lower c-Fos+ cells in Cg1 compared to PrL or IL. There was no 
significant difference in c-Fos activity between PrL and IL. In all the three 
subregions of mPFC there was significant enhancement of c-Fos activity in 
visual/HDB stimulation rats compared to control or visual stimulated rats. 
Abbreviations: Cg1: cingulate cortex; IL: infralimbic cortex; mPFC: medial 
prefrontal cortex; PrL: prelimbic cortex. Scale bar: 50 µm. 
 
 
118 
 
Table 3. p values of group-specific effects. 
 Control 
vs. 
Visual 
Control 
vs. HDB 
Control 
vs. 
Visual/ 
HDB 
(cFos+) 
Control 
vs. 
Visual/ 
HDB 
(cFos-) 
Visual 
vs. HDB 
Visual 
vs. 
Visual/ 
HDB 
(cFos+) 
HDB vs.  
Visual/ 
HDB 
(cFos+) 
Visual/ 
HDB 
(cFos+) vs.  
Visual/ 
HDB(cFos-) 
Number of 
cFos+ cells 
        
Cg1 0.077 0.034* 0.034* ─ 0.050* 0.050* 0.127 ─ 
PrL 0.034*
 
0.034* 0.034* ─ 0.050* 0.050* 0.050* ─ 
IL 0.077 0.034* 0.034* ─ 0.050* 0.050* 0.050* ─ 
Number of 
pyramidal cells 
        
Cg1 0.480 1.000 0.480 ─ 0.127 0.513 0.127 ─ 
PrL 0.724 0.724 0.724 ─ 0.827 0.827 0.275 ─ 
IL 0.724 0.480 0.289 ─ 0.376 0.513 0.050* ─ 
ChAT+ 
varicosity 
density 
        
Cg1 ─ ─ 0.034* 0.480 ─ ─ ─ 0.050* 
PrL ─ ─ 0.034* 1.000 ─ ─ ─ 0.050* 
IL 0.032* 0.032* 0.034* 0.157 1.000 1.000 0.275 0.050* 
ChAT+ 
varicosity 
diameter 
        
Cg1 ─ ─ 0.724 0.289 ─ ─ ─ 0.513 
PrL ─ ─ 0.077 0.289 ─ ─ ─ 0.827 
IL 0.289 0.724 0.034* 0.034* 0.513 0.050* 0.513 0.513 
ChAT+ fiber 
length 
        
Cg1 ─ ─ 1.000 0.034* ─ ─ ─ 0.127 
PrL ─ ─ 0.289 0.034* ─ ─ ─ 0.275 
IL 0.034* 0.0513 0.034* 0.034* 0.513 0.275 0.827 0.275 
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All values are obtained p values of group-specific effects in the c-Fos 
immunoreactivity and ChAT+ varicosity density/diameter and ChAT+ fiber length 
within microproximity of pyramidal cells in 4 groups of rats: control, visual 
stimulation only, HDB stimulation only, and visual/HDB stimulation. Symbol* 
indicates significant p values (Mann-Whitney U test, p ≤ 0.05, two-tailed). 
 
Figure 2.  
 
 
 
Figure 2. Colocalization of c-Fos and GluT(EAAC1) in pyramidal cells in layer 
V of mPFC. Representative examples of c-Fos (red, A) and GluT(EAAC1) (green, 
B) immunostaining and their colocalization (C) in layer V of PrL in the mPFC of 
visual/HDB stimulated rats. Arrowheads point to examples of colocalization of c-
Fos+ cells and pyramidal cells. Note that the majority of pyramidal cells were 
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immunoreactive for c-Fos, whereas only a small proportion of c-Fos+ cells were 
stained for GluT(EAAC1). Abbreviations: ChAT: choline acetyltransferase; 
GluT(EAAC1): glutamate transporter; mPFC: medial prefrontal cortex; PrL: 
prelimbic cortex. Scale bar: 50 µm. 
 
 
Activation-dependent elevation of the density of ChAT+ varicosities in 
layer V of the mPFC 
 
In layer V of the mPFC of visual/HDB stimulation group, a higher density of 
ChAT+ varicosities was found on axonal fiber segments within the vicinity (3 µm or 
less) of c-Fos+ pyramidal cells compared to those within the vicinity of non-
activated pyramidal cells in visual/HDB stimulation or control group, suggesting a 
localized activity-dependent enrichment of ChAT+ varicosities (Mann-Whitney Test, 
p ≤ 0.05, two-tailed, Fig. 3, 4, Table 3, 4). No significant difference was found in the 
ChAT+ varicosity density within the proximity of non-activated pyramidal cells 
between visual/HDB stimulation group and control group in all three subareas 
(Mann-Whitney Test, p = 0.034, two-tailed, Table 3, 4, Fig. 4), indicating the 
increase of ChAT+ varicosity density within the proximity of c-Fos+ pyramidal cells 
in visual/HDB stimulation group was indeed due to relevant neuronal activity. In the 
control group, all the quantification was done on c-Fos negative pyramidal cells, 
since 98% of the pyramidal cells were c-Fos negative (Table 2). 
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In layer V of IL a higher density of ChAT+ varicosities was found on axonal 
fiber segments within the vicinity of c-Fos+ pyramidal cells of both visual 
stimulation group (0.47 ± 0.03 per µm of ChAT+ fiber length) and HDB stimulation 
group (0.45 ± 0.04 per µm of ChAT+ fiber length) compared to those within the 
vicinity of c-Fos negative pyramidal cells in control group (0.31 ± 0.03 per µm of 
ChAT+ fiber length, Mann-Whitney Test, p = 0.032, two-tailed, Fig. 3, Table 3, 4), 
suggesting either visual stimulation alone or HDB stimulation alone could induce 
localized activity-dependent enrichment of ChAT+ varicosities in the mPFC.  The 
increase of the ChAT+ varicosity density within the microproximity of  c-Fos+ 
pyramidal cells was about the same level in these groups as in visual/HDB 
stimulation group, since no statistical difference was found between these groups 
(Mann-Whitney Test, p > 0.05, two-tailed, Fig. 3, Table 3, 5). 
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Figure 3.  
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Figure 3. Evaluation of ChAT+ varicosity density on fiber segments within 
microproximity of activated or nonactivated pyramidal cells. Representative 
examples of projection images of triple immunostaining for c-Fos (blue), 
GluT(EAAC1) (red) and ChAT (green) in layer V of the mPFC (A–P) of ChAT+ 
varicosity in microproximity of activated pyramidal cells in visual/HDB stimulation 
group, visual stimulation only group, and HDB stimulation only group (the three top 
panels), and for ChAT+ varicosity in microproximity of nonactivated pyramidal cells 
in the visual/HDB stimulation group and the control group (the bottom two panels) 
D',H',L',P', T': Drawing of ChAT+ fibers (green lines) within 3 µm microproximity 
(dashed line) of c-Fos+ pyramidal cells (red perimeter with a blue nucleus) or non-
activated pyramidal cells (red perimeter without blue nucleus) in layer V of the 
mPFC. Representative images were taken from IL and PrL. ChAT+ varicosities 
(illustrated by dots on the green ChAT+ fibers) were quantified on fiber segments 
within 3 µm microproximity of pyramidal cells. Note that an increased density of 
varicosities was seen in segments in microproximity of activated cells compared to 
non-activated cells. Abbreviations: ChAT: choline acetyltransferase; GluT(EAAC1): 
glutamate transporter; Cg1: cingulate cortex; IL: infralimbic cortex; mPFC: medial 
prefrontal cortex; PrL: prelimbic cortex. Scale bar: 10 µm. 
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Figure 4. 
 
 
 
Figure 4. ChAT+ varicosities density on fiber segments within microproximity 
of activated or nonactivated pyramidal cells. Within the visual/HDB stimulation 
group, the density of ChAT+ varicosities on fiber segments within microproximity of 
nonactivated cells (green bars) was lower than on fiber segments within 
microproximity of activated pyramidal cells (blue bars) in layer V of every subregion 
of mPFC investigated. In contrast, the density of ChAT+ varicosities fiber segments 
within microproximity of nonactivated cells in the control group (red bars) was not 
significantly different from those within microproximity of nonactivated cells in the 
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visual/HDB stimulation group, but significantly lower than those within 
microproximity of activated pyramidal cells in the visual/HDB stimulation. Symbol * 
indicate significant difference in the density of ChAT+ varicosities on fiber 
segments within microproximity of activated pyramidal cells compared to those 
within microproximity of nonactivated pyramidal cells (p≤0.05, Mann-Whitney U 
test, two-tailed). Abbreviations: Cg1: cingulate cortex; ChAT: choline 
acetyltransferase; IL: infralimbic cortex; PrL: prelimbic cortex. 
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Table 4. Density and diameter of ChAT+ varicosities and length of ChAT+ 
fiber segments within microproximity of Pyramidal cells in Layer V of mPFC. 
 
 IL PrL Cg1 
Visual/HDB stimulation     
Microproximity with 
c-Fos+ pyramidal cells 
   
Density of ChAT+ varicosities 0.51±0.06*& 0.49±0.06*& 0.48±0.03*& 
Diameter of ChAT+ varicosities(nm) 608±10& 602±14 601±28 
ChAT+ fiber length(µm) 9.9±1.1 9.7±1.5 9.4±2.2* 
Microproximity with non-activated 
pyramidal cells 
   
Density of ChAT+ varicosities 0.34±0.02* 0.34±0.05* 0.34±0.03* 
Diameter of ChAT+ varicosities(nm) 626±36▲ 598±24 608±20 
ChAT+ fiber length(µm) 9.1±0.9▲ 8.3±0.6▲ 7.1±0.4▲ 
Control     
Microproximity with non-activated 
pyramidal cells 
   
Density of ChAT+ varicosities 0.31±0.03&+ǂ 0.34±0.02& 0.32±0.04& 
Diameter of ChAT+ varicosities(nm) 581±6&▲ 580±16 596±15 
ChAT+ fiber length(µm) 12.9±1.1▲+ 10.9±0.9▲ 10.1±0.7▲ 
All values are means ± SEM in visual/HDB stimulation rats and control rats. 
Density of ChAT+ varicosities is expressed in number of varicosities / µm of ChAT+ 
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fiber segment. Diameter of ChAT+ varicosities is expressed in nm. ChAT+ fiber 
length is expressed in µm. Abbreviations: Cg1: cingulate cortex; ChAT: choline 
acetyltransferase; IL: infralimbic cortex; PrL: prelimbic cortex; GluT(EAAC1): 
glutamate transporter; HDB: horizontal limb of the diagonal band;  mPFC: medial 
prefrontal cortex. 
* p ≤ 0.05, Mann-Whitney U test, two-tailed,  comparing microproximity of 
Pyramidal /c-Fos+ cells to microproximity of Pyramidal cells not immunoreactive to 
c-Fos within visual/HDB stimulation group. 
& p ≤ 0.05, Mann-Whitney U test, two-tailed,  comparing microproximity of 
Pyramidal /c-Fos+ cells in visual/HDB stimulation group to microproximity of 
Pyramidal cells not immunoreactive to c-Fos in control group. 
▲ p ≤ 0.05, Mann-Whitney U test, two-tailed,  comparing microproximity of 
Pyramidal cells not immunoreactive to c-Fos in visual/HDB stimulation group to 
control group. 
+ p ≤ 0.05, Mann-Whitney U test, two-tailed,  comparing microproximity of 
Pyramidal /c-Fos+ cells in visual stimulation group to microproximity of Pyramidal 
cells not immunoreactive to c-Fos in control group. 
ǂ p ≤ 0.05, Mann-Whitney U test, two-tailed, comparing microproximity of 
Pyramidal /c-Fos+ cells in HDB stimulation group to microproximity of Pyramidal 
cells not immunoreactive to c-Fos in control group. 
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Table 5. Density and diameter of ChAT+ varicosities and length of ChAT+ 
fiber segments within microproximity of activated pyramidal cells in Layer V 
of IL. 
 
IL Visual 
stimulation 
HDB 
stimulation 
Visual/HDB 
stimulation 
Microproximity with 
c-Fos+ pyramidal cells 
   
Density of ChAT+ varicosities 0.47±0.03* 0.45±0.04* 0.51±0.06* 
Diameter of ChAT + varicosities (nm) 578±21 598±27 608±10* 
ChAT+ fiber length (µm) 9.3±1.6* 10.2±1.4 9.9±1.1 
 
All values are means ± SEM in 3 groups of rats: visual stimulation only, HDB 
stimulation only, and visual/HDB stimulation. No statistical significance was found 
among these 3 groups regarding ChAT+ varicosity density, diameter or fiber length 
(p > 0.05, Mann-Whitney U test, two-tailed). Density of ChAT+ varicosities is 
expressed in number of varicosities / µm of ChAT+ fiber segment. Diameter of 
ChAT+ varicosities is expressed in nm. ChAT+ fiber length is expressed in µm. 
Abbreviations: ChAT: choline acetyltransferase; IL: infralimbic cortex; HDB: 
horizontal limb of the diagonal band. 
* p ≤ 0.05, Mann-Whitney U test, two-tailed,  comparing microproximity of 
Pyramidal /c-Fos+ cells to microproximity of Pyramidal cells not immunoreactive to 
c-Fos in control group.  
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Diameter of ChAT+ varicosities in layer V of the mPFC 
 
The diameter of ChAT+ varicosities within the vicinity of c-Fos+ pyramidal 
cells or pyramidal cells of IL in visual/HDB stimulation group were significantly 
bigger than those within the vicinity of pyramidal cells of IL in control group and in 
visual group, which could suggest more modulation from HDB in IL compared to 
PrL and Cg1 (Mann-Whitney Test, p ≤ 0.05, two-tailed, Table 3, 4). 
 
No regional difference among Cg1, PrL, and IL was found for each 
parameter (Wilcoxon signed-rank test, p > 0.05, two-tailed). 
 
Longer ChAT+ fiber segment within microproximity of c-Fos+ 
pyramidal cells in layer V of Cg1 
 
ChAT+ fiber segments within the microproximity of c-Fos+ pyramidal cells in 
control group were significantly longer than those within the microproximity of c-
Fos activated pyramidal cells in Layer V of IL in visual/HDB stimulation group 
(Mann-Whitney Test, p = 0.034, two-tailed, Table 3, 4), indicating that enhanced 
varicosity density within the vicinity of c-Fos activated pyramidal cells was not due 
to longer fiber length. ChAT+ fiber segments within the microproximity of pyramidal 
cells in mPFC in control animals were significantly longer than those within the 
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microproximity of pyramidal cells in visual/HDB stimulation group (Mann-Whitney 
Test, p = 0.034, two-tailed, Table 3, 4). 
 
No significant regional difference was found among the three subareas 
regarding ChAT+ fiber length in the vicinity of pyramidal cells in visual/HDB 
stimulation group (Wilcoxon signed-rank test, p > 0.05, two-tailed).  
 
Discussion 
 
The primary interest of the current study was to verify whether the density of 
axonal varicosities in a specific axonal segment was related to the level of local 
neuronal activity. To this purpose, segments of ChAT+ fibers stimulated repetitively 
were analyzed in relation to their vicinity to mPFC pyramidal cells expressing or not 
the early gene c-Fos. The results show different level of modulation of mPFC 
pyramidal cells by visual and HDB cholinergic inputs. Significant elevation of the 
density of ChAT+ varicosities within the microproximity of c-Fos+ pyramidal cells 
compared to those within the microproximity of nonactivated cells was 
demonstrated. This suggests dynamics of the varicosities along the axon relatively 
to local neuronal interaction. 
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Activity-dependent modulation of pyramidal cells by HDB input in layer 
V of mPFC 
 
5 to 9% of the pyramidal cells were c-Fos immunoreactive in the mPFC of 
visually stimulated rats which was significantly more than in control groups. They 
were significantly lower when compared either with visual/HDB stimulation group 
(70%) or HDB stimulation alone (50%) group, suggesting the strong c-Fos 
activation in the mPFC cortex was mainly due to HDB stimulation. The c-Fos 
activation of the pyramidal cells in the mPFC by visual stimulation alone was most 
probably due to post-synaptic activation brought upon by visual sensory input into 
the PFC from associational sensory cortices (Ongur and Price, 2000, Kim et al., 
2003, Fenske et al., 2006), as already reported (Ricciardi et al., 2009, Greenberg 
et al., 2010, Majeed et al., 2011). The strong c-Fos+ immunoreactivity elicited by 
HDB stimulation, most likely resulted from direct HDB projections to the mPFC 
cells and local fibers (Laplante et al., 2005). Such strong c-Fos activation after 
acute basal forebrain stimulation has already been reported in fronto-parietal 
cortex of rats (Kocharyan et al., 2008). Moreover, the pairing of visual and HDB 
stimulation induced significantly higher c-Fos immunoreactivity in mPFC than either 
visual stimulation alone or HDB stimulation alone, suggesting a potentiation of 
mPFC pyramidal cells response to sensory stimuli by cholinergic projections, as 
shown in other cortical areas (Ricciardi et al., 2009, Greenberg et al., 2010).  Thus, 
the c-Fos activation of pyramidal cells in the mPFC in visual/HDB stimulation rats 
represented a combination of both sensory and cholinergic activation, with HDB 
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stimulation contributing more than visual stimulation itself. The frontal cortical 
representation of visual stimuli was thus primarily enhanced by HDB input into 
mPFC (Dotigny et al., 2008, Thomsen et al., 2010), both of which were suggested 
as part of cognitive mechanism (Sarter et al., 2003, Weidner et al., 2009). Our 
results were consistent with the assumed role of cortical projecting cholinergic 
system from basal forebrain in facilitating extrinsic sensory stimuli (Sarter et al., 
2006, Burk et al., 2008, Deiana et al., 2010). Visual stimulation paired with HDB 
stimulation enhanced c-Fos+ activity on a large scale, indicating the potential role 
of HDB as an important relay station in enhancing frontal cortical representation of 
visual stimuli, consistent with basal forebrain‟s role in enhancement of cognitive 
functions (Zaborszky et al., 1999, Zaborszky and Duque, 2000, Ramanathan et al., 
2009). 
 
In HDB stimulation group, about 60% of c-Fos+ cells were glutamatergic. It 
has been found that most pyramidal cells (78 – 90%) in layer V of the mPFC were 
within the proximity of cholinergic fibers (Zhang et al., 2010), suggesting a conjoint 
activation of the pyramidal cells by sensory or associative afferents and cholinergic 
projections. The majority (65-78%) of the pyramidal cells of layer V were c-Fos+ in 
visual/HDB stimulated rats, consistent with the well-documented importance of 
pyramidal cells in cognition in the frontal cortex (Spruston, 2008, Arnsten, 2009, 
Goldwater et al., 2009, Stahl, 2009, Lopez-Gil et al.). Our study was focused on the 
cholinergic input from the HDB, but it should be noted that GABAergic or 
glutamatergic projections from the HDB (Henny and Jones, 2008) could also have 
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contributed to the c-Fos signal in mPFC. As well, only a moderate proportion of c-
Fos+ cells (40% in Cg1, 32% in PrL, and 29% in IL) were pyramidal cells in 
visual/HDB stimulation group, which might suggest the activation of other 
phenotypes of intracortical neurons (Wang et al., 2010). 
 
Dynamics of varicosities as an index of localized neuronal activity 
 
The density of ChAT+ varicosities within the vicinity of c-Fos+ activated 
pyramidal cells in visual/HDB stimulation group was significantly elevated 
compared to those within the vicinity of non-activated pyramidal cells either in 
visual/HDB stimulation group or in control group, a piece of evidence supporting 
the modulation of the pyramidal cell activity by HDB projections into the mPFC, and 
thus varicosity density being a good index for local neuronal activity. Consistently, 
no significant difference was found in the ChAT+ varicosity density within the 
microproximity of non-activated pyramidal cells between visual/HDB stimulation 
group and control group, indicating the increase of varicosity density within the 
microproximity of activated pyramidal cells in visual/HDB stimulation group was 
indeed due to relevant neuronal activity. Dendritic arbors of the pyramidal cell 
could not be visualized with our GluT(EAAC1) antibody, but it might be possible 
that this microproximity relationship includes axo-dendritic interactions since 
dendrites are filled of cholinergic receptors. It is probable that the c-Fos expression 
by pyramidal cells was induced by ACh, as c-Fos is not expressed in cholinergic 
lesioned animals in visual cortex (Dotigny et al., 2008). However, as the c-Fos 
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expression was maintained even one week after the last HDB stimulation, we 
suggest that there was also some backward crosstalk from the pyramidal cell to the 
cholinergic fibers. This crosstalk could involve local factors released from activated 
mPFC neurons, such as potassium, glutamate, neurotrophins which could maintain 
the state of activation of the cholinergic fibers. This is complementary to previous 
results suggesting that local neurons are able to induce ACh release from the 
cholinergic fiber terminals (Laplante et al., 2005, Parikh et al., 2008). Also, 
recurrent collaterals from the pyramidal cells might influence local cholinergic 
fibers. Stimulation paradigm is another factor which could affect the formation of 
new varicosities, such as the type, intensity and duration  of the stimuli (Lendvai et 
al., 2000, De Paola et al., 2003, Nikonenko et al., 2003), as well as the age of the 
animals (Lendvai et al., 2000). 
 
In order to elucidate whether the change in ChAT+ varicosity density was 
due to local factors or intrinsic axonal properties, the enrichment of ChAT+ 
varicosities in microproximity of c-Fos+ pyramidal cells in IL was quantified in visual 
stimulation alone or HDB stimulation alone conditions. In both cases, the density of 
ChAT varicosities was equivalent to the one in the visual/HDB group. This 
suggests both types of stimulation could contribute to the dynamics of ChAT+ 
varicosities and thus varicosities dynamics were due to interaction with local 
neurons rather than activation of the fiber per se. This is consistent with the fact 
that activation of HDB fibers did not result in increased varicosity density in 
microproximity to the non-activated pyramidal cells. Thus, it seems that different 
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types of stimuli could induce the same level of varicosity enrichment, which should 
be investigated further. 
 
Our previous findings demonstrated significant elevation of ChAT+ and 
tyrosine hydroxylase+ varicosities on fiber segments within reciprocal 
microproximity of each other in the mPFC of normal adult rats (Zhang et al., 2010), 
sustaining ACh/DA interaction evidences in this cortex. The present study verified 
that dynamics of ChAT+ varicosity density was related to the level of activity of 
pyramidal cells in the mPFC at a subcellular level, suggesting that the density of 
varicosity can be used as an index for local neuronal interaction (Fig. 5). Such 
plastic structural changes are extensively described in the dendritic arbor of 
pyramidal cells, where the dynamic and number of dendritic spines is modulated by 
local neuronal activity. In case of dendritic spines, repetitive activation of the 
synapses reinforces the strength of post and presynaptic elements and lead to 
duplication of the synapse (Larkum et al., 2004, Shu et al., 2007, Spruston, 2008) 
to favor improved postsynaptic activation. 
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Figure 5.  
 
 
 
Figure 5. Schematic illustration of hypothetic duplication of the en passant 
varicosities due to repetitive neuronal activation. Repetitive activation (grey 
lines) of the cholinergic neurons in HDB could lead to induction of c-Fos (blue core) 
activation of pyramidal cells (red triangle) in mPFC and duplication of the 
cholinergic varicosities on their projecting fibers in vicinity of activated pyramidal 
cells. Whether this gain of varicosities is reversible remains to be determined 
(question mark). Abbreviations: HDB: horizontal limb of the diagonal band; mPFC: 
medial prefrontal cortex. 
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As well, recent studies suggest that varicosities spacing patterns seems 
regulated according to synaptic plasticity (Shepherd et al., 2002, Stettler et al., 
2006) although some other studies propose that varicosities on axons from cortical 
neurons are formed and spaced in a regulated manner (Sabo et al., 2006). 
Varicosities on CA3-CA1 axonal shafts were found to be spaced non-uniformly 
along the axons. On short scales, varicosity spacing was found to be highly 
variable but not random (Shepherd and Harris, 1998, Shepherd et al., 2002). As 
well, synaptic boutons gain and loss were observed in adult visual cortex (Stettler 
et al., 2006). The higher density of ChAT+ varicosities on fiber segments 
innervating c-Fos+ activated pyramidal cells corroborate these previous 
hypotheses and link the density of varicosities to neuronal activity. Appearing of 
new en passant varicosities might be either due to formation de novo or 
mobilization of previously existing ones to new sites as fast as 1-2 h after 
stimulation as shown for presynaptic axonal terminals (Friedman et al., 2000, 
Colicos et al., 2001), and may be correlated to the turnover of other neuronal 
elements in the same microenvironment (Trachtenberg et al., 2002). We suggest 
that duplication of the en passant varicosities could happen in repetitive neuronal 
activation (Fig. 5). Whether this gain of varicosities is reversible remains to be 
determined, but previous studies tend to suggest it (Stettler et al., 2006). The 
length of the fiber segment sharing the microproximity with the activated cells was 
elevated in Cg1 of visually/HDB stimulated animals, suggesting that the surface of 
interaction between the fiber and the pyramidal cell increases after repetitive 
interaction. This increase of surface interaction and number of varicosity would 
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result in increased ACh diffusion and putatively increased cholinergic transmission 
efficiency, which is consistent with our previous findings of more appositions 
between cholinergic and dopaminergic fibers in Cg1 despite its smallest fiber 
density compared to PrL and IL of mPFC (Zhang et al., 2010). In contrast, the 
diameter of the ChAT+ varicosities did not vary significantly, which suggests these 
structural changes were not due to increased number of vesicles in the varicosity 
before it splits but rather to formation of a distinct swelling along the axon. 
However, no regional difference was found suggesting that the fiber/neuron 
interaction is similar in all the mPFC subregion examined. 
 
Conclusion 
 
Investigating the local variation in the density of varicosities is a useful tool 
to visualize at a subcellular level plastic changes induced by functional interaction 
between neuronal systems and better understand the specificity of the neuronal 
network.
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Abstract 
 
In rats, selective depletion of cholinergic interneurons in the ventral striatum 
(nucleus accumbens or N.Acc.) results in a heightened behavioural sensitivity to 
amphetamine and impaired sensorimotor gating processes, suggesting a hyper-
responsiveness to dopamine (DA) activation in the N.Acc. We hypothesized that 
local cholinergic depletion may also trigger more widespread functional alterations, 
particularly in prefrontal cortex (PFC). Adult male Sprague-Dawley rats were 
injected bilaterally in the N.Acc. with an immunotoxin targeting choline 
acetyltransferase (ChAT).  Two weeks later, they were trained and tested for 
working memory performance using the delayed alternation paradigm in the T-
maze.  The same animals were subsequently implanted with voltammetric 
recording electrodes in the ventromedial PFC to measure in vivo extracellular DA 
release in response to mild tail pinch stress. The PFC was also examined for 
density of tyrosine hydroxylase (TH)-labelled varicosities.  In parallel, we also 
measured post-mortem tissue content of dopamine in another cohort of control and 
lesioned rats.   
 
Anti-ChAT lesioned rats showed significant impairments in working memory 
performance across delay intervals and demonstrated significant reductions in 
mesocortical DA activation which correlated with cognitive (memory) impairments. 
TH-labelled varicosities were also reduced in cortical layer V relative to controls. 
The basal prefrontal cortical level of DA was not significantly affected.  These data 
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suggest that local and selective depletion of cholinergic interneurons in N.Acc. 
triggers widespread functional alterations in mesocorticolimbic DA systems, 
including cognitive processes known to be under cortical DA regulation. The 
functional relevance of ventral striatal cholinergic deficits for schizophrenic 
symptomatology is discussed. 
 
Key words: Schizophrenia, Animal model, Immunohistochemistry, Saporin, 
Ventral striatum, In vivo voltammetry. 
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Introduction 
 
The ventral striatum or nucleus accumbens (N.Acc.) is a convergence zone 
for an abundance of limbic and prefrontal inputs of vital importance in the execution 
of a variety of adaptive behaviours  (Brog et al., 1993;Goto and Grace, 
2008;Groenewegen et al., 1999;Sesack and Grace, 2010;Wright and 
Groenewegen, 1995). Mesolimbic dopamine (DA) neurons originating in the ventral 
tegmental area (VTA) interact anatomically and functionally with cholinergic 
interneurons of the N.Acc. to modulate the activities of GABAergic medium-sized 
spiny neurons (Di et al., 1994), which provide outputs to motor circuits for the 
execution of behaviour, and provide feedback to the DA cell body region of the 
VTA (Berendse et al., 1992;Heimer et al., 1991;Usuda et al., 1998;Zahm and 
Heimer, 1990).  
 
Acetylcholine (ACh) regulates N.Acc. circuits in a manner seemingly 
opposite to DA, possibly by dampening the effect of excessive DA release (Hoebel 
et al., 2007), and a delicate balance between striatal DA and ACh activity is 
required for optimal functioning (Aosaki et al., 2010;Hikida et al., 2003;McGeer and 
McGeer, 1977).  Using a novel cholinergic immunotoxin approach, we have shown 
that local and selective reduction in the number of cholinergic neurons in N.Acc. 
greatly enhances the behavioural activating effects of amphetamine (Laplante et 
al., 2011). The same lesions disrupted sensorimotor gating processes (impaired 
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prepulse inhibition of the acoustic startle response), an effect reversed by the DA 
antagonist haloperidol. Both the behavioural hyper-responsiveness and 
sensorimotor gating deficits are consistent with proposed roles of DA in the N.Acc. 
(Messier et al., 1992;Swerdlow et al., 1990). 
 
Reduced cholinergic function in N.Acc. may be especially relevant for 
schizophrenia, since studies of post mortem schizophrenic brains reported a 
significant loss of cholinergic cells, selective to the ventral striatum (Holt et al., 
1999;Holt et al., 2005). Given that schizophrenia is also characterized by hypo-
functional prefrontal DAergic activity and prefrontally mediated working memory 
deficits (Goldman-Rakic, 1994;Grace, 1991;Weinberger, 1987), our purpose was to 
examine whether local N.Acc. cholinergic depletion could induce similar deficits in 
rats. In other words, could this local, subcortical manipulation cause functional 
alterations in prefrontal cortical circuitry. 
 
 To this end, we first measured post-mortem brain tissue content of ACh and 
DA and relevant metabolites in PFC and N.Acc.  Secondly, we compared lesioned 
and control rats in a working memory task (delayed alternation in T-maze) and in 
the ability to activate the mesocortical DA system, as measured by the in vivo 
release of extracellular PFC DA in response to a mildly activating stressor. We also 
wanted to know if potential lesion-induced changes in PFC DA activation and 
working memory performance were correlated. Additionally, we examined 
immunoreactivity for tyrosine hydroxylase (TH) in PFC as further evidence of 
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possible functional changes in the mesocortical DA system following N.Acc. 
cholinergic depletion.  
 
Materials and methods 
 
Adult male Sprague-Dawley rats (250-275 g) were obtained from Charles 
River (St-Constant QC) and housed in pairs with food and water ad libitum in a 
temperature- and humidity-controlled room with a 12-h light/dark cycle. 
Experiments were carried out in accordance with the Canadian Council on Animal 
Care Guidelines and approved by our local ethics committee for animal 
experimentation. 
 
Lesion of cholinergic neurons 
As previously described (Laplante et al., 2011) rats were anesthetised with 
isoflurane 5% for induction and 3-4 % for maintenance in an oxygen flow of 0.6 
l/min with a Labvet apparatus (Dispomed Ltd, Joliette QC) and secured into a 
stereotaxic frame.  A 33 gauge needle was lowered into the N.Acc. at the 
coordinates: AP + 1.6 mm; ML  1.4 from bregma;  DV – 7.5  from dura (Paxinos 
and Watson, 1982).  A saporin-based IgG immunotoxin targeting choline 
acetyltransferase (ChAT; Advanced Targeting Systems Inc, San Diego CA; cat No 
IT-42) was administered bilaterally (0.5 l per side, 0.5 g/l in PBS) at a flow rate 
of 0.1 l/min for 5 min (n = 12 rats), allowing an additional five minutes for diffusion.  
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Because saporin is a ribosome-inactivating protein that has to be internalised to 
exert its toxicity (Stirpe et al., 1983), controls (n = 11) received the same 
amount/volume of saporin coupled to a rabbit IgG antibody (Advanced Targeting 
Systems Inc, cat No IT-35) with no ability to target neurons. Rats were sutured and 
returned to their home cage for a minimum of two weeks.   
 
Delayed alternation testing of working memory 
Delayed alternation testing was performed as previously described (Aultman 
and Moghaddam, 2001, Lipska et al., 2002) with modifications. The dimensions of 
the central arm of the T-maze, constructed with grey PVC, were 50 × 12 × 33 cm 
and 40 × 12 × 33 cm for each lateral arm, which were equipped with a sliding door. 
There was a 2 cm diameter hole at the end of each lateral arm (1 cm deep to 
conceal food from view). Food reward consisted of a piece of Kellogg‟s Froot 
Loops cereal.  
 
After three days of initial handling (5 min/day), rats were habituated to the 
maze for 8-10 days and were food restricted to 15 g/day throughout all phases of 
testing. For the first three days of habituation, rats were exposed to the T-maze for 
a 15 min exploration with the doors raised and food available in both arms. 
Subsequently, animals were exposed to 10 forced-alternation trials (one arm 
closed) per day until they would consistently run to the ends of the open arms for 
food (5-7 days).  
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Then delayed alternation training began. After a randomly chosen forced run 
into a baited arm and a 10 s delay interval in the holding cage, the animal was 
placed back in the central arm with access to both arms but with bait only in the 
arm opposite to that entered in the previous forced run. Upon entering a choice 
arm, that door was closed. Rats received ten trials (forced run–delayed choice) per 
day, with a 20 s inter-trial interval. Random arm sequences were used which 
included five forced runs to each of the right (R) and left (L) arms (e.g., R-R-L-R-L-
L-R-L-R-L). A different sequence was used each day, but sequences were the 
same for all rats. The maze was cleaned with 70% alcohol between rats. 
 
Testing began for three additional days and was conducted similarly, but 
using three different delay intervals (1-2, 10 or 40 s). On each of the three test 
days, rats received 8 trials at each delay interval in random sequence (24 
trials/day). Data are expressed as percentage of correct choices. After completion 
of testing, rats were again fed ad libitum. 
 
In vivo voltammetry (chronoamperommetry) 
One week following working memory testing, each rat underwent stereotaxic 
implantation (anesthesia as above) of a voltammetric recording electrode, 
optimized for the detection of DA. Electrode construction, calibration and recording 
parameters are similar to earlier studies (Stevenson et al., 2003, Laplante et al., 
2005, Zhang et al., 2005). Each electrochemical probe consisted of three 30μm-
diameter carbon fibers (Avco Specialty Materials, Lowell, MA) extending 50–100 
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μm beyond the epoxy-sealed tip of a pulled glass capillary. The fibers were coated 
with a 5% solution of the ion exchange polymer Nafion (Aldrich, Milwaukee, WI), 
promoting the exchange of cations like DA and repelling anions like ascorbic acid 
(AA) and 3,4-dihydroxyphenylacetic acid (DOPAC). Prior to implantation, 
electrodes were calibrated in 0.1 M PBS, pH 7.4, containing 250 μM AA to 
determine sensitivity and selectivity for DA against AA. All electrodes used had 
DA/AA selectivity ratios >1000:1 and a highly linear response (r > 0.997) to 
increasing concentrations of DA. Recording electrodes were implanted in the DA-
rich terminal area of the ventromedial PFC of the right hemisphere at the following 
coordinates: AP + 3.2 mm (re. Bregma); ML + 0.8 and DV - 4.2 mm (dura). Rats 
were also implanted with a Ag/AgCl reference electrode in the posterior cortical 
surface. Miniature pin connectors soldered to the voltammetric and reference 
electrodes were inserted into a Carleton connector (Ginder Scientific, Ottawa ON). 
This assembly was then secured with acrylic dental cement to three stainless steel 
screws threaded into the cranium. 
 
Stress testing 
Four days after surgery, rats were placed in specially constructed 
voltametric testing chambers (40 x 40 x 75 cm high) and the rats implants were 
connected to a headstage attached via shielded cable to a swivel at the top of the 
chamber, in turn linked to a computer-controlled chronoamperometric control box 
(FAST, Quanteon, Lexington, KY). Rats were habituated to the test chamber for 60 
min, which allowed the DA dependent signal to reach a stable baseline. A mild tail 
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pinch stress (5 min) was then initiated by placing a rubber-coated metal clip 
approximately an inch from the tip of the tail, with sufficient pressure that the rat 
could not shake it off. Recordings continued an additional 60 min after removal of 
the clip to ensure that stress-induced elevations in extracellular DA returned to 
baseline. The primary measure of interest was the peak or maximal increase in DA 
concentration relative to pre-stress baseline. Data points for DA levels were plotted 
at 5 min intervals over the session. A second identical test was conducted the 
following day to examine potential group differences in either habituation or 
sensitization of stress-induced DA activation. 
 
Electrochemical recordings and data format. 
An oxidative potential of +0.55 mV, with respect to the reference electrode, 
was applied to the electrode for 100 ms at 5 Hz. The amplitude of the resulting 
oxidation current was digitized and integrated over the last 80 ms of each pulse. 
Every 10 digitized current measures were summed, displayed on a video monitor 
at 2 s intervals, and converted to molar equivalent DA concentration based on the 
in vitro calibration factor for each electrode. The reduction current generated when 
the potential was set to 0.0 mV for 100 ms was similarly digitized and summed. 
With these conditions, the magnitude of the reduction current in response to 
increases in DA is typically 60–80% that of the oxidation current (Red/Ox ratio = 
0.6-0.8). In contrast, the oxidation of AA is nearly irreversible (Red/Ox ≈ 0) and 
DOPAC almost completely reversible (0.9-1.0), while norepinephrine (NE) and 
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serotonin (5-hydroxytryptophan; 5-HT) are 0.4-0.5 and 0.1-0.3, respectively 
(Gratton et al., 1989, Doherty and Gratton, 1992, 1996). 
 
As electrodes are individually calibrated in vitro with a DA standard, in vivo 
increases in oxidation current are expressed as μM (or nM) DA equivalents relative 
to the signal reference point at the onset of stress. This technique does not 
quantify an absolute baseline value or concentration of DA (pre-stress), rather the 
change in concentration as a function of stress. 
 
It must be noted that particularly in PFC, there may be a minor contribution 
of NE to the “DA-dependent” signal, although we believe this to be minimal. First, 
all recordings in the study had Red/Ox ratios in the 0.55-0.75 range, characteristic 
of DA. With the same technique and location in ventromedial PFC (where DA 
innervation is quite dense), stress-induced “DA” increases are pronounced, 
whereas slightly more dorsally where there is less DA, but similar amounts of NE, 
the stress response is greatly diminished (Doherty and Gratton, 1996). In the same 
study, the selective DA reuptake blocker GBR 12909 markedly increased the 
stress-induced signal increases in the ventromedial regions. Finally, the electrodes 
themselves are 3-4 times more sensitive (in vitro) to the same concentration of DA 
as NE (personal observations). Nonetheless, a possible contribution of NE to our 
recorded signal should still be considered when we refer to the DA response. 
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Perfusion and immunohistochemistry 
For complete details about tissue preparation, see Laplante et al. (2011). 
Rats were anesthetised with urethane (1.3 g/kg i.p., 0.25g/ml) and perfused 
transcardially with 0.9% NaCl (100 ml), followed by 700 ml of ice-cold 4% 
paraformaldehyde in 0.1 M sodium tetraborate buffer (pH 9.5). Brain coronal 
sections were cut at 30 μm in four one-in-four series throughout the extent of the 
PFC and N.Acc. Two series were immunostained for ChAT and tyrosine 
hydroxylase (TH) and one series was stained with thionin to confirm electrode 
placements in PFC. 
 
Brain sections were incubated with the primary antibody goat anti-ChAT 
1:2000 or rabbit anti-TH 1:1000 (Chemicon, Temecula CA) in KPBS with 0.3% 
triton X-100, 2% rabbit or goat serum for 48 h at 4º C. The primary antibodies were 
respectively detected using biotinylated rabbit anti-goat and goat anti-rabbit 
immunoglobulins (Vector Laboratories, Burlingame CA) 1:200 with avidin-DH-
biotinylated horseradish peroxidase-H-complex (Vectastain Elite ABC kit, Vector 
Laboratories) and diaminobenzidine (DAB) reaction product was developed using 
glucose oxidase method with nickel enhancement. 
 
Quantification 
The number of ChAT-positive neurons throughout the N.Acc. (15-18 
sections examined per rat) was quantified as previously detailed (Laplante et al., 
2011). To confirm whether the cholinergic cell loss was restricted to the N.Acc., we 
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quantified the density of ChAT expressing neurons in two brain structures adjacent 
to the injection site: the diagonal band and the dorsal striatum. Images of these 
regions were acquired with a CX41 microscope (Olympus, Markham, ON) 
equipped with an Infinity 2 camera (Lumenera Corporation, Ottawa ON). For the 
analysis, the most anterior sections of the diagonal band have been selected 
because of their closest proximity to the injection sites. Regarding the dorsal 
striatum, we selected sections at the level of the injection sites. The cell counting 
and surface measurement were performed with Image J software (National 
Institute of Health, Bethesda, MD). The analysis was performed on the entire 
surface of the diagonal band, but for the dorsal striatum the measurements were 
done in a 0.5 mm wide strip along the border with the N.Acc. 
 
Quantification of TH-labelled varicosities was carried out as previously 
described (Zhang et al., 2010, Zhang et al., 2011). Measurements were done in 
layer V of the ventromedial prefrontal cortex due to its high density of DA nerve 
terminals and the involvement of this cortical layer in the pathological states of 
schizophrenia (Black et al., 2004). Two sections at the level of medial PFC (2.7 
mm anterior to Bregma) were examined per animal. In total, 84 photographs from 
21 rats were acquired with a Leica DC 500 digital camera (Leica Microsystems, 
Herrbrugg, Switzerland), 40X lens (oil) and exported to Adobe Photoshop for 
further quantification. Each image corresponded to a field size of 0.09 mm2 (0.34 
mm x 0.27 mm), and 7.71 mm2 of cortical area, 0.1 mm above the ventral border 
of the infralimbic cortex and the second at 0.2 mm above toward the dorsal border 
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of infralimbic cortex. Quantification of the number of TH varicosities (ellipsoid 
swellings, usually with darker staining) on fiber segments in the plane of focus 
were carried out on microphotographs (Figure 7). The fibers (1 pixel thick line) and 
varicosities were reproduced and sharpened on another optical layer using 
Photoshop CS3 and the length was quantified on Image J (Rasband, 1997-2009). 
In total, 274.51 mm of TH fiber segments were evaluated. 
 
Post mortem tissue neurotransmitter levels. 
In a second experimental cohort, lesioned and control animals (12 per 
group) were sacrificed two weeks post-surgery by decapitation following rapid 
isoflurane anesthesia and brains were quickly removed and dissected on ice. 
Tissue sampling was performed as described previously (Duchesne et al., 2009) 
with slight modification. Although the main region of interest was the N.Acc (core 
and shell), the neighbouring dorsal striatum (caudate and putamen), PFC 
(infralimbic and prelimbic) were also investigated. Tissue samples for the left and 
right hemispheres were obtained using a 2mm diameter stainless steel punch and 
rapidly frozen at −80 ºC for later neurochemical analysis. Brain samples were 
thawed, weighed and sonicated in 500 μl of 0.12M perchloric acid. Homogenates 
were centrifuged at 13,000 g for 5 min and pellet was kept for western blot analysis 
whereas supernatants were filtered through 22 μm microcentrifuge filters (Fisher 
Sci.) for neurotransmitter quantification. 
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To determine the tissue content of ACh from the filtered supernatant, 50 μl 
were injected into an ESA Coulochem III high pressure liquid chromatography 
(HPLC) system-equipped separating column with post column enzymatic reaction 
and electrochemical detection (Day et al., 2001). ACh was separated from other 
molecules by an ACH-250 (ESA Inc, Chelmsford MA) column (250 × 3.2 mm). 
From this column, the eluate then passed through an ACH-SPR enzyme reactor 
(ESA) containing acetylcholinesterase (AChE; EC 3.1.1.7) and choline oxidase (EC 
1.1.3.17). The separated ACh and choline react with the enzymes to give 
stoichiometric yield of hydrogen peroxide, which is electrochemically detected with 
an analytical cell, model 5040 equipped with platinum electrode at a potential of 
+300 mV. As recommended by the manufacturer, the mobile phase consist of a 
100 mM aqueous sodium phosphate buffer, pH 8.0, containing 2 mM 1-
octanesulfonic acid sodium salt and 0.005% of reagent MB (provided by ESA) and 
is delivered at 0.35 ml/min by a dual piston pump (1525U; Waters, Milford MA) and 
is degassed online. With these conditions, ACh elutes at ∼8.5 minutes. Sample 
concentrations were calculated by comparison with known standards. ACh tissue 
levels are expressed as pmol/mg wet tissue weight. 
 
To quantify the catecholamines, 10 μl from the filtered supernatant were 
injected into an ESA Coulochem III high performance liquid chromatography 
system with electrochemical detection (HPLC-EC). Mobile phase and HPLC 
parameters were as previously described (Duchesne et al., 2009). The 
concentration of DA and its major metabolite DOPAC were computed based on 
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calibration curves with known amounts of standards. Tissue levels were expressed 
as pg/mg wet tissue weight. Levels of 5-HT and its metabolite 5-
hydroxyindoleacetic acid (5-HIAA) were also assessed. (Levels of norepinephrine 
and homovanillic acid were not easily quantified with the present protocol). 
 
Statistical analysis 
For the quantification of ChAT immunoreactive neurons and the 
quantification of neurotransmitters and their metabolites, two-way repeated-
measures analysis of variance (ANOVA) was conducted for the analysis of the 
main effect of experimental groups (lesion effect) and brain hemisphere as 
repeated-measures factor, and interaction between these two factors. Regarding 
TH-labelled varicosities, significant differences between experimental groups were 
determined by independent t-tests. For the first ten days of working memory 
testing, a two-way (ANOVA) was conducted with "lesion" as independent factor 
and "day" as repeated measures factor. On each of the three subsequent test 
days, similar ANOVAs were conducted with "delay interval" as the repeated 
measure. Voltammetry data for each day were presented and analysed as (5 min) 
time samples with repeated measures. The mean peak (maximal) DA responses 
were analysed with "day" as repeated measure. Post hoc Bonferonni tests were 
conducted following significant interactions. In addition, Pearson analyses were 
performed to examine correlations between DA responses and working memory 
performance within groups.  
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Results 
 
Cholinergic cell loss in N. Acc. 
Immunohistochemistry findings demonstrated that infusion of the anti-ChAT 
IgGsaporin toxin resulted in a mean reduction of 72 % in the number of neurons 
expressing ChAT within the N.Acc. relative to the rabbit IgG-saporin controls 
(Figure 1; F(1,21) = 65.32; p < 0.0001 for main effect of lesion). Depletion of 
cholinergic neurons was present in both core and shell of the N.Acc. but was 
restricted to this brain region as no reduction in ChAT neurons was observed in the 
diagonal band (Figure 2A; F(1,21) = 0.58; p = 0.45 for main effect of lesion) or the 
dorsal striatum (Figure 2B; F(1,21) = 2.53; p = 0.13 for main effect of lesion).  
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Figure 1: A) ChAT-expressing cells counted bilaterally throughout the extent of the 
N.Acc. Data represent mean ± SEM, (n = 11-12 in each group). Post-hoc analysis 
revealed significant differences between control and lesioned groups in both 
hemispheres (* p < 0.001). B) Representative sections of ChAT-immunostained 
tissues of N.Acc. from rabbit IgG-saporin-treated control rats and C) anti-ChAT 
IgG-saporin-treated rats. Scale = 200 μm. ac: anterior commissure. 
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Figure 2: Density of ChAT immunolabelled cells in the left and right sides of the A) 
diagonal band and B) dorsal striatum. Data represent mean ± SEM, (n = 11-12 in 
each group). No significant differences were found between control and lesioned 
groups in either of these adjacent brain regions, confirming the selectivity of lesions 
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in the N.Acc. Representative sections of ChAT-immunostained tissues of the 
diagonal band of a control (C) and lesioned rat (E) and dorsal striatum control (D) 
and lesion (F). Scale = 1 mm 
 
Delayed alternation performance in the T-maze 
During the ten days of delayed alternation testing (10 s delays), a significant main 
effect of lesion was observed (F(1,189) = 11.85, p = 0.0024), with anti-ChAT 
lesioned rats showing a consistently lower percentage of correct choices than 
controls, which achieved greater than 90% correct responding by day 3 (Figure 3). 
A main effect of day was also seen (F(9,189) = 4.73, p < 0.0001) reflecting the 
general improvement in performance, and there was no significant interaction 
between lesion and day (F(9,189) = 1.08, p = 0.377). 
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Figure 3: Performance in the T-maze for delayed-alternation training over ten 
consecutive days. Each rat was given 10 trials a day with an inter-trial delay of 10 
s. Data are expressed as percent of correct choices and represent means ± SEM 
(n = 11-12). Anti-ChAT lesioned rats showed significant impairments across the 
training period. See text for statistical details. 
 
Figure 4 shows the effects of lesions on working memory with different delay 
intervals. On day 1, controls outperformed lesioned rats across delays (lesion 
effect, F(1,42) = 8.30, p = 0.009). A main effect of delay (F(2,42) = 3.60, p = 0.036) 
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reflected the greater difficulty inherent with longer delays and there was no lesion x 
delay interaction (F(2,42) = 0.91, p = 0.41). Day 2 however, did not reveal a 
significant lesion effect (F(1,42) = 0.32, p = 0.58), as controls performed somewhat 
more poorly than usual, especially at short delays. The delay effect just failed to 
reach significance as well (F(2,42) = 2.97, p = 0.062) and the lesion x delay 
interaction was not significant (F(2,42) = 0.40, p = 0.67). Day 3 showed the same 
pattern as day 1 with significant effects of lesion (F(1,42) = 6.73, p = 0.017) and 
delay (F(2,42) = 10.29, p = 0.0002), but no interaction (F(2,42) = 0.51, p = 0.60). 
Taken together, lesioned animals showed substantial impairment in performance of 
the delayed alternation task. 
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Figure 4: Percent of correct choice during testing sessions for three consecutive 
days using three different delay periods within each day, A to C respectively. Data 
represent means ± SEM (n = 11-12). Lesioned rats were particularly impaired 
across delays on the first and third days of testing. See text for statistical details. 
 
 
In vivo voltammetry 
Three rats (2 controls, 1 lesion) were excluded from this analysis for defective or 
misplaced electrodes. Stress-induced increases in extracellular DA in PFC are 
shown in Figure 5. On the first stress test (Figure 5B), anti-ChAT lesioned rats 
showed significantly smaller increases in cortical DA release than controls (F(1,216) 
= 4.93, p = 0.0394). There were also significant effects of time (F(12,216) = 20.95, 
p < 0.0001) and lesion x time interaction (F(12,216) = 2.92, p = 0.0009). The group 
difference was especially pronounced at 5 minutes (around the time of the peak 
response). A similar pattern was seen on the second stress test (Figure 5C), 
although the main effect of lesion just missed significance (F(1,216) = 3.99, p = 
0.0612). Significant effects of time (F(12,216) = 15.97, p < 0.0001) and lesion x 
time interaction (F(12,216) = 1.89, p = 0.0369) were again observed, with the 
greatest group difference seen at the 10 min point. On both days, mean DA 
elevations were greater in controls than lesions from the first time point at 5 
minutes after stress onset until 45 minutes. Figure 5D shows the mean peaks DA 
responses, which typically occur for individual rats between 5 and 15 minutes from 
stress onset (actual data is collected every 2 s). A main effect of lesion was again 
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seen (F(1,18) = 6.75, p = 0.018) with no effect for days (repeated measure; F(1,18) 
= 0.67, p = 0.42) or lesion x day interaction (F(1,18) = 0.23, p = 0.63). Thus, anti-
ChAT lesioned rats showed consistently lower levels of DAergic activation relative 
to controls, and neither group sensitized nor habituated to the stressor on second 
exposure. 
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Figure 5: A) Histological representation of a coronal section of a rat brain stained 
with thionin demonstrating the location of the voltammetric recording electrode in 
the ventromedial prefrontal cortex (scale = 2 mm; the notch in the right lateral side 
is an intentional mark to identify the right hemisphere). All acceptable placements 
were located within the deep layers (4-6) of infralimbic or ventral prelimbic cortex. 
Extracellular DA release in the PFC of rats in response to 5 min tail pinch stress 
(black bar) on two consecutive days (B and C). Data are expressed as changes in 
electrochemical signal (nM DA equivalent) relative to pre-stress baseline (time 0). 
Anti-ChAT lesioned rats showed significant impairments in the ability to mount a 
mesocortical DA response to mild stress. See text for statistical details (*p < 0.05; 
**p < 0.01). D) Mean peak stress-induced increases in extracellular DA release. 
Data represent means ± SEM (n = 9-11). 
 
 
Correlations with cognitive performance  
As a measure of presumed working memory in the delayed alternation task, we 
averaged the performance on all trials with 40 s delays of the last 3 days of testing 
as this represents the greatest challenge to working memory. We then averaged 
the peak DA responses on both stress exposures. These variables were 
significantly correlated as shown in Figure 6, within the lesioned group (r(11) = 
0.629, p = 0.038), but not controls (r(9) = 0.238, p = 0.54). This means that rats 
with the greatest deficits in mesocortical DA activation also showed the greatest 
impairments in cognitive function. 
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Figure 6: Working memory and mesocortical DA activation in anti-ChAT lesioned 
rats. Memory performance (based on 40 s delays) was significantly correlated with 
the degree of DAergic activation, measured separately in response to mild stress 
(p = 0.038). This suggests that cognitive impairments in rats with N.Acc. cholinergic 
depletion may be dependent on deficits in mesocortical DA function. 
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PFC tyrosine hydroxylase (TH) labelling 
Layer V of infralimbic cortex was prominently innervated by TH fibers (Figure 7). 
These fibers were diffusedly distributed and constantly bore varicosities which 
appeared as ellipsoid swellings with darker staining compared to fiber segments 
devoid of varicosities. The density of TH varicosities was significantly decreased 
(11.2 %) in the lesioned rats compared to controls (T(19) = 2.83, p = 0.011). Fiber 
segment length also tended to be shorter in lesioned rats (2.79 ± 0.24 mm/0.09 
mm2) than controls (3.79 ± 0.61 mm/0.09 mm2), but this was not significant (T(19) 
= 1.58, p = 0.13), indicating the variation in the density of TH varicosities was not 
solely due to variation in fiber length. 
Figure 7 
 
Figure 7: Quantification of TH varicosity density on fiber segments in layer V of IL 
cortex in control (A-D) and lesioned (E-H) animals. Microphotographs were taken 
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and then analyzed using Photoshop. The varicosities on fiber segments are 
indicated by the black dots (B, D, F, H). A decreased density of varicosities was 
seen in segments of lesioned animals. Scale bar: 50 μm (A, B, E, F); 10 μm (C, D, 
G, H). The density of TH varicosities on fiber segments in layer V (I) was lower in 
lesioned animals compared to controls (* p = 0.011). Horizontal lines represent 
means for each group. 
 
 
Quantification of neurotransmitters in brain tissue 
In our second cohort of animals, the micro-injection of the anti-ChAT IgG-saporin 
toxin into the N. Acc resulted in an average 33.6 % reduction in the tissue level of 
ACh in this area relative to controls (Figure 8A F(1,22) = 19.17, p = 0.001 for the 
main effect of lesion). On the other hand, the level of ACh was not affected in the 
ventromedial PFC, nor in the adjacent dorsal striatum (Figure 8B,C). Thus the 
effects of the neurotoxic injection into accumbens only affected ACh levels locally, 
without affecting adjacent structures, confirming again the localization of lesion 
effects on cholinergic function. In the N.Acc, although there is an apparent 
decrease in the levels of both DA and DOPAC in lesioned animals (see Table I), 
these trends did not reach statistical significance (for the main effect of lesion DA: 
F(1,22) = 2.71, p = 0.11 DOPAC: F(1,22) = 1.81, p = 0.19). In the dorsal striatum 
(Table II), the DOPAC/DA ratio was found to be lower in lesion rats compared to 
controls (F(1,22) = 5.56, p = 0.028 for the main effect of lesion). This appears to be 
the combined result of slightly lower DOPAC levels and slightly higher DA levels in 
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the lesioned group, although individually non-significant. In the PFC (Table III), no 
DAergic measures of basal tissue content were significantly altered as a function of 
N.Acc. cholinergic lesions (although serotonin turnover did appear to be slightly 
affected by lesions, F(1,22) = 5.12, p = 0.034). Therefore, in terms of basal tissue 
measures of DAergic systems, cholinergic depletion in N.Acc. appears to have 
somewhat greater effects on subcortical regions than on the mesocortical DA 
system. 
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Figure 8: Quantification of ACh in brain tissue sample from A) nucleus accumbens 
B) dorsal striatum and C) prefrontal cortex. There was a significant reduction in 
ACh level in the N.Acc in rats injected with the ChAT immunotoxin. Data represent 
mean ± SEM, (n = 12 in each group). * p < 0.05; **p < 0.01 relative to control 
hemisphere. 
 
Table I : Catecholamine levels in the nucleus accumbens 
Nucleus 
Accumbens 
                Control                              
        Left                    Right                          
        α-ChAT Lesion    
       Left                  Right 
 
 DA 
DOPAC 
DOPAC / DA ratio 
 
   8485 ± 710           8808 ± 563 
   2091 ± 154           2290 ± 181 
  0.263 ± 0.026       0.275 ± 0.032 
 
 7479 ± 429          7558 ± 544         
 1859 ± 119          2052 ± 148 
0.257 ± 0.023      0.299 ± 0.042 
 
5-HT 
5-HIAA 
5-HT / 5-HIAA ratio           
 
   623.7 ± 76.1        669.0 ± 80.4 
   761.7 ± 99.2        810.4 ± 82.6 
     1.29 ± 0.08          1.34 ± 0.08   
 
699.7 ± 58.5        754.8 ± 99.9                 
902.1 ± 62.3        869.6 ± 46.4  
  1.33 ± 0.07          1.30 ± 0.12 
 
Data represent mean ± SEM. (n = 12 per group)    
H: main effect of brain hemisphere.  L: main effect of lesion 
Value are in pg / mg tissue 
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Table II: Catecholamine levels in the Dorsal Striatum 
Dorsal Striatum                 Control                              
        Left                    Right                          
   α-ChAT Lesion    
Left                 Right 
 
 
 
 DA 
DOPAC 
DOPAC / DA ratio 
 
13857 ± 739        13447 ± 843 
  1928 ± 135          1841 ± 156 
 0.139 ± 0.007      0.136 ± 0.006 
 
14016 ± 723       14047 ± 1136         
  1651 ± 162         1653 ± 114 
 0.117 ± 0.008     0.120 ± 0.006 
 
 
 
 
L p = 0.028 
 
5-HT 
5-HIAA 
5-HT / 5-HIAA ratio           
 
 366.5 ± 26.3        392.9 ± 39.9 
 501.4 ± 31.1        493.1 ± 35.0 
   1.42 ± 0.101        1.31 ± 0.084   
 
 399.4 ± 38.8       392.6 ± 28.2 
505.9 ± 40.4        509.6 ± 40.8  
  1.32 ± 0.087        1.32 ± 0.088 
 
 
 
Data represent mean ± SEM. (n = 12 per group)    
H: main effect of brain hemisphere.  L: main effect of lesion 
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Table III: Catecholamine levels in the prefrontal cortex 
Prefrontal Cortex                 Control                              
        Left                    Right                          
       α-ChAT Lesion    
       Left                  Right 
 
 
 
 DA 
DOPAC 
DOPAC / DA ratio 
 
   144.4 ± 9.8         138.2 ± 15.2 
     39.3 ± 3.0           29.9 ± 4.4 
   0.278 ± 0.019     0.231 ± 0.036 
 
 157.3 ± 23.7       136.0 ± 9.3         
   33.7 ± 6.1           28.5 ± 2.7 
 0.254 ± 0.054     0.217 ± 0.020 
 
 
 
H p = 0.089 
 
 
 
 
5-HT 
5-HIAA 
5-HT / 5-HIAA ratio           
 
   650.7 ± 30.9        607.2 ± 37.6 
   370.5 ± 16.9        405.5 ± 34.9 
   0.579 ± 0.030      0.669 ± 0.043   
 
709.0 ± 42.5        619.6 ± 38.9                 
367.9 ± 24.9        347.4 ± 20.7  
0.520 ± 0.017      0.570 ± 0.025 
 
H p = 0.033 
 
 
 
L p = 0.034 
H p = 0.009 
 
Data represent mean ± SEM. (n = 12 per group)    
H: main effect of brain hemisphere.  L: main effect of lesion 
Value are in pg / mg tissue 
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Discussion 
 
Similar to our previous report (Laplante et al., 2011), the infusion of anti-
ChAT saporin immunotoxin produced substantial depletion of cholinergic neurons 
(72%) within the N.Acc., but not in adjacent structures (diagonal band and dorsal 
striatum).  The extent of local depletion was greater than in our initial study (44%), 
possibly due to variability in toxin efficacy or the slightly longer time between 
injection and sacrifice in the present study (7-8 weeks compared to 5-6 weeks).  
The same lesion procedure also decreased significantly the intra-accumbens level 
of ACh without affecting the choline level, in accordance with cholinergic cell loss.  
Similarly to the immunohistochemistry results, the ACh levels were unchanged in 
dorsal striatum and PFC, the latter receiving cholinergic input from the horizontal 
limb of the diagonal band (Bigl et al., 1982;Laplante et al., 2005). Together, these 
data indicate that lesions are restricted to the injection site.  
 
The quantification of ACh in cerebral tissue is a suitable complementary 
method to immunohistochemistry to determine the extent of the lesions.  These two 
approaches require different processing (fresh tissue dissection for the former vs 
fixation for the latter) and are therefore exclusive.  Immunohistochemistry confers 
an optimal spatial resolution to assess neuronal loss in sub-regions.  On the other 
hand, the fresh tissue sampling for HPLC analysis may include N.Acc tissue not 
irrigated by the toxin injection which then, might dilute the observable lesion effect.   
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Cholinergic depletion was associated with working memory deficits along 
with physiological and structural alterations in the PFC.  The importance of central 
cholinergic systems on working memory processes is well documented, especially 
in relation to the hippocampus or PFC (Durkin, 1994;Givens and Olton, 
1990;Granon et al., 1995;Hironaka et al., 2001). The striatum also plays a 
regulatory role on working memory functions as ablation of cholinergic interneurons 
in striatum in mice using a transgenic/immunotoxic approach also resulted in 
impaired spatial delayed alternation performance in the T-maze (Kitabatake et al., 
2003). The N.Acc. has previously been implicated in memory processes as well 
(Setlow, 1997) and electrolytic or excitotoxic lesions of this structure result in 
working memory impairment (Gal et al., 1997;Jongen-Relo et al., 2003). Our 
results suggest that cholinergic mechanisms in the N.Acc. may be specifically 
involved in working memory processes. We have also observed (in separate 
animals) that the same cholinergic lesions impair spontaneous alternation 
behaviour in a cross maze as a further implication of the role of cholinergic 
mechanisms in N.Acc. in working memory processes (unpublished observations).  
 
The present findings also suggest that these effects may be mediated by 
feedback pathways modulating mesocortical DA function. Thus cholinergic 
depletion in N.Acc. exerts not only local effects, but triggers a functional 
reorganization in corticolimbic DA circuits, reflected in a deficient response of 
mesocortical DA neurons (originating in the VTA) to salient stimuli such as mild 
stress. Neuronal projections from the N.Acc to the substantia nigra pars compacta 
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(Nauta et al., 1978), the origin of the nigrostriatal DAergic pathway, provide an 
anatomical substrate for a possible regulation of DA activity in the dorsal striatum 
by the N.Acc.    
 
Electrophysiological studies in monkeys (Schultz et al., 1993) have shown 
that the DA neurons of the VTA (moreso than substantia nigra) respond phasically 
to salient reward and conditioned cues in a manner essential for learning delayed 
responding tasks. Working memory tasks like the one presently employed, rely on 
the functional integrity of the PFC (Aultman and Moghaddam, 2001;Sanchez-
Santed et al., 1997). Prefrontal cortical DA is a key regulator of these cognitive 
functions in rats and monkeys (Brozoski et al., 1979;Granon et al., 2000;Seamans 
et al., 1998;Williams and Goldman-Rakic, 1995), and best cognitive performance 
requires an optimal window of cortical DA activity (D1-mediated), as either too 
much or too little DA results in poor working memory (Chudasama and Robbins, 
2004;Goldman-Rakic et al., 2000;Zahrt et al., 1997). This relationship is further 
supported by the positive correlation we report between working memory 
performance and PFC DA activation in response to mild stress within the lesioned 
animals. The fact that this correlation was not significant in controls may indicate 
that the latter were already performing at close to optimal levels and thus were less 
variable.  
 
In the PFC and N.Acc, the tissue levels of DA, DOPAC and the DOPAC/DA 
ratio were not significantly affected after local lesions of cholinergic neurons 
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indicating an unaltered tonic DA activity.  Similar observations have been reported 
in the striatum after cholinergic cells depletion (Kaneko et al., 2000). Our lesions 
have affected the serotonergic transmission only in the PFC.  However, more 
investigations are required to fully describe this effect.  
 
Cholinergic depletion within the N.Acc. also led to structural alterations in 
the PFC, reflected in reduced density of TH varicosities. It has been suggested that 
the density of varicosities in an axonal segment are related to the level of neuronal 
activity (Zhang et al., 2011;Zhang et al., 2010). Consistent with cortical plasticity, 
synaptic varicosities or “boutons” are dynamic structures that can be formed and 
removed (De, V et al., 2006;Stettler et al., 2006).  Similar to experience-induced 
increases in the number of dendritic spines and axonal synaptic boutons (Stettler 
et al., 2006), it is possible that the present reduction of TH-labelled varicosities 
reflects a hypoactive mesocortical DA (and/or noradrenaline) system, although the 
nature of these effects requires further mechanistic studies. 
 
Deficient mesocortical DA function may itself induce or exacerbate a hyper-
responsivity to mesolimbic DA stimulation. In this view, several studies have 
demonstrated that direct depletion of PFC DA leads to heightened responsiveness 
of N.Acc. in response to pharmacological challenge or stress (Deutch, 
1992;Mitchell and Gratton, 1992;Pycock et al., 1980). However, the notion that 
striatal or N.Acc. manipulations can lead to functional alterations in PFC has 
received less attention (Simpson et al., 2010). Some data have suggested changes 
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in PFC functions and innervation patterns with the latter direction of modulation 
(Deniau et al., 1994;Kitabatake et al., 2003;Middleton and Strick, 2002). Of 
particular interest, it has been shown that transient over-expression of D2 receptors 
restricted to striatum of mice induced impairments in working memory and 
behavioural flexibility, and reduced cortical DA turnover (Kellendonk et al., 2006). 
Such findings are consistent with recent proposals that striatal dysfunction may be 
of primary importance to the cognitive deficits of schizophrenia (Simpson et al., 
2010). Consistent with existing theories of schizophrenia, where a hypofunctional 
cortical DA state exists with hyper-responsive subcortical (striatal) DA function 
(Davis et al., 1991;Grace, 1991;Weinberger, 1987), the latter view proposes 
pathways by which the latter could causally lead to the former. One prominent 
possibility involves modulation of striatal outputs to the mesocortical DA cell bodies 
of the VTA and one proposed means of dampening this system (in addition to 
striatal D2 overactivity), was diminished activity of cholinergic striatal interneurons 
(Simpson et al., 2010). 
 
We presently confirm that local N.Acc. cholinergic depletion leads to 
impaired mesocortical DA activation in freely behaving rats, quite possibly via 
feedback from the N.Acc. to the VTA. If such a cholinergic deficit also leads to a 
similar reduction in activity in the mesolimbic DA projection back to the N.Acc., one 
might expect a compensatory upregulation of postsynaptic DA receptors 
(prominently D2-like) in the N.Acc. Such a scenario would explain the behavioural 
hyper-responsiveness to amphetamine we have previously shown as a 
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consequence of these lesions (Laplante et al., 2011). This would also be consistent 
with the lesion-induced deficits in sensorimotor gating and their reversal by the D2 
antagonist haloperidol(Laplante et al., 2011). Taken together, it suggests that 
reduction in N.Acc. cholinergic function not only induces local effects, but is 
capable of inducing widespread functional changes in cortical/subcortical networks. 
 
The present cholinergic lesions in the N.Acc. may be particularly relevant to 
the neuropathology of schizophrenia, as post-mortem studies in schizophrenic 
patients have revealed lower densities of ChAT immuno-labelled neurons (Holt et 
al., 1999) and ChAT mRNA expressing cells in the ventral striatum (Holt et al., 
2005). Cholinergic cell density in the nucleus basalis of Meynert (el Mallakh et al., 
1991) and the pedunculopontine nucleus (German et al., 1999) were comparatively 
unaffected in schizophrenic brains. Loss of intra-accumbens cholinergic 
interneurons (Boissiere et al., 1997;Lehericy et al., 1989;Selden et al., 1994) and 
working memory impairments (Kensinger et al., 2003) have also been reported in 
Alzheimer‟s disease. However, the damage to forebrain cholinergic systems is far 
more extensive and nonspecific (Davies and Maloney, 1976;Lehericy et al., 
1993;Whitehouse et al., 1982).   
 
In summary, selective depletion of cholinergic interneurons in N.Acc. leads 
to impairment in working memory and reduced activation of the mesocortical DA 
projection to the PFC which is consistent with theories of schizophrenia (Davis et 
al., 1991;Grace, 1991;Weinberger, 1987).  Moreover, these lesions also reduced 
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the number of TH-labelled varicosities in PFC.  Interestingly, reductions in TH-
labeled axon length and varicosities have been observed in the DA-rich, deep 
cortical layers in schizophrenic patients (Akil et al., 1999;Benes et al., 1997).  The 
present data add to previous findings that the same manipulation in N.Acc. induced 
a behavioural hypersensitivity to psychostimulants and impaired sensorimotor 
gating (reversed by antipsychotics). Given the relevance of the above processes to 
schizophrenia (Lipska and Weinberger, 2000), we propose that the selective loss 
of cholinergic neurons seen in the ventral striatum (Holt et al., 2005;Holt et al., 
1999) may be of greater causal significance to a wide array of schizophrenic 
symptomatology than is commonly appreciated. Future studies will further 
investigate the mechanistic consequences of this neuropathological defect. 
 
Abbreviations: 5-HIAA, 5-hydroxyindoleacetic acid; 5-HT, serotonin or 5-
hydroxytryptophan ACh, acetylcholine; ChAT, choline acetyltransferase; DA, 
dopamine; DOPAC 3,4-dihydroxyphenylacetic acid; N.Acc., nucleus accumbens; 
PFC, prefrontal cortex; TH, tyrosine hydroxylase; VTA, ventral tegmental area.  
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CHAPTER V 
 
GENERAL DISCUSSION 
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In the present research, the immediate microenvironment (Descarries et al., 
1997) of cholinergic fibers, dopaminergic fibers, and pyramidal cells in the rat 
mPFC were investigated to evaluate the functional potential of their spatial 
interrelationships via the mode of diffuse transmission. The results demonstrated a 
preferential microproximity between cholinergic fibers, dopaminergic fibers and 
pyramidal cells in the rat mPFC. The functional importance of these spatial 
interrelationships was supported by the dynamics of cholinergic and dopaminergic 
en passant varicosities associated with relevant neuronal activity in these different 
transmitter systems. 
. 
V.1 Viewing and analyzing the microenvironment of ACh 
and DA fibers and pyramidal cells via confocal 
microscopy 
 
V.1.1 Viewing 3D microenvironment via confocal microscopy 
 
It is important to explore into three-dimensional extracellular 
microenvironment of a neuronal modulator to understand its position and function 
in a continuous neuronal network. There is a wealth of 3D information on the 
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immediate microenvironment of transmitters like ACh or DA. Confocal microscope 
offers a means to collect substantial high resolution 3D information in single slices 
(Hibbs, 2004), and multi-fluorophore labeling makes it possible to study the 
neuroanatomical interactions among multiple types of neuronal elements. 
Therefore, in the present studies the three-dimensional distance between each 
system was assessed and the plasticity of axon varicosities on ACh and DA fibers 
in relation to their reciprocal microproximity was examined via confocal 
microscopy.  
 
V.1.2 Definition of microproximity 
 
The 3 µm maximal distance between two neuronal elements used in this 
research was a conservative estimate of the radius of a sphere within which ACh 
concentration should be able to induce significant effects at receptors. Thus far, 
data on the temporal and spatial parameters of diffuse transmission are scarce. 
However,  “fast nonsynaptic transmission” has been proposed for ACh (Lendvai 
and Vizi, 2008) due to the quick hydrolysis action of AChE (Descarries et al., 1997, 
Descarries, 1998, Sarter et al., 2009b). In addition, a variety of factors may limit the 
real sphere of influence from the diffusion of a diffusible neurotransmitter, such as 
the tortuosity of diffusion, the diffusion coefficient of the neurotransmitter, the 
sensitivity and location of specific receptors, and the heterogeneity of the 
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neurotransmitter concentrations in the microenvironment (Nicholson and Sykova, 
1998, Peters and Michael, 2000). 
 
V.2 A novel way of analyzing neuroanatomical 
interactions between fibers 
 
This research provides a novel way to analyze the neuroanatomical 
interrelationships between fiber systems. So far as we know, these are the first 
studies that endeavored to analyze and quantify the three-dimensional 
microenvironment of different neuronal elements (Chapter II), as well of the 
plasticity of fiber morphology within this spatial distance associated with relevant 
local neuronal activities (Chapter III). Due to this novel aspect of our research, it 
was notpossible to apply traditional stereology to the analysis and quantification of 
the 3D microproximity between neuronal elements. Traditional stereology uses 
unbiased methods to estimate first-order stereological parameters such as length, 
number and surface area (Peters and Michael, 2000), but it is not adapted for 
analyzing or quantifying the 3D microproximity between neuronal elements 
(personal communication with Dr. Peter R. Mouton on his stereology workshop in 
Montreal, 2008). For this reason, the analysis and quantification of the 
neuroanatomical data in the present research were accomplished semi-manually, 
usingthe confocal software Leica lite and LAS AF lite. This labor intensive task was 
carried out in each ROI, to measure the distance between each fiber segment as 
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well as the diameter of each varicosity along each individual fiber segment within 
and outside the defined microproximity to the related element under investigation.  
 
V.3 Axon varicosity – a link between the modulators and 
other elements in a neuronal network  
 
V.3.1 Combined modulation of the pyramidal neuronal output by 
ACh and DA  
 
72% to 80% pyramidal cells examined in layer V were within microproximity 
of both ACh and DA fibers (Chapter II), suggesting the possibility of a combined 
modulation by ACh and DA of the output of pyramidal cells to subcortical areas 
(Shipp, 2007). This was consistent with previous findings that each pyramidal 
neuron having D4R mRNA co-expresses M1R mRNA, which indicates combination 
of cholinergic and dopaminergic signaling pathways at the single cell level 
(Vysokanov et al., 1998). Convergence of actions from different neurotransmitters 
is a general feature of neurotransmitter responses in the CNS (McCormick, 1992). 
The prefrontal pyramidal cells in Layer V potentially process and integrate large 
numbers of diverse inputs to their soma, dendrites and axon to to process the 
extrinsic sensory stimuli and send them to subcortical structures (Spruston, 2008).  
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V.3.2 Functional importance of the microproximity between 
cholinergic fiber segments and dopaminergic fiber segments 
 
V.3.2.1 Modulation of DA on ACh in the mPFC 
 
Only a small proportion (9–18%) of the cholinergic fibers was observed to be 
within 3 µm from dopaminergic fibers in the rat mPFC (Chapter II), suggesting a 
relatively weak direct influence of DA on cortical cholinergic fibers. This might be 
because DA doesn‟t exhibit robust diffuse transmission features in the mPFC as 
ACh does. A relatively high synaptic incidence was indeed observed for the DA 
varicosities in rat anteromedial cortex (Seguela et al., 1988). Nevertheless, there 
was an enrichment of the density of dopaminergic axon varicosities (Chapter II) in 
the microproximity of ACh fibers, raising the probability of direct biological effects of 
DA on the small proportion of cholinergic fibers within such a distance. 
 
Cortical dopaminergic activity could induce ACh release via indirect 
pathways in a neuronal network. Dopaminergic neurons could release glutamate 
as co-transmitter (Trudeau, 2004, Descarries et al., 2008) to modulate pyramidal 
neuronal activity, which could subsequently exert the modulatory effect on 
cholinergic fibers within the immediate microenvironment. In addition, nAChRs 
present on glutamate terminals can increase glutamate release which coordinately 
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induces dopamine release from neighboring boutons (Livingstone et al., 2010). 
Dopaminergic neurons in VTA project to BF and their axons synapse on BF 
cholinergic cells. Therefore, DA may modulate BF cholinergic neurons which 
project to innervate the mPFC (Gaykema and Zaborszky, 1996, Smiley et al., 
1999).  
 
V.3.2.2 Modulation of ACh on DA in the mPFC 
 
20-40% of dopaminergic fibers were within the 3 µm of microproximity of 
cholinergic fibers in the rat mPFC, with an enrichment of cholinergic varicosities 
juxtaposed to those dopaminergic fibers (Chapter II), raising the possibility of direct 
axo-axonic modulation of ACh on DA transmission in the mPFC. nAChRs may 
have an extrasynaptic location on presynaptic DA terminals to exert their 
modulatory influence in the CNS (Jones et al., 2001, Wonnacott et al., 2006, Exley 
and Cragg, 2008).  
 
On the other hand, ACh could also exert its influence on DA transmission 
via indirect pathways. For example, α7 nAChR have an indirect effect on DA 
release through the modulation of amino acid transmitters (Wonnacott et al., 2006). 
ACh may modulate GABA release onto DA neurons via nAChRs present on 
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presynaptic GABAergic boutons within the VTA to exert its impact on mPFC 
dopaminergic fibers (Yang et al., 2011).  
 
V.3.3 Enrichment of cholinergic axonal varicosities following local 
neuronal activity in pyramidal cells and ascending HDB 
cholinergic projection in the mPFC 
 
Concomitant visual and HDB electrical stimulation resulted in significant 
increases in the cholinergic varicosity density within the vicinity of c-Fos activated 
pyramidal cells in the rat mPFC, compared to the vicinity of nonactivated pyramidal 
cells in the same group and the control group (Chapter III). This observation 
indicated that a change in axon varicosity density is associated with neuronal 
activity supported by the relationship between pyramidal cells in the mPFC and 
ascending HDB cholinergic fibers (Luiten et al., 1987, Gaykema et al., 1990).  
 
HDB electrical stimulation provided a major contribution to the c-Fos 
expression of pyramidal neurons in the mPFC of rats with visual and HDB 
stimulation. The facilitation of PFC pyramidal cell activity by the BF cholinergic 
prefrontal projection is part of the “Bottom-up” mechanism underlying attention 
(Sarter et al., 2003), which could be executed via ascending cholinergic fibers 
innervating pyramidal cells, probably through presynaptic nAChRs on 
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glutamatergic terminals (Fabian-Fine et al., 2001, Jones and Wonnacott, 2004, 
Rousseau et al., 2005), and mAChRs expressed by mPFC pyramidal neurons 
(Vysokanov et al., 1998). 
 
On the other hand, the enhanced pyramidal activity could also exert some 
backward crosstalk to the cholinergic fibers in its vicinity and contribute to the 
dynamics of the cholinergic varicosities. Pyramidal neuronal activity modulates the 
cholinergic effects in the PFC (Briand et al., 2007, Quarta et al., 2007, Parikh and 
Sarter, 2008). The NMDA receptor antagonist CPP was shown to remove the tonic 
glutamate activity, which antagonizes the attentional enhancing properties of 
nicotine (Quarta et al., 2007), in keeping with a reciprocal modulation between 
cholinergic afferents and the pyramidal cells they innervate.  
 
V.3.4 The association between relevant neuronal activity and 
dopaminergic axonal varicosity density in the rat mPFC following 
cholinergic depletion of the nucleus accumbens 
 
Cholinergic depletion within the nucleus accumbens (N.Acc.) resulted in 
significant impairments in working memory performance and reduced density of 
dopaminergic varicosities in the infralimbic cortex, reflecting a hypoactive 
mesocortical DA system. This DA hypoactivity was probably induced via feedback 
from the N.Acc. to the VTA (Chapter IV).  
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On the other hand, decreased DA activity presumably disrupts the 
interaction between DA and pyramidal cells. Disruption of the glutamate-dopamine 
interaction may alter the function of PFC and its interconnected areas, such as the 
N.Acc., leading to an impairment of memory performance (Del Arco and Mora, 
2005).  It has been proposed that a D2R-mGluR interaction in PFC modulates the 
activity of the meso-limbic dopamine system (Del Arco and Mora, 2005), consistent 
with our findings that  the majority of pyramidal cells expressed D2R markers in the 
mPFC of Drd1a-tdTomato/Drd2-EGFP transgenic mice (Chapter II). 
 
V.3.5 Combining the modulators and the neuronal networks to 
achieve a delicate balance through dynamics of en passant 
varicosity density 
 
The present research demonstrates that an enrichment of cholinergic and 
dopaminergic varicosities on fiber segments in the rat mPFC is associated with 
neuronal activity resulting from the interaction between the cholinergic and 
dopaminergic systems and pyramidal cells in a large and complex neuronal 
network. Although this hypothetic network is composed of subsystems 
interconnected at different levels such as fibers and soma from different regions 
(Figure V.1, and Chapter II-IV), it is still a simplistic picture. The ascending BF 
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cholinergic projection and the VTA dopaminergic projection converge onto the 
same pyramidal cells in the mPFC to co-modulate the PFC output facilitating 
cognitive processes. The PFC in turn sends glutamatergic (and GABAergic) 
projections to the BF to control its activity. The PFC also sends glutamatergic 
projection to the N.Acc., whose own activity is under the control of the glutamate-
dopamine balance in PFC.   
 
Figure V.1  
 
 
Figure V.1 Schematic illustration of a hypothetic neuronal network 
composed of different neuronal subsystems. The PFC receives BF cholinergic 
projection and VTA dopaminergic projections. These two ascending fiber systems 
converge on the same pyramidal cells in the PFC to co-modulate the PFC output to 
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facilitate cognitive processes. PFC in turn sends glutamatergic projections to the 
BF for its control of the subcortical areas. The PFC also sends glutamatergic 
projection to the nucleus accumbens, which is therefore controlled by the 
glutamate-dopamine balance in PFC.  This figure is a modified version from (Sarter 
et al., 2009b) Abbreviations: ACh: acetylcholine; BF: basal forebrain; DA: 
dopamine; GABA:  ץ-aminobutyric acid; Glu: glutamate; NAc: nucleus accumbens; 
PFC: prefrontal cortex; VTA: ventral tegmental area 
 
It is noteworthy that the varicosity density of cholinergic fibers depended on 
local neuronal activity resulting from the reciprocal interaction between cholinergic 
fibers and the pyramidal neurons of the mPFC (Chapter III). Thus, the structural 
plasticity of axon varicosities reflects how the modulators and the neuronal 
networks are intimately combined to achieve the processing of specific aspects of 
cognitive functions. The density of axon varicosities thus makes the link between 
different levels in a network – the cellular level (the axonal zone of interaction) and 
the system level (ascending cholinergic fibers from HDB and pyramidal cells of 
mPFC), and combines the impact of ACh diffuse transmission and the prefrontal 
neuronal network to achieve the required balance for cognitive processing (Figure 
V.2). 
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 Figure V.2 
 
 
 
Figure V.2 Density of axon varicosities – a link between the cellular 
level and the systemic levels in the prefrontal neuronal network. The 
dynamics of cholinergic axon varicosities combines the impact of ACh diffuse 
transmission and the prefrontal neuronal network in the delicate processing of 
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cognitive functions. Top panel: Enhanced varicosity density on cholinergic and 
dopaminergic fiber segments within their microproximity, compared to those 
outside this microproximity. Bottom panel: Enrichment of cholinergic axon 
varicosities due to local neuronal activity from the ACh-pyramidal neuron 
interaction in the mPFC. Abbreviations: ACh: acetylcholine; BF: basal forebrain; 
DA: dopamine; HDB: horizontal limb of the diagonal band of Broca; mPFC: medial 
prefrontal cortex; VTA: ventral tegmental area   
 
V.4 The importance of ACh diffuse transmission  
 
The results from this research confirm the importance of ACh diffuse 
transmission in the PFC (Umbriaco et al., 1994, Descarries et al., 1997, 
Descarries, 1998). The enrichment of cholinergic axon varicosities within the 
vicinity of dopaminergic fibers (Chapter 2) or activated pyramidal cells (Chapter 3) 
suggests that diffuse transmission of ACh is an integral component of the 
prefrontal executive network.  Therefore, the diffusion of ACh and its impactin the 
PFC should not be ignored any more, and needs to be taken into consideration in 
neuroscience research, particularly when trying to examine the cellular 
mechanisms correlated with specific aspects of cognitive functions.  Denying or 
ignoring the existence of nonsynaptic transmission of ACh will over-simplify the 
principles and structures of a complex and intricate prefrontal neuronal network, 
and lead to incomplete and biased conclusions. 
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The dynamic view of axonal interactions in the present research suggests a 
novel way to investigate the functional role of diffuse transmission of a neuronal 
transmitter in brain. This might be the first step leading to novel experimental 
designs exploring the specific features of ACh diffuse transmission in the PFC in 
vivo. Novel techniques also need to be developed to suit the needs of studying the 
properties of diffuse transmission in the CNS. For example, much neuroanatomical 
software could be modified to examine and quantify certain anatomical features of 
the 3D extracellular space in the microenvironment.  
 
V.5 Future perspective 
 
V.5.1 Particularly to this research 
 
         The present Ph.D. research has analyzed the spatial interrelationships 
between the three transmitter-dependent systems in the mPFC, the cholinergic and 
dopaminergic systems and the pyramidal cells. However, there is a strong 
probability that for a specific aspect of cognitive function, the neuronal network 
involved consists of much more than these three systems. For example, the 
GABAergic system interacts with ACh, DA and pyramidal cells in the PFC to exert 
a crucial role in cognitive functions (Wang et al., 2002, Zhong et al., 2003, Guidotti 
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et al., 2005, Balla et al., 2009, Del Arco et al., 2011). However, the capacity of our 
current confocal microscopes limits the simultaneous visualization of no more than 
three fluorophores. It would be interesting to evaluate the reciprocal spatial 
distance among more than three neuronal elements in the PFC.  
 
         It would be also of great interest to design novel experiments to test if 
different types of extrinsic stimuli could have different impacts on the densities of 
axonal varicosities. In this research the visual stimulation and HDB electrical 
stimulation produced the same effects on the density of axon varicosities along 
fibers. However, better knowledge of the functional pathways in the circuits will be 
needed to test such a hypothesis. The pathways of visual stimulation processing in 
the PFC and the pathways of cholinergic activation need to be further clarified, as 
well as the properties of other neuronal elements induced by such stimulation, 
such as the cholinergic receptors present on pyramidal cells, dopaminergic fibers 
and other fiber systems in the PFC, and GABAergic neurons in their vicinity. 
Besides, knowledge of both the temporal and spatial properties of those neuronal 
elements induced by such stimulation is required.  
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V.5.2 General speculation 
 
Much more remains to be understood about how the prefrontal neuronal 
components are connected with each other, and how the diffuse transmission of 
neuromodulators are combined at the different levels in a neuronal network to 
process extrinsic and intrinsic stimuli. To be able to close the explanatory gap 
between the local neuronal activity at the subcellular level in the PFC and the 
animal‟s behavior level, further knowledge about the diffusive properties of a 
neurotransmitter and the structure of the extracellular space are required, as well 
as extensive knowledge of the specific properties of neuronal components of the 
executive network at different levels (subcellular, cellular, and of the systems).  
Novel techniques will need to be developed to explore the network properties. 
Those techniques should not “truncate” some levels and limit the scientific 
observation at specific levels. 
 
An open mind is also necessary to comprehend the extensive complexity of 
the neuronal network, which is composed of probably incredibly large numbers of 
systems and subsystems, plus a big variety of neuronal modulatory substances. 
The specific aspects of cognitive functions are generated from a delicate balance 
of all the components of a neuronal network. Disruption at any point in this network 
might lead to complication of many components, and thus detrimental to certain 
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cognitive processes. Innovative ways of thinking are required to link between 
different levels of a network and integrate all the data from different components to 
generate a whole picture.  
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